<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <!-- AppResources meta begin -->
        <script type="text/javascript">var ncbi_startTime = new Date();</script>
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="">

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="pmc"><meta name="ncbi_pdid" content="article"><meta name="ncbi_acc" content=""><meta name="ncbi_domain" content="nihpa"><meta name="ncbi_report" content="record"><meta name="ncbi_type" content="fulltext"><meta name="ncbi_objectid" content=""><meta name="ncbi_pcid" content="/articles/PMC5821586/"><meta name="ncbi_app" content="pmc">
        <!-- Logger end -->
        
        <title>Bone mineral density in children with acute lymphoblastic leukemia</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css"><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE"><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5821586/"><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/"><meta name="citation_journal_title" content="Cancer"><meta name="citation_title" content="Bone mineral density in children with acute lymphoblastic leukemia"><meta name="citation_authors" content="Hiroto Inaba, Xueyuan Cao, Alice Han, John C. Panetta, Kirsten K. Ness, Monika L. Metzger, Jeffrey E. Rubnitz, Raul C. Ribeiro, John T. Sandlund, Sima Jeha, Cheng Cheng, Ching-Hon Pui, Mary V. Relling, Sue C. Kaste"><meta name="citation_date" content="1 March 2018"><meta name="citation_issue" content="5"><meta name="citation_volume" content="124"><meta name="citation_firstpage" content="1025"><meta name="citation_doi" content="10.1002/cncr.31184"><meta name="citation_abstract_html_url" content="/pmc/articles/PMC5821586/?report=abstract"><meta name="citation_pmid" content="29266176"><meta name="DC.Title" content="Bone mineral density in children with acute lymphoblastic leukemia"><meta name="DC.Type" content="Text"><meta name="DC.Publisher" content="NIH Public Access"><meta name="DC.Contributor" content="Hiroto Inaba"><meta name="DC.Contributor" content="Xueyuan Cao"><meta name="DC.Contributor" content="Alice Han"><meta name="DC.Contributor" content="John C. Panetta"><meta name="DC.Contributor" content="Kirsten K. Ness"><meta name="DC.Contributor" content="Monika L. Metzger"><meta name="DC.Contributor" content="Jeffrey E. Rubnitz"><meta name="DC.Contributor" content="Raul C. Ribeiro"><meta name="DC.Contributor" content="John T. Sandlund"><meta name="DC.Contributor" content="Sima Jeha"><meta name="DC.Contributor" content="Cheng Cheng"><meta name="DC.Contributor" content="Ching-Hon Pui"><meta name="DC.Contributor" content="Mary V. Relling"><meta name="DC.Contributor" content="Sue C. Kaste"><meta name="DC.Date" content="2018 Mar 1"><meta name="DC.Identifier" content="10.1002/cncr.31184"><meta name="DC.Language" content="en"><meta property="og:title" content="Bone mineral density in children with acute lymphoblastic leukemia"><meta property="og:type" content="article"><meta property="og:description" content="Children with acute lymphoblastic leukemia (ALL) can develop reduced bone mineral density (BMD). However, data from patients treated on a frontline regimen without cranial irradiation are limited, and no genome-wide analysis has been reported.Lumbar BMDs ..."><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5821586/"><meta property="og:site_name" content="PubMed Central (PMC)"><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png"><meta name="twitter:card" content="summary"><meta name="twitter:site" content="@ncbi"><meta name="ncbi_feature" content="associated_data"><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css"><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print"><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/'"><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css"><script type="text/javascript" src="/core/mathjax/2.6.1/MathJax.js?config=/corehtml/pmc/js/mathjax-config-classic.3.4.js"></script><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-hhspa.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">
        div.pmc_para_cit li.highlight,
        div.pmc_para_cit li.highlight .one_line_source
        { background: #E0E0E0; }
        a.bibr.highlight { background: #E0E0E0; } 
      </style><meta name="cited_in_systematic_reviews" content=""><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC5821586/epub/"><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC5821586/pdf/nihms926145.pdf">

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico"><meta name="ncbi_phid" content="CE8D1C79DD5A5081000000000985057A.m_8">
<meta name="referrer" content="origin-when-cross-origin"><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css"><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print"><script async="1" src="https://www.google-analytics.com/analytics.js"></script><style type="text/css">.MathJax_Preview {color: #888}
#MathJax_Message {position: fixed; left: 1px; bottom: 2px; background-color: #E6E6E6; border: 1px solid #959595; margin: 0px; padding: 2px 8px; z-index: 102; color: black; font-size: 80%; width: auto; white-space: nowrap}
#MathJax_MSIE_Frame {position: absolute; top: 0; left: 0; width: 0px; z-index: 101; border: 0px; margin: 0px; padding: 0px}
.MathJax_Error {color: #CC0000; font-style: italic}
</style><style type="text/css">.MathJax_Hover_Frame {border-radius: .25em; -webkit-border-radius: .25em; -moz-border-radius: .25em; -khtml-border-radius: .25em; box-shadow: 0px 0px 15px #83A; -webkit-box-shadow: 0px 0px 15px #83A; -moz-box-shadow: 0px 0px 15px #83A; -khtml-box-shadow: 0px 0px 15px #83A; border: 1px solid #A6D ! important; display: inline-block; position: absolute}
.MathJax_Menu_Button .MathJax_Hover_Arrow {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 4px; -webkit-border-radius: 4px; -moz-border-radius: 4px; -khtml-border-radius: 4px; font-family: 'Courier New',Courier; font-size: 9px; color: #F0F0F0}
.MathJax_Menu_Button .MathJax_Hover_Arrow span {display: block; background-color: #AAA; border: 1px solid; border-radius: 3px; line-height: 0; padding: 4px}
.MathJax_Hover_Arrow:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_Hover_Arrow:hover span {background-color: #CCC!important}
</style><style type="text/css">#MathJax_Zoom {position: absolute; background-color: #F0F0F0; overflow: auto; display: block; z-index: 301; padding: .5em; border: 1px solid black; margin: 0; font-weight: normal; font-style: normal; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; -webkit-box-sizing: content-box; -moz-box-sizing: content-box; box-sizing: content-box; box-shadow: 5px 5px 15px #AAAAAA; -webkit-box-shadow: 5px 5px 15px #AAAAAA; -moz-box-shadow: 5px 5px 15px #AAAAAA; -khtml-box-shadow: 5px 5px 15px #AAAAAA; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_ZoomOverlay {position: absolute; left: 0; top: 0; z-index: 300; display: inline-block; width: 100%; height: 100%; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
#MathJax_ZoomFrame {position: relative; display: inline-block; height: 0; width: 0}
#MathJax_ZoomEventTrap {position: absolute; left: 0; top: 0; z-index: 302; display: inline-block; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
</style><style type="text/css">#MathJax_About {position: fixed; left: 50%; width: auto; text-align: center; border: 3px outset; padding: 1em 2em; background-color: #DDDDDD; color: black; cursor: default; font-family: message-box; font-size: 120%; font-style: normal; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 15px; -webkit-border-radius: 15px; -moz-border-radius: 15px; -khtml-border-radius: 15px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_About.MathJax_MousePost {outline: none}
.MathJax_Menu {position: absolute; background-color: white; color: black; width: auto; padding: 5px 0px; border: 1px solid #CCCCCC; margin: 0; cursor: default; font: menu; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 5px; -webkit-border-radius: 5px; -moz-border-radius: 5px; -khtml-border-radius: 5px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
.MathJax_MenuItem {padding: 1px 2em; background: transparent}
.MathJax_MenuArrow {position: absolute; right: .5em; padding-top: .25em; color: #666666; font-size: .75em}
.MathJax_MenuActive .MathJax_MenuArrow {color: white}
.MathJax_MenuArrow.RTL {left: .5em; right: auto}
.MathJax_MenuCheck {position: absolute; left: .7em}
.MathJax_MenuCheck.RTL {right: .7em; left: auto}
.MathJax_MenuRadioCheck {position: absolute; left: .7em}
.MathJax_MenuRadioCheck.RTL {right: .7em; left: auto}
.MathJax_MenuLabel {padding: 1px 2em 3px 1.33em; font-style: italic}
.MathJax_MenuRule {border-top: 1px solid #DDDDDD; margin: 4px 3px}
.MathJax_MenuDisabled {color: GrayText}
.MathJax_MenuActive {background-color: #606872; color: white}
.MathJax_MenuDisabled:focus, .MathJax_MenuLabel:focus {background-color: #E8E8E8}
.MathJax_ContextMenu:focus {outline: none}
.MathJax_ContextMenu .MathJax_MenuItem:focus {outline: none}
#MathJax_AboutClose {top: .2em; right: .2em}
.MathJax_Menu .MathJax_MenuClose {top: -10px; left: -10px}
.MathJax_MenuClose {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; font-family: 'Courier New',Courier; font-size: 24px; color: #F0F0F0}
.MathJax_MenuClose span {display: block; background-color: #AAA; border: 1.5px solid; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; line-height: 0; padding: 8px 0 6px}
.MathJax_MenuClose:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_MenuClose:hover span {background-color: #CCC!important}
.MathJax_MenuClose:hover:focus {outline: none}
</style></head>
    <body class="article" id="ui-ncbiexternallink-4"><div id="MathJax_Message" style="display: none;"></div>
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list ui-ncbibasicmenu orientation_hort" id="navcontent" role="menubar"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt" role="presentation"><a class="ui-ncbimenu-link-first" href="/" role="menuitem" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo"></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources" tabindex="-1" role="menuitem">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto" tabindex="-1" role="menuitem">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi" style="top: -0.4em;"><iframe src="https://eutils.ncbi.nlm.nih.gov/entrez/eutils/emyncbi.fcgi?cmd=htmlportal&amp;currenturl=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5821586%2F" style="border:none; height:2.5em; width:40em;" scrolling="no"></iframe></div></div>
                            <div class="header">
    <div class="res_logo">
  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>
  <div class="NLMLogo">
    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>
    <br>
    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>
  </div>
</div>
    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" class="last" data-ac_dict="pmc-search-autocomplete">PMC</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><div class="jig-ncbiclearbutton-wrap ui-ncbiclearbutton-wrap box-shadow"><input name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'pmc-search-autocomplete',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'yes'" aria-haspopup="true" aria-autocomplete="list" role="textbox" type="text"><a class="reset" href="#" style="visibility: hidden;"><img src="/core/jig/1.14.8/img/clear.png" alt="Clear input"></a></div></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/pmc/advanced/">Advanced</a>
                    </li><li>
                        <a href="/pmc/journals/">Journal list</a>
                    </li><li class="help">
                        <a target="_blank" href="/books/NBK3825/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <div class="container">
    <div id="maincontent" class="content eight_col col">
        <div class="navlink-box">
            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="article-entrez-filter"><a href="/pmc/?term=hhs%20author%20manuscript[filter]" class="navlink">HHS Author Manuscripts</a></li><li class="accid">PMC5821586</li></ul>
        </div>

        <!-- Journal banner -->
        <div class="pmc-page-banner whole_rhythm"><div><img src="/corehtml/pmc/pmcgifs/logo-hhspa.png" alt="Logo of nihpa" usemap="#logo-imagemap"><map id="logo-imagemap" name="logo-imagemap"><area shape="rect" coords="0,57,255,75" alt="About Author manuscripts" title="About Author manuscripts" href="https://www.ncbi.nlm.nih.gov/pmc/about/authorms.html" ref="https://www.ncbi.nlm.nih.gov/pmc/about/authorms.html"><area shape="rect" coords="256,57,500,75" alt="Submit a manuscript" title="Submit a manuscript" href="https://www.nihms.nih.gov/" ref="reftype=publisher&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="rect" coords="0,0,499,74" alt="HHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;" title="HHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;" href="https://www.ncbi.nlm.nih.gov/pmc/about/public-access/" ref="reftype=publisher&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"></map></div> </div>
        
        <!--component id='MainPortlet' label='search-reference'/-->
        
        <!-- Book content -->
        <div class="">
            
        
            
            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden'" id="ui-ncbiinpagenav-1"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><span role="menubar"><a href="#" role="menuitem" aria-expanded="false" aria-haspopup="true">Cancer</a></span>. Author manuscript; available in PMC 2019 Mar 1.</div><div></div><div>Published in final edited form as:</div><div style="margin-left:1em"><div class="fm-vol-iss-date"><a href="/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;retmode=ref&amp;cmd=prlinks&amp;id=29266176" target="pmc_ext" ref="reftype=publisher&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CArticle%7CFree%20Access"><span class="cit">Cancer. 2018 Mar 1; 124(5): 1025–1035. </span></a></div><span class="fm-vol-iss-date">Published online 2017 Dec 19. </span> <span class="doi">doi:&nbsp;<a href="//dx.doi.org/10.1002%2Fcncr.31184" target="pmc_ext" ref="reftype=other&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1002/cncr.31184</a></span></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC5821586</span></div><div class="fm-citation-manuscriptid"><span class="fm-citation-ids-label">NIHMSID: </span><span>NIHMS926145</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/29266176">29266176</a></div></div></div></div><h1 class="content-title">Bone mineral density in children with acute lymphoblastic leukemia</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Inaba%20H%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29266176" class="affpopup" co-rid="_co_idm139927702193360" co-class="co-affbox">Hiroto Inaba</a>, MD, PhD,<sup>1,</sup><sup>2</sup> <a href="/pubmed/?term=Cao%20X%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29266176" class="affpopup" co-rid="_co_idm139927753928656" co-class="co-affbox">Xueyuan Cao</a>, PhD,<sup>3,</sup><sup>4</sup> <a href="/pubmed/?term=Han%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29266176" class="affpopup" co-rid="_co_idm139927699516240" co-class="co-affbox">Alice Han</a>,<sup>1</sup> <a href="/pubmed/?term=Panetta%20JC%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29266176" class="affpopup" co-rid="_co_idm139927699514256" co-class="co-affbox">John C. Panetta</a>, PhD,<sup>5</sup> <a href="/pubmed/?term=Ness%20KK%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29266176" class="affpopup" co-rid="_co_idm139927702559600" co-class="co-affbox">Kirsten K. Ness</a>, PhD,<sup>6</sup> <a href="/pubmed/?term=Metzger%20ML%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29266176" class="affpopup" co-rid="_co_idm139927713234816" co-class="co-affbox">Monika L. Metzger</a>, MD,<sup>1,</sup><sup>2</sup> <a href="/pubmed/?term=Rubnitz%20JE%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29266176" class="affpopup" co-rid="_co_idm139927713646720" co-class="co-affbox">Jeffrey E. Rubnitz</a>, MD, PhD,<sup>1,</sup><sup>2</sup> <a href="/pubmed/?term=Ribeiro%20RC%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29266176" class="affpopup" co-rid="_co_idm139927715751712" co-class="co-affbox">Raul C. Ribeiro</a>, MD,<sup>1,</sup><sup>2</sup> <a href="/pubmed/?term=Sandlund%20JT%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29266176" class="affpopup" co-rid="_co_idm139927698644320" co-class="co-affbox">John T. Sandlund</a>, MD,<sup>1,</sup><sup>2</sup> <a href="/pubmed/?term=Jeha%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29266176" class="affpopup" co-rid="_co_idm139927698641344" co-class="co-affbox">Sima Jeha</a>, MD,<sup>1,</sup><sup>2</sup> <a href="/pubmed/?term=Cheng%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29266176" class="affpopup" co-rid="_co_idm139927703303744" co-class="co-affbox">Cheng Cheng</a>, PhD,<sup>3</sup> <a href="/pubmed/?term=Pui%20CH%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29266176" class="affpopup" co-rid="_co_idm139927715044848" co-class="co-affbox">Ching-Hon Pui</a>, MD,<sup>1,</sup><sup>2</sup> <a href="/pubmed/?term=Relling%20MV%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29266176" class="affpopup" co-rid="_co_idm139927702671280" co-class="co-affbox">Mary V. Relling</a>, PharmD,<sup>5,</sup><sup>7</sup> and  <a href="/pubmed/?term=Kaste%20SC%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29266176" class="affpopup" co-rid="_co_idm139927698784576" co-class="co-affbox">Sue C. Kaste</a>, DO<sup>8,</sup><sup>9</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm139927702193360"><h3 class="no_margin">Hiroto Inaba</h3><p>  <sup>1</sup>Department of Oncology, St. Jude Children’s Research Hospital, Memphis, Tennessee</p><p>  <sup>2</sup>Department of Pediatrics, University of Tennessee Health Science Center, Memphis, Tennessee</p><div>Find articles by <a href="/pubmed/?term=Inaba%20H%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29266176">Hiroto Inaba</a></div></div><div id="_co_idm139927753928656"><h3 class="no_margin">Xueyuan Cao</h3><p>  <sup>3</sup>Department of Biostatistics, St. Jude Children’s Research Hospital, Memphis, Tennessee</p><p>  <sup>4</sup>Department of Acute and Tertiary Care, University of Tennessee Health Science Center, Memphis, Tennessee</p><div>Find articles by <a href="/pubmed/?term=Cao%20X%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29266176">Xueyuan Cao</a></div></div><div id="_co_idm139927699516240"><h3 class="no_margin">Alice Han</h3><p>  <sup>1</sup>Department of Oncology, St. Jude Children’s Research Hospital, Memphis, Tennessee</p><div>Find articles by <a href="/pubmed/?term=Han%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29266176">Alice Han</a></div></div><div id="_co_idm139927699514256"><h3 class="no_margin">John C. Panetta</h3><p>  <sup>5</sup>Department of Pharmaceutical Sciences, St. Jude Children’s Research Hospital, Memphis, Tennessee</p><div>Find articles by <a href="/pubmed/?term=Panetta%20JC%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29266176">John C. Panetta</a></div></div><div id="_co_idm139927702559600"><h3 class="no_margin">Kirsten K. Ness</h3><p>  <sup>6</sup>Department of Epidemiology and Cancer Control, St. Jude Children’s Research Hospital, Memphis, Tennessee</p><div>Find articles by <a href="/pubmed/?term=Ness%20KK%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29266176">Kirsten K. Ness</a></div></div><div id="_co_idm139927713234816"><h3 class="no_margin">Monika L. Metzger</h3><p>  <sup>1</sup>Department of Oncology, St. Jude Children’s Research Hospital, Memphis, Tennessee</p><p>  <sup>2</sup>Department of Pediatrics, University of Tennessee Health Science Center, Memphis, Tennessee</p><div>Find articles by <a href="/pubmed/?term=Metzger%20ML%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29266176">Monika L. Metzger</a></div></div><div id="_co_idm139927713646720"><h3 class="no_margin">Jeffrey E. Rubnitz</h3><p>  <sup>1</sup>Department of Oncology, St. Jude Children’s Research Hospital, Memphis, Tennessee</p><p>  <sup>2</sup>Department of Pediatrics, University of Tennessee Health Science Center, Memphis, Tennessee</p><div>Find articles by <a href="/pubmed/?term=Rubnitz%20JE%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29266176">Jeffrey E. Rubnitz</a></div></div><div id="_co_idm139927715751712"><h3 class="no_margin">Raul C. Ribeiro</h3><p>  <sup>1</sup>Department of Oncology, St. Jude Children’s Research Hospital, Memphis, Tennessee</p><p>  <sup>2</sup>Department of Pediatrics, University of Tennessee Health Science Center, Memphis, Tennessee</p><div>Find articles by <a href="/pubmed/?term=Ribeiro%20RC%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29266176">Raul C. Ribeiro</a></div></div><div id="_co_idm139927698644320"><h3 class="no_margin">John T. Sandlund</h3><p>  <sup>1</sup>Department of Oncology, St. Jude Children’s Research Hospital, Memphis, Tennessee</p><p>  <sup>2</sup>Department of Pediatrics, University of Tennessee Health Science Center, Memphis, Tennessee</p><div>Find articles by <a href="/pubmed/?term=Sandlund%20JT%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29266176">John T. Sandlund</a></div></div><div id="_co_idm139927698641344"><h3 class="no_margin">Sima Jeha</h3><p>  <sup>1</sup>Department of Oncology, St. Jude Children’s Research Hospital, Memphis, Tennessee</p><p>  <sup>2</sup>Department of Pediatrics, University of Tennessee Health Science Center, Memphis, Tennessee</p><div>Find articles by <a href="/pubmed/?term=Jeha%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29266176">Sima Jeha</a></div></div><div id="_co_idm139927703303744"><h3 class="no_margin">Cheng Cheng</h3><p>  <sup>3</sup>Department of Biostatistics, St. Jude Children’s Research Hospital, Memphis, Tennessee</p><div>Find articles by <a href="/pubmed/?term=Cheng%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29266176">Cheng Cheng</a></div></div><div id="_co_idm139927715044848"><h3 class="no_margin">Ching-Hon Pui</h3><p>  <sup>1</sup>Department of Oncology, St. Jude Children’s Research Hospital, Memphis, Tennessee</p><p>  <sup>2</sup>Department of Pediatrics, University of Tennessee Health Science Center, Memphis, Tennessee</p><div>Find articles by <a href="/pubmed/?term=Pui%20CH%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29266176">Ching-Hon Pui</a></div></div><div id="_co_idm139927702671280"><h3 class="no_margin">Mary V. Relling</h3><p>  <sup>5</sup>Department of Pharmaceutical Sciences, St. Jude Children’s Research Hospital, Memphis, Tennessee</p><p>  <sup>7</sup>Department of Clinical Pharmacy, University of Tennessee Health Science Center, Memphis, Tennessee</p><div>Find articles by <a href="/pubmed/?term=Relling%20MV%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29266176">Mary V. Relling</a></div></div><div id="_co_idm139927698784576"><h3 class="no_margin">Sue C. Kaste</h3><p>  <sup>8</sup>Department of Diagnostic Imaging, St. Jude Children’s Research Hospital, Memphis, Tennessee</p><p>  <sup>9</sup>Department of Radiology, University of Tennessee Health Science Center, Memphis, Tennessee</p><div>Find articles by <a href="/pubmed/?term=Kaste%20SC%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29266176">Sue C. Kaste</a></div></div></div></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm139927703766208_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm139927703766208_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm139927703766208_ai" style="display:none"><div class="fm-affl" id="A1" lang="en">  <sup>1</sup>Department of Oncology, St. Jude Children’s Research Hospital, Memphis, Tennessee</div><div class="fm-affl" id="A2" lang="en">  <sup>2</sup>Department of Pediatrics, University of Tennessee Health Science Center, Memphis, Tennessee</div><div class="fm-affl" id="A3" lang="en">  <sup>3</sup>Department of Biostatistics, St. Jude Children’s Research Hospital, Memphis, Tennessee</div><div class="fm-affl" id="A4" lang="en">  <sup>4</sup>Department of Acute and Tertiary Care, University of Tennessee Health Science Center, Memphis, Tennessee</div><div class="fm-affl" id="A5" lang="en">  <sup>5</sup>Department of Pharmaceutical Sciences, St. Jude Children’s Research Hospital, Memphis, Tennessee</div><div class="fm-affl" id="A6" lang="en">  <sup>6</sup>Department of Epidemiology and Cancer Control, St. Jude Children’s Research Hospital, Memphis, Tennessee</div><div class="fm-affl" id="A7" lang="en">  <sup>7</sup>Department of Clinical Pharmacy, University of Tennessee Health Science Center, Memphis, Tennessee</div><div class="fm-affl" id="A8" lang="en">  <sup>8</sup>Department of Diagnostic Imaging, St. Jude Children’s Research Hospital, Memphis, Tennessee</div><div class="fm-affl" id="A9" lang="en">  <sup>9</sup>Department of Radiology, University of Tennessee Health Science Center, Memphis, Tennessee</div><div id="FN1">Corresponding author: Hiroto Inaba, MD, PhD, Department of Oncology, St. Jude Children’s Research Hospital, 262 Danny Thomas Place, Mail Stop 260, Memphis, TN 38105-2794, USA. Tel: +1-901-595-3144; Fax: +1-901-521-9005; <a href="mailto:dev@null" data-email="gro.edujts@abani.otorih" class="oemail">gro.edujts@abani.otorih</a></div><div id="FN2">M. V. Relling and S. C. Kaste contributed equally to this work.</div></div><div class="fm-article-notes fm-panel half_rhythm"></div><div class="permissions fm-panel half_rhythm hide" id="idm139927703766208_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright notice</a> </div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div>The publisher's final edited version of this article is available free at <a href="/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;retmode=ref&amp;cmd=prlinks&amp;id=29266176" target="pmc_ext" ref="reftype=publisher&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CArticle%7CFree%20Access">Cancer</a></div><div>See other articles in PMC that <a href="/pmc/articles/PMC5821586/citedby/">cite</a> the published article.</div></div></div></div><div class="sec"></div><div id="ass-data" class="tsec fm-sec whole_rhythm" data-section="Featured_PMC_Datacitation"><div class="goto jig-ncbiinpagenav-goto-container"><span role="menubar"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="menuitem" aria-expanded="false" aria-haspopup="true">Go to:</a></span></div><h2 class="ui-helper-clearfix" id="ui-ncbiinpagenav-heading-3">Associated Data</h2><dl data-count="3" class="box-data-suppmats whole_rhythm no_bottom_margin"><dt><a href="#" rid="data-suppmats" data-ga-action="click_feat_toggler" data-ga-label="Supplementary Materials" class="pmctoggle">Supplementary Materials</a></dt><dd id="data-suppmats" style="display: none;"><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>Supp FigS1.</strong></div><div><a href="/pmc/articles/PMC5821586/bin/NIHMS926145-supplement-Supp_FigS1.tif" data-ga-action="click_feat_suppl">NIHMS926145-supplement-Supp_FigS1.tif</a><span style="color:gray"> (341K)</span></div><div class="small guid">GUID:&nbsp;79B0777D-AD50-4371-A8B2-306116E2C038</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>Supp FigS2.</strong></div><div><a href="/pmc/articles/PMC5821586/bin/NIHMS926145-supplement-Supp_FigS2.tif" data-ga-action="click_feat_suppl">NIHMS926145-supplement-Supp_FigS2.tif</a><span style="color:gray"> (719K)</span></div><div class="small guid">GUID:&nbsp;E8CC8007-7731-43F8-89F1-478D35CC1A3E</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>Supp TableS1-6.</strong></div><div><a href="/pmc/articles/PMC5821586/bin/NIHMS926145-supplement-Supp_TableS1-6.docx" data-ga-action="click_feat_suppl">NIHMS926145-supplement-Supp_TableS1-6.docx</a><span style="color:gray"> (64K)</span></div><div class="small guid">GUID:&nbsp;F5681738-5FE5-4860-A4A5-24631FE39206</div></div></dd></dl></div><div id="idm139927713698240" class="tsec sec" lang="en"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm139927713698240title">Abstract</h2><!--article-meta--><div><div id="S1" class="sec sec-first"><h3 id="S1title">BACKGROUND</h3><p id="P1" class="p p-first-last">Children with acute lymphoblastic leukemia (ALL) can develop reduced bone mineral density (BMD). However, data from patients treated on a frontline regimen without cranial irradiation are limited, and no genome-wide analysis has been reported.</p></div><div id="S2" class="sec"><h3 id="S2title">METHODS</h3><p id="P2" class="p p-first-last">Lumbar BMDs were evaluated by quantitative computed tomography at diagnosis, after 120 weeks of continuation therapy, and after 2 years off therapy in pediatric ALL patients (aged 2–18 years at diagnosis) treated on the St. Jude Total XV protocol. Clinical, pharmacokinetic, and genetic risk factors associated with decreased BMD Z-scores were evaluated.</p></div><div id="S3" class="sec"><h3 id="S3title">RESULTS</h3><p id="P3" class="p p-first-last">The median BMD Z-score in 363 patients was 0.06 at diagnosis, declined to −1.08 at week 120, but partly recovered to −0.72 after 2 years off therapy; BMD in patients with low BMD Z-scores at diagnosis remained low after therapy. Older age (≥10 years vs. 2–9.9 years at diagnosis; <em>P</em>&lt;0.001), higher BMD Z-score at diagnosis (<em>P</em>=0.001), and larger area under the plasma drug concentration–time curve (AUC) for dexamethasone in weeks 7 and 8 of continuation therapy (<em>P</em>=0.001) were associated with a greater decrease in BMD Z-score from diagnosis to week 120. Single-nucleotide polymorphisms in 2 genes important in osteogenesis and bone mineralization (<em>COL11A1</em> [rs2622849, <em>P</em>=2.39×10<sup>−7</sup>] and <em>NELL1</em> [rs11025915, <em>P</em>=4.07×10<sup>−6</sup>]) were associated with a decrease in BMD Z-score. <em>NELL1</em> (<em>P</em>=0.003) was also associated with a larger dexamethasone AUC.</p></div><div id="S4" class="sec sec-last"><h3 id="S4title">CONCLUSIONS</h3><p id="P4" class="p p-first-last">BMD Z-scores decreased during therapy, especially in patients with clinical, pharmacokinetic, and genetic risk factors. Early recognition of BMD changes and strategies to optimize bone health are essential.</p></div></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text">acute lymphoblastic leukemia, bone mineral density, children, chemotherapy, single-nucleotide polymorphism</span></div></div><div id="S5" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S5title">INTRODUCTION</h2><p id="P5" class="p p-first">The survival rate for acute lymphoblastic leukemia (ALL) has increased to approximately 90% as a result of the introduction of risk-based treatment and improved supportive care.<sup><a href="#R1" rid="R1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_668014885" role="button" aria-expanded="false" aria-haspopup="true">1</a></sup> However, ALL treatment can itself have adverse effects. In healthy children, bone mineral density (BMD) continues to increase until early in the third decade of life,<sup><a href="#R2" rid="R2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_668014878" role="button" aria-expanded="false" aria-haspopup="true">2</a></sup> but children with ALL can develop reduced BMD due to the disease, its treatment, nutritional deficiencies, and/or physical inactivity.<sup><a href="#R3" rid="R3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_668014850" role="button" aria-expanded="false" aria-haspopup="true">3</a>–<a href="#R6" rid="R6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_668014898" role="button" aria-expanded="false" aria-haspopup="true">6</a></sup> Glucocorticoids decrease bone formation by promoting apoptosis of osteoblasts and osteocytes, increasing bone resorption, and disturbing the calcium balance by reducing intestinal absorption of calcium and increasing its renal excretion.<sup><a href="#R3" rid="R3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_668014884" role="button" aria-expanded="false" aria-haspopup="true">3</a></sup> Endocrine abnormalities after cranial irradiation also contribute to bone morbidity.<sup><a href="#R3" rid="R3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_668014861" role="button" aria-expanded="false" aria-haspopup="true">3</a></sup> Although we have shown that prophylactic cranial irradiation can be safely omitted from the treatment of childhood ALL,<sup><a href="#R7" rid="R7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_668014847" role="button" aria-expanded="false" aria-haspopup="true">7</a></sup> there is only limited data on BMD in patients treated on a regimen without cranial irradiation.</p><p id="P6" class="p p-last">Candidate gene studies have identified several single-nucleotide polymorphisms (SNPs) associated with low BMD in patients with ALL, including ones in the vitamin D receptor (<em>VDR</em>) 5′-end (<em>Cdx-2/GATA</em> polymorphism) haplotype 3 (<em>P</em> = 0.01),<sup><a href="#R8" rid="R8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_668014886" role="button" aria-expanded="false" aria-haspopup="true">8</a></sup> the genes encoding methylenetetrahydrofolate reductase (the <em>MTHFR</em> 677 T allele) and methionine synthase reductase (the <em>MTRR</em> 66 G allele) (<em>P</em> ≤ 0.01 with 2 or more risk alleles),<sup><a href="#R9" rid="R9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_668014897" role="button" aria-expanded="false" aria-haspopup="true">9</a></sup>
<em>CRHR1</em> (the G allele of rs1876828, <em>P</em> = 0.02 for boys),<sup><a href="#R10" rid="R10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_668014896" role="button" aria-expanded="false" aria-haspopup="true">10</a></sup> and <em>RAPGEF5</em> (the T allele of rs6461639, <em>P</em> = 0.016).<sup><a href="#R11" rid="R11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_668014863" role="button" aria-expanded="false" aria-haspopup="true">11</a></sup> However, there has been no genome-wide analysis of low BMD in patients with ALL. Therefore, we evaluated clinical, pharmacokinetic, and genetic risk factors influencing BMD, especially those associated with a decline in BMD Z-score during therapy, in children with ALL treated on a contemporary protocol without cranial irradiation.</p></div><div id="S6" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S6title">METHODS</h2><div id="S7" class="sec sec-first"><h3 id="S7title">Patients</h3><p id="P7" class="p p-first-last">Pediatric patients aged 1–18 years at diagnosis of ALL were enrolled on the Total XV protocol (ClinicalTrials.gov identifier: <a id="__tag_668014944" class="tag_hotlink" href="https://clinicaltrials.gov/ct2/show/NCT00137111" ref="reftype=extlink-clinical-trial&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CBody&amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov"><span class="tag-json" style="display:none">{"type":"clinical-trial","attrs":{"text":"NCT00137111","term_id":"NCT00137111"}}</span>NCT00137111</a>) at St. Jude Children’s Research Hospital (St. Jude) from 2000 to 2007.<sup><a href="#R7" rid="R7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_668014883" role="button" aria-expanded="false" aria-haspopup="true">7</a></sup> Patients aged 1–2 years at diagnosis and those with Down syndrome were excluded, and those who died, experienced relapse, or underwent hematopoietic stem cell transplant (HSCT) were removed from analyses involving subsequent BMD evaluations. The study was approved by the St. Jude Institutional Review Board.</p></div><div id="S8" class="sec"><h3 id="S8title">Treatment</h3><p id="P8" class="p p-first-last">Total XV therapy and risk classification are described elsewhere.<sup><a href="#R7" rid="R7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_668014859" role="button" aria-expanded="false" aria-haspopup="true">7</a></sup> Patients received prednisone at 40 mg/m<sup>2</sup>/day for 28 days during induction and 5-day dexamethasone pulses every 4 weeks during continuation weeks 1 to 100 at 8 mg/m<sup>2</sup>/day for low-risk (LR) patients and 12 mg/m<sup>2</sup>/day for standard/high-risk (S/HR) patients. During re-induction I (weeks 7–9 of continuation) and II (weeks 17–19), all patients received dexamethasone at 8 mg/m<sup>2</sup>/day on days 1 to 8 and days 15 to 21, resulting in a cumulative prednisone dose of 1120 mg/m<sup>2</sup> (for all patients) plus a dexamethasone dose of 1160 mg/m<sup>2</sup> (for LR patients) or 1620 mg/m<sup>2</sup> (for S/HR patients).<sup><a href="#R7" rid="R7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_668014868" role="button" aria-expanded="false" aria-haspopup="true">7</a>, <a href="#R12" rid="R12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_668014848" role="button" aria-expanded="false" aria-haspopup="true">12</a></sup> During remission induction, patients received 6 doses of L-asparaginase (10,000 units/m<sup>2</sup>/dose) during the first 19 days, and patients with minimal residual disease (MRD) of 1% or more on day 19 received 3 more doses. Low-risk patients received 9 doses of L-asparaginase (10,000 units/m<sup>2</sup>/dose) during each re-induction, whereas S/HR patients received 19 weekly doses (25,000 units/m<sup>2</sup>/dose) starting in week 1. Consolidation treatment consisted of high-dose methotrexate (a targeted steady-state concentration of 33 μM for LR patients and 65 μM for S/HR patients) given in 4 courses over 8 weeks with daily mercaptopurine. No cranial irradiation was used.</p></div><div id="S9" class="sec"><h3 id="S9title">Bone mineral density</h3><p id="P9" class="p p-first-last">Quantitative computed tomography (QCT) data on vertebral trabecular BMD were obtained for the lumbar spine (L1/L2) at diagnosis, after 120 weeks of continuation therapy (when female patients completed treatment), after 146 weeks of continuation therapy (for male patients only, who then completed all treatment), and 2 years after completing therapy. Data were obtained with a Siemens SOMATOM-Plus spiral CT scanner (Siemens, Iselin, NY) and Mindways QCT calibration phantoms and software (Mindways Software, Austin, TX) as previously reported.<sup><a href="#R13" rid="R13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_668014864" role="button" aria-expanded="false" aria-haspopup="true">13</a></sup> References for vertebral BMD Z-scores based on age and sex were provided by the manufacturer of the QCT software (Mindways Software).<sup><a href="#R14" rid="R14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_668014869" role="button" aria-expanded="false" aria-haspopup="true">14</a></sup> The 2 vertebral BMD measurements were averaged, and the BMD Z-scores were used for analysis. A BMD Z-score of less than −1.5 was defined as indicating low BMD in this study.</p></div><div id="S10" class="sec"><h3 id="S10title">Dexamethasone and methotrexate pharmacokinetics and cortisol and lipid levels</h3><p id="P10" class="p p-first">Blood samples for measuring dexamethasone levels were drawn before and after the morning dexamethasone doses (at 1, 2, 4, and 8 h) on days 1 and 8 of re-induction I (in weeks 7 and 8 of continuation treatment).<sup><a href="#R12" rid="R12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_668014893" role="button" aria-expanded="false" aria-haspopup="true">12</a>, <a href="#R15" rid="R15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_668014857" role="button" aria-expanded="false" aria-haspopup="true">15</a></sup> Dexamethasone pharmacokinetic parameters were estimated by fitting a 1-compartment model to the plasma concentration–time data by using maximum <em>a posteriori</em> probability estimation, as implemented in ADAPT II (Biomedical Simulations Resource, Los Angeles, CA). Plasma methotrexate concentrations were measured by a fluorescence polarization immunoassay (TDxFLx System, Abbott, Chicago, IL) at pre-dose and at between 0.5 and 6 h, 23 h, and 42 h after the start of methotrexate infusion.<sup><a href="#R16" rid="R16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_668014874" role="button" aria-expanded="false" aria-haspopup="true">16</a>, <a href="#R17" rid="R17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_668014889" role="button" aria-expanded="false" aria-haspopup="true">17</a></sup> Pharmacokinetic parameters were estimated with a 2-compartment first-order model in ADAPT II.</p><p id="P11" class="p p-last">Heparinized blood samples were drawn on day 1 of week 7 of the continuation phase.<sup><a href="#R12" rid="R12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_668014879" role="button" aria-expanded="false" aria-haspopup="true">12</a></sup> Serum cortisol levels were determined by high-performance liquid chromatography. High- and low-density lipoproteins, cholesterol, and triglycerides were measured with a colorimetric enzymatic assay on a Cobas Integra system (Roche Diagnostics).</p></div><div id="S11" class="sec"><h3 id="S11title">Statistical analysis</h3><p id="P12" class="p p-first-last">Associations of clinical characteristics with BMD Z-scores at each time point were evaluated with the rank-sum test or Spearman correlation test. Associations of BMD Z-score categories (≥0, ≥−1.5 to &lt;0, and &lt;−1.5) between two time points were tested with the chi-square test. To account for baseline data and the lack of a race-specific BMD Z-score reference, the analyses for the associations of clinical characteristics and BMD Z-score changes between 2 time points (from diagnosis to week 120 and from week 120 to 2 years off therapy) were adjusted for baseline BMD Z-score (at diagnosis or week 120) and race (white, black, or other) in the linear regression model. The BMD Z-score categories (≥ −1.5 vs. &lt;−1.5) at week 120 and 2 years off therapy were modeled in logistic regression with clinical characteristics as predictors, adjusting for baseline BMD Z-score and race. The independent effect of each factor with a <em>P</em>-value of less than 0.10 was determined by multivariable analysis. The associations of dexamethasone and methotrexate pharmacokinetics and albumin, lipid, and cortisol levels with changes in BMD Z-scores from diagnosis to week 120 were evaluated after adjustments for BMD Z-score at diagnosis and race, and after additional adjustments for age and treatment risk in the multiple linear regression framework. In this analysis, the area under the plasma drug concentration–time curve (AUC) for dexamethasone was evaluated for each increment of 50 nM*h, and the triglyceride, total cholesterol, LDL, and HDL levels were considered for each increment of 20 mg/dL. Multivariable analysis was performed with factors identified by best-set model selection analysis using the Akaike information criterion (AIC). Statistical and computational analyses were performed using “R” Version 3.3.1 software (<a href="http://www.r-project.org" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">www.r-project.org</a>) and SAS Version 9.4 software.</p></div><div id="S12" class="sec sec-last"><h3 id="S12title">Genome-wide association study (GWAS)</h3><p id="P13" class="p p-first">Germline DNA samples were collected at remission and genotyped with the Affymetrix GeneChip Human Mapping 100K and 500K Array Sets. We studied 481,281 SNP genotypes after excluding 51,271 SNPs because of a low minor-allele frequency (&lt;1%) or poor call rate (&lt;95%).</p><p id="P14" class="p p-last">For this genome-wide association study (GWAS), SNP genotypes were evaluated for associations with BMD Z-score changes from diagnosis to week 120 of continuation treatment with significance levels of <em>P</em> &lt; 1 × 10<sup>−4</sup>, as selected by information-profiling criteria after adjustments for age, treatment risk, BMD Z-score at diagnosis, and genetic ancestry. The Spearman rank correlation test was used to evaluate the associations between the SNPs that are significantly associated with BMD Z-score changes from diagnosis to week 120 and the dexamethasone AUC.<sup><a href="#R18" rid="R18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_668256269" role="button" aria-expanded="false" aria-haspopup="true">18</a></sup></p></div></div><div id="S13" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S13title">RESULTS</h2><div id="S14" class="sec sec-first"><h3 id="S14title">Patients and QCT data</h3><p id="P15" class="p p-first">Of the 409 patients treated, 26 patients aged between 1 and 2 years at diagnosis and 10 patients with Down syndrome were excluded, and 10 had not undergone QCT evaluation of their BMD, leaving 363 patients who had undergone at least one QCT evaluation (<a href="/pmc/articles/PMC5821586/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Fig. 1</span></a> and <a href="#SD3" rid="SD3" class=" supplementary-material">Supplemental Table S1</a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F1" co-legend-rid="lgnd_F1"><a href="/pmc/articles/PMC5821586/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139927716227632" class="figure"><a href="/pmc/articles/PMC5821586/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=5821586_nihms926145f1.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is nihms926145f1.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC5821586/bin/nihms926145f1.jpg"></a></div><div id="largeobj_idm139927716227632" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC5821586/figure/F1/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F1"><div><a class="figpopup" href="/pmc/articles/PMC5821586/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1">Figure 1</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>CONSORT diagram</strong><p id="__p15">Abbreviations: BMD, bone mineral density; HSCT, hematopoietic stem cell transplant</p></div></div></div><p id="P16" class="p p-last"><a href="/pmc/articles/PMC5821586/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a> show the cross-sectional BMD Z-scores and their categories at each time point. The median BMD Z-score was 0.06 at diagnosis, decreased to −1.08 at week 120, but improved to −0.72 at 2 years after therapy. There were no differences in BMD Z-score between male and female patients. Of note, although other clinical characteristics did not differ, the available BMD Z-scores at diagnosis and week 120 in 232 patients who had a QCT examination at 2 years off therapy were lower than those in 72 patients who did not have a QCT examination (<a href="#SD3" rid="SD3" class=" supplementary-material">Supplemental Table S2</a>). The median Z-scores at diagnosis were −0.05 (range, −3.27 to 3.56) for 216 patients who had a QCT examination and 0.30 (range, −2.12 to 2.68) for 66 patients who did not have an examination (<em>P</em> = 0.009). The median Z-scores at week 120 were −1.13 (range, −5.93 to 2.05) for 219 patients who had a QCT examination and −0.92 (range, −4.73 to 1.31) for 58 patients who did not have an examination (<em>P</em> = 0.043). When the BMD Z-scores were categorized as ≥0, ≥ −1.5 to &lt;0, or &lt;−1.5, the percentage of patients with a BMD Z-score of &lt;−1.5 was 6.5%, 37.8%, and 25.4% at diagnosis, week 120, and 2 years off therapy, respectively. There were significant associations in the BMD Z-score categories between any two time points (<em>P</em> &lt; 0.001 for all 3 association tests); most of the patients with BMD Z-scores of less than −1.5 at diagnosis remained in the same category at the subsequent time points (<a href="#SD3" rid="SD3" class=" supplementary-material">Supplemental Table S3</a>). However, 14 of 108 patients (13.0%) with BMD Z-scores of 0 or higher and 31 of 95 patients (32.6%) with BMD Z-scores of at least −1.5 but less than 0 at diagnosis had BMD Z-scores of less than −1.5 at 2 years off therapy.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T1"><h3>Table 1</h3><!--caption a7--><div class="caption"><p id="__p17">Cross-sectional data on bone mineral density Z-score</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139927698637824" class="xtable"><table frame="box" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1" valign="middle" align="left">Z-score</th><th rowspan="1" colspan="1" valign="middle" align="center">All patients<br><em>N</em></th><th rowspan="1" colspan="1" valign="middle" align="center">Median (range)</th><th rowspan="1" colspan="1" valign="middle" align="center">Female<br><em>N</em></th><th rowspan="1" colspan="1" valign="middle" align="center">Female, median (range)</th><th rowspan="1" colspan="1" valign="middle" align="center">Male<br><em>N</em></th><th rowspan="1" colspan="1" valign="middle" align="center">Male, median (range)</th><th rowspan="1" colspan="1" valign="middle" align="center"><em>P</em>-value</th></tr></thead><tbody><tr><td rowspan="1" colspan="1" valign="top" align="left"><strong>Diagnosis</strong></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"> <strong>All patients</strong></td><td rowspan="1" colspan="1" valign="top" align="center">340</td><td rowspan="1" colspan="1" valign="top" align="center">0.06 (−3.27 to 3.56)</td><td rowspan="1" colspan="1" valign="top" align="center">145</td><td rowspan="1" colspan="1" valign="top" align="center">0.09 (−3.27 to 3.56)</td><td rowspan="1" colspan="1" valign="top" align="center">195</td><td rowspan="1" colspan="1" valign="top" align="center">0.06 (−2.52 to 2.68)</td><td rowspan="1" colspan="1" valign="top" align="center">0.995</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">  <strong>≥0</strong></td><td rowspan="1" colspan="1" valign="top" align="center">182 (53.5%)</td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center">76 (52.4%)</td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center">106 (54.4%)</td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">  <strong>≥ −1.5 to 0</strong></td><td rowspan="1" colspan="1" valign="top" align="center">136 (40.0%)</td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center">58 (40.0%)</td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center">78 (40.0%)</td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">  <strong>&lt; −1.5</strong></td><td rowspan="1" colspan="1" valign="top" align="center">22 (6.5%)</td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center">11 (7.6%)</td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center">11 (5.6%)</td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td></tr><tr><td colspan="8" rowspan="1" valign="bottom" align="left">
<hr></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"><strong>Week 120</strong></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"> <strong>All patients</strong></td><td rowspan="1" colspan="1" valign="top" align="center">296</td><td rowspan="1" colspan="1" valign="top" align="center">−1.08 (−5.93 to 2.05)</td><td rowspan="1" colspan="1" valign="top" align="center">134</td><td rowspan="1" colspan="1" valign="top" align="center">−1.10 (−5.93 to 2.05)</td><td rowspan="1" colspan="1" valign="top" align="center">162</td><td rowspan="1" colspan="1" valign="top" align="center">−1.05 (−5.62 to 1.43)</td><td rowspan="1" colspan="1" valign="top" align="center">0.714</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">  <strong>≥0</strong></td><td rowspan="1" colspan="1" valign="top" align="center">51 (17.2%)</td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center">25 (18.7%)</td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center">26 (16.1%)</td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">  <strong>≥ −1.5 to 0</strong></td><td rowspan="1" colspan="1" valign="top" align="center">133 (44.9%)</td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center">57 (42.5%)</td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center">76 (46.9%)</td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">  <strong>&lt; −1.5</strong></td><td rowspan="1" colspan="1" valign="top" align="center">112 (37.8%)</td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center">52 (38.8%)</td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center">60 (37.0%)</td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td></tr><tr><td colspan="8" rowspan="1" valign="bottom" align="left">
<hr></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"><strong>(Week 146)</strong></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"> <strong>All patients</strong></td><td rowspan="1" colspan="1" valign="top" align="center">151</td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center">151</td><td rowspan="1" colspan="1" valign="top" align="center">−0.92 (−4.16 to 2.13)</td><td rowspan="1" colspan="1" valign="top" align="center">N/A</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">  <strong>≥0</strong></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center">34 (22.5%)</td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">  <strong>≥ −1.5 to 0</strong></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center">68 (45.1%)</td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">  <strong>&lt; −1.5</strong></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center">49 (32.5%)</td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td></tr><tr><td colspan="8" rowspan="1" valign="bottom" align="left">
<hr></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"><strong>2 years off therapy</strong></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"> <strong>All patients</strong></td><td rowspan="1" colspan="1" valign="top" align="center">232</td><td rowspan="1" colspan="1" valign="top" align="center">−0.72 (−3.56 to 2.46)</td><td rowspan="1" colspan="1" valign="top" align="center">108</td><td rowspan="1" colspan="1" valign="top" align="center">−0.66 (−3.1 to 2.46)</td><td rowspan="1" colspan="1" valign="top" align="center">124</td><td rowspan="1" colspan="1" valign="top" align="center">−0.75 (−3.56 to 2.45)</td><td rowspan="1" colspan="1" valign="top" align="center">0.446</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">  <strong>≥0</strong></td><td rowspan="1" colspan="1" valign="top" align="center">71 (30.6%)</td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center">37 (34.3%)</td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center">34 (27.4%)</td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">  <strong>≥ −1.5 to 0</strong></td><td rowspan="1" colspan="1" valign="top" align="center">102 (44.0%)</td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center">44 (40.7%)</td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center">58 (46.8%)</td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">  <strong>&lt; −1.5</strong></td><td rowspan="1" colspan="1" valign="top" align="center">59 (25.4%)</td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center">27 (25.0%)</td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center">32 (25.8%)</td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td></tr></tbody></table></div><div id="largeobj_idm139927698637824" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC5821586/table/T1/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="TFN1"><p id="__p18" class="p p-first-last">Abbreviation: N/A, not applicable</p></div></div></div></div><div id="S15" class="sec"><h3 id="S15title">Clinical characteristics associated with QCT BMD Z-score values</h3><p id="P17" class="p p-first"><a href="#SD3" rid="SD3" class=" supplementary-material">Supplemental Table S4</a> and <a href="#SD1" rid="SD1" class=" supplementary-material">Supplemental Figure S1</a> show the associations between BMD Z-scores and presenting clinical factors. At diagnosis, patients aged 10 years or older had a median BMD-Z-score of 0.50, which was higher than that of the normal controls and those aged 2–9.9 years had a median Z-score of (−0.09), which was comparable to that of the controls. In multivariable analysis, age 10 years or older (vs. 2–9.9 years) was significantly associated with a higher BMD Z-score (<em>P</em> = 0.030). Age 10 years or older at diagnosis and a lower BMD Z-score at diagnosis were significantly associated with a lower BMD Z-score at week 120 (<em>P</em> &lt; 0.001 for both). Lower BMD Z-scores at week 120 correlated with lower BMD Z-scores at 2 years after therapy (<em>P</em> &lt; 0.001).</p><p id="P18"><a href="/pmc/articles/PMC5821586/table/T2/" target="table" class="fig-table-link figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span>Table 2</span></a> and <a href="#SD1" rid="SD1" class=" supplementary-material">supplemental Figures S1</a> and <a href="#SD2" rid="SD2" class=" supplementary-material">S2</a> show clinical factors associated with the changes in BMD Z-score from diagnosis to week 120 and from week 120 to 2 years off therapy, with adjustment for baseline BMD Z-score and race. In multivariable analysis, age 10 years or older at diagnosis, compared with 2–9.9 years, and a greater decrease in height Z-score from diagnosis to week 120 were significantly associated with a greater decline in BMD Z-score from diagnosis to week 120 (<em>P</em> &lt; 0.001 and <em>P</em> = 0.009, respectively). Patients aged 10 years or older at diagnosis had a significantly greater increase in BMD Z-score from week 120 to 2 years off therapy than did those aged 2–9.9 years (<em>P</em> &lt; 0.001).</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T2"><h3>TABLE 2</h3><!--caption a7--><div class="caption"><p id="__p19">Factors associated with bone mineral density Z-score changes</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139927704671104" class="xtable"><table frame="box" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1" valign="middle" align="left">Clinical characteristics</th><th colspan="5" rowspan="1" valign="middle" align="center">2 years off therapy from week 120</th><th colspan="4" rowspan="1" valign="middle" align="center">Week 120 from diagnosis</th></tr><tr><th colspan="10" rowspan="1" valign="bottom" align="left">
<hr></th></tr><tr><th rowspan="1" colspan="1" valign="middle" align="left">Variables</th><th rowspan="1" colspan="1" valign="middle" align="center"><em>N</em></th><th rowspan="1" colspan="1" valign="middle" align="center">Coefficient</th><th rowspan="1" colspan="1" valign="middle" align="center">95% CI</th><th rowspan="1" colspan="1" valign="middle" align="center">Individual factor<sup>a</sup><br><em>P</em></th><th rowspan="1" colspan="1" valign="middle" align="center">Multivariable<sup>b</sup><br><em>P</em></th><th rowspan="1" colspan="1" valign="middle" align="center"><em>N</em></th><th rowspan="1" colspan="1" valign="middle" align="center">Coefficient</th><th rowspan="1" colspan="1" valign="middle" align="center">95% CI</th><th rowspan="1" colspan="1" valign="middle" align="center">Individual factor<sup>a</sup><br><em>P</em></th></tr></thead><tbody><tr><td rowspan="1" colspan="1" valign="top" align="left"><strong>Age</strong></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"> <strong>2–9.9 years</strong></td><td rowspan="1" colspan="1" valign="top" align="center">202</td><td rowspan="1" colspan="1" valign="top" align="center">0.976</td><td rowspan="1" colspan="1" valign="top" align="center">0.685 to 1.268</td><td rowspan="1" colspan="1" valign="top" align="center">&lt;0.001</td><td rowspan="1" colspan="1" valign="top" align="center">&lt;0.001</td><td rowspan="1" colspan="1" valign="top" align="center">164</td><td rowspan="1" colspan="1" valign="top" align="center">−0.524</td><td rowspan="1" colspan="1" valign="top" align="center">−0.768 to −0.280</td><td rowspan="1" colspan="1" valign="top" align="center">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"> <strong>≥10 years</strong></td><td rowspan="1" colspan="1" valign="top" align="center">74</td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center">55</td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"><strong>Sex</strong></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"> <strong>Female</strong></td><td rowspan="1" colspan="1" valign="top" align="center">124</td><td rowspan="1" colspan="1" valign="top" align="center">0.031</td><td rowspan="1" colspan="1" valign="top" align="center">−0.242 to 0.303</td><td rowspan="1" colspan="1" valign="top" align="center">0.826</td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"> <strong>Male</strong></td><td rowspan="1" colspan="1" valign="top" align="center">152</td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"><strong>WBC at diagnosis</strong></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"> <strong>&lt;50 × 10<sup>9</sup>/L</strong></td><td rowspan="1" colspan="1" valign="top" align="center">209</td><td rowspan="1" colspan="1" valign="top" align="center">−0.054</td><td rowspan="1" colspan="1" valign="top" align="center">−0.373 to 0.266</td><td rowspan="1" colspan="1" valign="top" align="center">0.743</td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center">167</td><td rowspan="1" colspan="1" valign="top" align="center">−0.028</td><td rowspan="1" colspan="1" valign="top" align="center">−0.286 to 0.231</td><td rowspan="1" colspan="1" valign="top" align="center">0.834</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"> <strong>≥50 × 10<sup>9</sup>/L</strong></td><td rowspan="1" colspan="1" valign="top" align="center">67</td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center">52</td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"><strong>Lineage</strong></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"> <strong>B lineage</strong></td><td rowspan="1" colspan="1" valign="top" align="center">233</td><td rowspan="1" colspan="1" valign="top" align="center">0.474</td><td rowspan="1" colspan="1" valign="top" align="center">0.102 to 0.847</td><td rowspan="1" colspan="1" valign="top" align="center">0.013</td><td rowspan="1" colspan="1" valign="top" align="center">0.440</td><td rowspan="1" colspan="1" valign="top" align="center">186</td><td rowspan="1" colspan="1" valign="top" align="center">−0.133</td><td rowspan="1" colspan="1" valign="top" align="center">−0.447 to 0.181</td><td rowspan="1" colspan="1" valign="top" align="center">0.407</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"> <strong>T lineage</strong></td><td rowspan="1" colspan="1" valign="top" align="center">43</td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center">33</td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"><strong>CNS involvement</strong></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"> <strong>CNS negative</strong></td><td rowspan="1" colspan="1" valign="top" align="center">216</td><td rowspan="1" colspan="1" valign="top" align="center">0.146</td><td rowspan="1" colspan="1" valign="top" align="center">−0.181 to 0.473</td><td rowspan="1" colspan="1" valign="top" align="center">0.382</td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center">175</td><td rowspan="1" colspan="1" valign="top" align="center">−0.168</td><td rowspan="1" colspan="1" valign="top" align="center">−0.439 to 0.103</td><td rowspan="1" colspan="1" valign="top" align="center">0.224</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"> <strong>CNS positive</strong></td><td rowspan="1" colspan="1" valign="top" align="center">60</td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center">44</td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"><strong>Risk</strong></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"> <strong>Low</strong></td><td rowspan="1" colspan="1" valign="top" align="center">149</td><td rowspan="1" colspan="1" valign="top" align="center">0.646</td><td rowspan="1" colspan="1" valign="top" align="center">0.375 to 0.917</td><td rowspan="1" colspan="1" valign="top" align="center">&lt;0.001</td><td rowspan="1" colspan="1" valign="top" align="center">0.218</td><td rowspan="1" colspan="1" valign="top" align="center">124</td><td rowspan="1" colspan="1" valign="top" align="center">−0.159</td><td rowspan="1" colspan="1" valign="top" align="center">−0.383 to 0.066</td><td rowspan="1" colspan="1" valign="top" align="center">0.167</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"> <strong>Standard/high</strong></td><td rowspan="1" colspan="1" valign="top" align="center">127</td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center">95</td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"><strong>Height Z-score change</strong></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"> <strong>Week 120 from diagnosis</strong></td><td rowspan="1" colspan="1" valign="top" align="center">276</td><td rowspan="1" colspan="1" valign="top" align="center">0.335</td><td rowspan="1" colspan="1" valign="top" align="center">0.104 to 0.566</td><td rowspan="1" colspan="1" valign="top" align="center">0.005</td><td rowspan="1" colspan="1" valign="top" align="center">0.009</td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"> <strong>2 years off therapy from week 120</strong></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center">218</td><td rowspan="1" colspan="1" valign="top" align="center">−0.022</td><td rowspan="1" colspan="1" valign="top" align="center">−0.287 to 0.242</td><td rowspan="1" colspan="1" valign="top" align="center">0.868</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"><strong>BMI Z-score change</strong></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"> <strong>Week 120 from diagnosis</strong></td><td rowspan="1" colspan="1" valign="top" align="center">276</td><td rowspan="1" colspan="1" valign="top" align="center">0.201</td><td rowspan="1" colspan="1" valign="top" align="center">0.063 to 0.339</td><td rowspan="1" colspan="1" valign="top" align="center">0.005</td><td rowspan="1" colspan="1" valign="top" align="center">0.146</td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"> <strong>2 years off therapy from week 120</strong></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center">218</td><td rowspan="1" colspan="1" valign="top" align="center">−0.097</td><td rowspan="1" colspan="1" valign="top" align="center">−0.233 to 0.039</td><td rowspan="1" colspan="1" valign="top" align="center">0.163</td></tr></tbody></table></div><div id="largeobj_idm139927704671104" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC5821586/table/T2/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="TFN2"><sup>a</sup>Data are adjusted for baseline BMD Z-scores and race. For 2 years off therapy from week 120, data are additionally adjusted for sex.</div><div id="TFN3"><sup>b</sup>Multivariable analysis was performed to determine the independent effect of each individual factor that had a <em>P</em>–value of less than 0.10.</div><div id="TFN4"><p id="__p22" class="p p-first-last">Abbreviations: CI, confidence interval; WBC, white blood cell count; CNS, central nervous system; BMI, body mass index</p></div></div></div><p id="P19" class="p p-last">When clinical characteristics associated with a low BMD Z-score (&lt;−1.5) are evaluated after adjustment for baseline BMD Z-score and race, patients aged 10 years or older at diagnosis were at significantly higher risk for a low BMD Z-score at week 120 when compared with patients aged 2–9.9 years (<em>P</em> = 0.003) (<a href="#SD3" rid="SD3" class=" supplementary-material">Supplemental Table S5</a>).</p></div><div id="S16" class="sec"><h3 id="S16title">Association of dexamethasone and methotrexate pharmacokinetics and albumin and lipid levels with QCT BMD Z-scores at week 120</h3><p id="P20" class="p p-first-last">We evaluated the associations of changes in BMD Z-score from diagnosis to week 120 with dexamethasone and methotrexate pharmacokinetics and with albumin, lipid, and cortisol levels adjusted for BMD Z-score at diagnosis and race, and also with additional adjustments for age at diagnosis and treatment risk, by using a multiple linear regression model (<a href="/pmc/articles/PMC5821586/table/T3/" target="table" class="fig-table-link figpopup" rid-figpopup="T3" rid-ob="ob-T3" co-legend-rid=""><span>Table 3</span></a>). In the latter model, the average AUCs for dexamethasone in continuation weeks 7 and 8 (<em>P</em> &lt; 0.001) and triglyceride (<em>P</em> = 0.021) and cholesterol (<em>P</em> = 0.018) levels in week 7 were negatively associated with changes in BMD Z-score, and the albumin level in week 7 (<em>P</em> = 0.017) was positively associated with such changes. These suggest that larger dexamethasone AUCs, higher triglyceride and cholesterol levels, and lower albumin levels result in a greater decrease in BMD Z-score from diagnosis to week 120.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T3"><h3>TABLE 3</h3><!--caption a7--><div class="caption"><p id="__p23">Association of bone mineral density Z-score changes from diagnosis to week 120 with dexamethasone and methotrexate pharmacokinetics and albumin, lipid, and cortisol levels</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139927716426256" class="xtable"><table frame="box" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="3" colspan="1" valign="middle" align="left">Variables</th><th rowspan="3" colspan="1" valign="middle" align="center"><em>N</em></th><th colspan="3" rowspan="1" valign="middle" align="center">Individual factor<sup>a</sup></th><th colspan="3" rowspan="1" valign="middle" align="center">Multiple linear regression<sup>b</sup></th></tr><tr><th colspan="6" rowspan="1" valign="bottom" align="center">
<hr></th></tr><tr><th rowspan="1" colspan="1" valign="middle" align="center">Coefficient</th><th rowspan="1" colspan="1" valign="middle" align="center">95% CI</th><th rowspan="1" colspan="1" valign="middle" align="center"><em>P</em></th><th rowspan="1" colspan="1" valign="middle" align="center">Coefficient</th><th rowspan="1" colspan="1" valign="middle" align="center">95% CI</th><th rowspan="1" colspan="1" valign="middle" align="center"><em>P</em></th></tr></thead><tbody><tr><td rowspan="1" colspan="1" valign="top" align="left">Average of dexamethasone AUCs in weeks 7 and 8 of continuation</td><td rowspan="1" colspan="1" valign="top" align="center">241</td><td rowspan="1" colspan="1" valign="top" align="center">−0.070</td><td rowspan="1" colspan="1" valign="top" align="center">−0.094 to −0.046</td><td rowspan="1" colspan="1" valign="top" align="center">&lt;0.001</td><td rowspan="1" colspan="1" valign="top" align="center">−0.047</td><td rowspan="1" colspan="1" valign="top" align="center">−0.073 to −0.021</td><td rowspan="1" colspan="1" valign="top" align="center">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Average methotrexate AUCs during consolidation</td><td rowspan="1" colspan="1" valign="top" align="center">276</td><td rowspan="1" colspan="1" valign="top" align="center">−0.025</td><td rowspan="1" colspan="1" valign="top" align="center">−0.036 to −0.013</td><td rowspan="1" colspan="1" valign="top" align="center">&lt;0.001</td><td rowspan="1" colspan="1" valign="top" align="center">−0.025</td><td rowspan="1" colspan="1" valign="top" align="center">−0.052 to 0.001</td><td rowspan="1" colspan="1" valign="top" align="center">0.062</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Albumin level (g/dL) in week 7 of continuation</td><td rowspan="1" colspan="1" valign="top" align="center">263</td><td rowspan="1" colspan="1" valign="top" align="center">0.512</td><td rowspan="1" colspan="1" valign="top" align="center">0.313 to 0.711</td><td rowspan="1" colspan="1" valign="top" align="center">&lt;0.001</td><td rowspan="1" colspan="1" valign="top" align="center">0.342</td><td rowspan="1" colspan="1" valign="top" align="center">0.063 to 0.622</td><td rowspan="1" colspan="1" valign="top" align="center">0.017</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Triglyceride level (mg/dL) in week 7 of continuation</td><td rowspan="1" colspan="1" valign="top" align="center">250</td><td rowspan="1" colspan="1" valign="top" align="center">−0.038</td><td rowspan="1" colspan="1" valign="top" align="center">−0.054 to −0.021</td><td rowspan="1" colspan="1" valign="top" align="center">&lt;0.001</td><td rowspan="1" colspan="1" valign="top" align="center">−0.021</td><td rowspan="1" colspan="1" valign="top" align="center">−0.038 to −0.003</td><td rowspan="1" colspan="1" valign="top" align="center">0.021</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Total cholesterol level (mg/dL) in week 7 of continuation</td><td rowspan="1" colspan="1" valign="top" align="center">250</td><td rowspan="1" colspan="1" valign="top" align="center">−0.122</td><td rowspan="1" colspan="1" valign="top" align="center">−0.183 to −0.061</td><td rowspan="1" colspan="1" valign="top" align="center">&lt;0.001</td><td rowspan="1" colspan="1" valign="top" align="center">−0.073</td><td rowspan="1" colspan="1" valign="top" align="center">−0.134 to −0.013</td><td rowspan="1" colspan="1" valign="top" align="center">0.018</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">LDL level (mg/dL) in week 7 of continuation</td><td rowspan="1" colspan="1" valign="top" align="center">250</td><td rowspan="1" colspan="1" valign="top" align="center">−0.037</td><td rowspan="1" colspan="1" valign="top" align="center">−0.120 to 0.047</td><td rowspan="1" colspan="1" valign="top" align="center">0.394</td><td rowspan="1" colspan="1" valign="top" align="center">−0.035</td><td rowspan="1" colspan="1" valign="top" align="center">−0.115 to 0.045</td><td rowspan="1" colspan="1" valign="top" align="center">0.396</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">HDL level (mg/dL) in week 7 of continuation</td><td rowspan="1" colspan="1" valign="top" align="center">250</td><td rowspan="1" colspan="1" valign="top" align="center">0.135</td><td rowspan="1" colspan="1" valign="top" align="center">−0.034 to 0.305</td><td rowspan="1" colspan="1" valign="top" align="center">0.119</td><td rowspan="1" colspan="1" valign="top" align="center">−0.004</td><td rowspan="1" colspan="1" valign="top" align="center">−0.169 to 0.161</td><td rowspan="1" colspan="1" valign="top" align="center">0.961</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Cortisol level (μg/dL) in week 7 of continuation</td><td rowspan="1" colspan="1" valign="top" align="center">263</td><td rowspan="1" colspan="1" valign="top" align="center">0.017</td><td rowspan="1" colspan="1" valign="top" align="center">−0.003 to 0.037</td><td rowspan="1" colspan="1" valign="top" align="center">0.101</td><td rowspan="1" colspan="1" valign="top" align="center">0.007</td><td rowspan="1" colspan="1" valign="top" align="center">−0.012 to 0.026</td><td rowspan="1" colspan="1" valign="top" align="center">0.468</td></tr></tbody></table></div><div id="largeobj_idm139927716426256" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC5821586/table/T3/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="TFN5"><sup>a</sup><em>P-</em>value after adjustment for bone mineral density Z-score at diagnosis and race</div><div id="TFN6"><sup>b</sup><em>P-</em>value after adjustment for bone mineral density Z-score at diagnosis, race, age, and treatment risk</div><div id="TFN7"><p id="__p26" class="p p-first-last">Average of dexamethasone AUCs in weeks 7 and 8 was evaluated for the change of 50 nM*h, and triglyceride, total cholesterol, LDL, and HDL levels were examined for each increment of 20 mg/dL.</p></div><div id="TFN8"><p id="__p27" class="p p-first-last">Abbreviations: CI, confidence interval; AUC, area under the plasma drug concentration–time curve; LDL, low-density lipoprotein; HDL, high-density lipoprotein</p></div></div></div></div><div id="S17" class="sec"><h3 id="S17title">Multivariable analysis for factors associated with BMD Z-scores at week 120</h3><p id="P21" class="p p-first-last">To evaluate factors significant for the changes in BMD Z-score from diagnosis to week 120 with multivariable analysis, we performed best-set model selection analysis with the AIC by using the age group, leukemia risk, BMD Z-score at diagnosis, race, lineage, Z-score changes for height and body mass index from diagnosis to week 120, average of the week 7 and week 8 dexamethasone AUCs, average methotrexate AUCs during consolidation, and albumin, triglyceride, and total cholesterol levels in week 7 of continuation therapy (<a href="#SD3" rid="SD3" class=" supplementary-material">Supplemental Table S6</a>). The best model fit (AIC 649.924) included the age group, leukemia risk, BMD Z-score at diagnosis, race, average of the week 7 and week 8 dexamethasone AUCs, average methotrexate AUCs during consolidation, and total cholesterol level in week 7. In multivariable analysis with these factors, age 10 years or older at diagnosis (<em>P</em> &lt; 0.001), higher BMD Z-score at diagnosis (<em>P</em> = 0.001), and greater average of the week 7 and week 8 dexamethasone AUCs (<em>P</em> = 0.001) were associated with a greater decrease in BMD Z-score from diagnosis to week 120 (<a href="/pmc/articles/PMC5821586/table/T4/" target="table" class="fig-table-link figpopup" rid-figpopup="T4" rid-ob="ob-T4" co-legend-rid=""><span>Table 4</span></a>).</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T4"><h3>TABLE 4</h3><!--caption a7--><div class="caption"><p id="__p28">Multivariable analysis for factors associated with bone mineral density Z-score changes from diagnosis to week 120</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139927715946272" class="xtable"><table frame="box" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1" valign="bottom" align="left">Characteristics</th><th rowspan="1" colspan="1" valign="bottom" align="center">Estimate</th><th rowspan="1" colspan="1" valign="bottom" align="center">Standard error</th><th rowspan="1" colspan="1" valign="bottom" align="center"><em>P</em></th></tr></thead><tbody><tr><td rowspan="1" colspan="1" valign="top" align="left">Low vs. standard/high risk</td><td rowspan="1" colspan="1" valign="top" align="center">−0.461</td><td rowspan="1" colspan="1" valign="top" align="center">−1.189 to 0.267</td><td rowspan="1" colspan="1" valign="top" align="center">0.216</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Race, black vs. white</td><td rowspan="1" colspan="1" valign="top" align="center">0.290</td><td rowspan="1" colspan="1" valign="top" align="center">−0.072 to 0.651</td><td rowspan="1" colspan="1" valign="top" align="center">0.117</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Race, other vs. white</td><td rowspan="1" colspan="1" valign="top" align="center">−0.575</td><td rowspan="1" colspan="1" valign="top" align="center">−1.267 to 0.117</td><td rowspan="1" colspan="1" valign="top" align="center">0.105</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Age, ≥10 vs. 2–9.9 years</td><td rowspan="1" colspan="1" valign="top" align="center">−0.732</td><td rowspan="1" colspan="1" valign="top" align="center">−1.119 to −0.344</td><td rowspan="1" colspan="1" valign="top" align="center">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">BMD Z-score at diagnosis</td><td rowspan="1" colspan="1" valign="top" align="center">−0.224</td><td rowspan="1" colspan="1" valign="top" align="center">−0.356 to −0.092</td><td rowspan="1" colspan="1" valign="top" align="center">0.001</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Average of dexamethasone AUCs for weeks 7 and 8 of continuation</td><td rowspan="1" colspan="1" valign="top" align="center">−0.047</td><td rowspan="1" colspan="1" valign="top" align="center">−0.074 to −0.021</td><td rowspan="1" colspan="1" valign="top" align="center">0.001</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Total cholesterol level (mg/dL) in week 7 of continuation</td><td rowspan="1" colspan="1" valign="top" align="center">−0.057</td><td rowspan="1" colspan="1" valign="top" align="center">−0.118 to 0.005</td><td rowspan="1" colspan="1" valign="top" align="center">0.074</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Average methotrexate AUCs during consolidation</td><td rowspan="1" colspan="1" valign="top" align="center">−0.023</td><td rowspan="1" colspan="1" valign="top" align="center">−0.051 to 0.005</td><td rowspan="1" colspan="1" valign="top" align="center">0.102</td></tr></tbody></table></div><div id="largeobj_idm139927715946272" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC5821586/table/T4/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="TFN9"><p id="__p29" class="p p-first-last">Abbreviations: BMD, bone mineral density; AUC, area under the plasma drug concentration–time curve</p></div><div id="TFN10"><p id="__p30" class="p p-first-last">Average of dexamethasone AUCs in weeks 7 and 8 was evaluated for the change of 50 nM*h, and total cholesterol was examined for each increment of 20 mg/dL.</p></div></div></div></div><div id="S18" class="sec sec-last"><h3 id="S18title">Genomic study</h3><p id="P22" class="p p-first">We investigated which of 481,281 germline SNP genotypes were associated with BMD Z-score changes from diagnosis to continuation week 120 (<a href="/pmc/articles/PMC5821586/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Fig. 2A</span></a>). <a href="/pmc/articles/PMC5821586/table/T5/" target="table" class="fig-table-link figpopup" rid-figpopup="T5" rid-ob="ob-T5" co-legend-rid=""><span>Table 5</span></a> shows the 38 SNPs with <em>P</em>-values of less than 1.0 × 10<sup>−4</sup>, of which 19 were annotated to 16 genes.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F2" co-legend-rid="lgnd_F2"><a href="/pmc/articles/PMC5821586/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139927698640400" class="figure"><a href="/pmc/articles/PMC5821586/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=5821586_nihms926145f2.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is nihms926145f2.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC5821586/bin/nihms926145f2.jpg"></a></div><div id="largeobj_idm139927698640400" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC5821586/figure/F2/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F2"><div><a class="figpopup" href="/pmc/articles/PMC5821586/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2">Figure 2</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Single-nucleotide polymorphisms that are associated with bone mineral density (BMD) Z-score changes from diagnosis to week 120 of continuation therapy</strong><p id="__p16">Data are adjusted for age at diagnosis, treatment risk, BMD Z-scores at diagnosis, and ancestry group. Manhattan plots (A) and box plots (B and C) for <em>COL11A1</em> and <em>NELL1</em> are shown.</p></div></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T5"><h3>Table 5</h3><!--caption a7--><div class="caption"><p id="__p31">Single-nucleotide polymorphisms that are associated with bone mineral density Z-score changes from diagnosis to week 120 and dexamethasone AUC</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139927698862064" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th colspan="2" rowspan="1" valign="bottom" align="left">SNP information
<hr></th><th colspan="4" rowspan="1" valign="bottom" align="center">Association with bone mineral density Z-score change from diagnosis to week 120<sup>a</sup>
<hr></th><th colspan="2" rowspan="1" valign="bottom" align="center">Association with dexamethasone AUC
<hr></th></tr><tr><th rowspan="1" colspan="1" valign="middle" align="left">SNPID</th><th rowspan="1" colspan="1" valign="middle" align="center">Gene</th><th rowspan="1" colspan="1" valign="middle" align="center">Risk allele frequency</th><th rowspan="1" colspan="1" valign="middle" align="center">Risk allele</th><th rowspan="1" colspan="1" valign="middle" align="center"><em>P</em></th><th rowspan="1" colspan="1" valign="middle" align="center">Coefficient</th><th rowspan="1" colspan="1" valign="middle" align="center"><em>P</em></th><th rowspan="1" colspan="1" valign="middle" align="center">Spearman correlation</th></tr></thead><tbody><tr><td rowspan="1" colspan="1" valign="top" align="left">rs2622849</td><td rowspan="1" colspan="1" valign="top" align="center"><em>COL11A1</em></td><td rowspan="1" colspan="1" valign="top" align="center">0.051</td><td rowspan="1" colspan="1" valign="top" align="center">T</td><td rowspan="1" colspan="1" valign="top" align="center">2.39E-07</td><td rowspan="1" colspan="1" valign="top" align="center">−1.071</td><td rowspan="1" colspan="1" valign="top" align="center">0.291</td><td rowspan="1" colspan="1" valign="top" align="center">0.063</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">rs11025915</td><td rowspan="1" colspan="1" valign="top" align="center"><em>NELL1</em></td><td rowspan="1" colspan="1" valign="top" align="center">0.025</td><td rowspan="1" colspan="1" valign="top" align="center">A</td><td rowspan="1" colspan="1" valign="top" align="center">4.07E-06</td><td rowspan="1" colspan="1" valign="top" align="center">−1.306</td><td rowspan="1" colspan="1" valign="top" align="center">0.003</td><td rowspan="1" colspan="1" valign="top" align="center">0.176</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">rs1986582</td><td rowspan="1" colspan="1" valign="top" align="center"><em>–</em></td><td rowspan="1" colspan="1" valign="top" align="center">0.120</td><td rowspan="1" colspan="1" valign="top" align="center">G</td><td rowspan="1" colspan="1" valign="top" align="center">7.17E-06</td><td rowspan="1" colspan="1" valign="top" align="center">−0.629</td><td rowspan="1" colspan="1" valign="top" align="center">0.421</td><td rowspan="1" colspan="1" valign="top" align="center">0.048</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">rs17047225</td><td rowspan="1" colspan="1" valign="top" align="center"><em>TLL1</em></td><td rowspan="1" colspan="1" valign="top" align="center">0.050</td><td rowspan="1" colspan="1" valign="top" align="center">C</td><td rowspan="1" colspan="1" valign="top" align="center">7.51E-06</td><td rowspan="1" colspan="1" valign="top" align="center">−0.815</td><td rowspan="1" colspan="1" valign="top" align="center">0.964</td><td rowspan="1" colspan="1" valign="top" align="center">0.003</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">rs2668354</td><td rowspan="1" colspan="1" valign="top" align="center"><em>SRGAP3</em></td><td rowspan="1" colspan="1" valign="top" align="center">0.659</td><td rowspan="1" colspan="1" valign="top" align="center">A</td><td rowspan="1" colspan="1" valign="top" align="center">1.00E-05</td><td rowspan="1" colspan="1" valign="top" align="center">−0.471</td><td rowspan="1" colspan="1" valign="top" align="center">0.307</td><td rowspan="1" colspan="1" valign="top" align="center">0.061</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">rs7514670</td><td rowspan="1" colspan="1" valign="top" align="center"><em>–</em></td><td rowspan="1" colspan="1" valign="top" align="center">0.849</td><td rowspan="1" colspan="1" valign="top" align="center">A</td><td rowspan="1" colspan="1" valign="top" align="center">1.14E-05</td><td rowspan="1" colspan="1" valign="top" align="center">−0.552</td><td rowspan="1" colspan="1" valign="top" align="center">0.734</td><td rowspan="1" colspan="1" valign="top" align="center">−0.020</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">rs12127272</td><td rowspan="1" colspan="1" valign="top" align="center"><em>–</em></td><td rowspan="1" colspan="1" valign="top" align="center">0.320</td><td rowspan="1" colspan="1" valign="top" align="center">G</td><td rowspan="1" colspan="1" valign="top" align="center">1.23E-05</td><td rowspan="1" colspan="1" valign="top" align="center">−0.453</td><td rowspan="1" colspan="1" valign="top" align="center">0.481</td><td rowspan="1" colspan="1" valign="top" align="center">0.042</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">rs9931454</td><td rowspan="1" colspan="1" valign="top" align="center"><em>–</em></td><td rowspan="1" colspan="1" valign="top" align="center">0.787</td><td rowspan="1" colspan="1" valign="top" align="center">C</td><td rowspan="1" colspan="1" valign="top" align="center">2.11E-05</td><td rowspan="1" colspan="1" valign="top" align="center">−0.495</td><td rowspan="1" colspan="1" valign="top" align="center">0.824</td><td rowspan="1" colspan="1" valign="top" align="center">0.013</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">rs11122844</td><td rowspan="1" colspan="1" valign="top" align="center"><em>–</em></td><td rowspan="1" colspan="1" valign="top" align="center">0.192</td><td rowspan="1" colspan="1" valign="top" align="center">C</td><td rowspan="1" colspan="1" valign="top" align="center">2.22E-05</td><td rowspan="1" colspan="1" valign="top" align="center">−0.501</td><td rowspan="1" colspan="1" valign="top" align="center">0.729</td><td rowspan="1" colspan="1" valign="top" align="center">0.021</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">rs3849317</td><td rowspan="1" colspan="1" valign="top" align="center"><em>–</em></td><td rowspan="1" colspan="1" valign="top" align="center">0.723</td><td rowspan="1" colspan="1" valign="top" align="center">C</td><td rowspan="1" colspan="1" valign="top" align="center">3.01E-05</td><td rowspan="1" colspan="1" valign="top" align="center">−0.425</td><td rowspan="1" colspan="1" valign="top" align="center">0.938</td><td rowspan="1" colspan="1" valign="top" align="center">−0.005</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">rs1151982</td><td rowspan="1" colspan="1" valign="top" align="center"><em>–</em></td><td rowspan="1" colspan="1" valign="top" align="center">0.017</td><td rowspan="1" colspan="1" valign="top" align="center">T</td><td rowspan="1" colspan="1" valign="top" align="center">3.07E-05</td><td rowspan="1" colspan="1" valign="top" align="center">−1.476</td><td rowspan="1" colspan="1" valign="top" align="center">0.163</td><td rowspan="1" colspan="1" valign="top" align="center">0.082</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">rs4766635</td><td rowspan="1" colspan="1" valign="top" align="center"><em>–</em></td><td rowspan="1" colspan="1" valign="top" align="center">0.641</td><td rowspan="1" colspan="1" valign="top" align="center">A</td><td rowspan="1" colspan="1" valign="top" align="center">3.10E-05</td><td rowspan="1" colspan="1" valign="top" align="center">−0.421</td><td rowspan="1" colspan="1" valign="top" align="center">0.561</td><td rowspan="1" colspan="1" valign="top" align="center">0.035</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">rs885339</td><td rowspan="1" colspan="1" valign="top" align="center"><em>–</em></td><td rowspan="1" colspan="1" valign="top" align="center">0.247</td><td rowspan="1" colspan="1" valign="top" align="center">T</td><td rowspan="1" colspan="1" valign="top" align="center">3.34E-05</td><td rowspan="1" colspan="1" valign="top" align="center">−0.418</td><td rowspan="1" colspan="1" valign="top" align="center">0.259</td><td rowspan="1" colspan="1" valign="top" align="center">0.068</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">rs7957299</td><td rowspan="1" colspan="1" valign="top" align="center"><em>PPTC7</em></td><td rowspan="1" colspan="1" valign="top" align="center">0.657</td><td rowspan="1" colspan="1" valign="top" align="center">C</td><td rowspan="1" colspan="1" valign="top" align="center">3.69E-05</td><td rowspan="1" colspan="1" valign="top" align="center">−0.371</td><td rowspan="1" colspan="1" valign="top" align="center">0.702</td><td rowspan="1" colspan="1" valign="top" align="center">0.023</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">rs17000495</td><td rowspan="1" colspan="1" valign="top" align="center"><em>MUC16</em></td><td rowspan="1" colspan="1" valign="top" align="center">0.801</td><td rowspan="1" colspan="1" valign="top" align="center">G</td><td rowspan="1" colspan="1" valign="top" align="center">4.02E-05</td><td rowspan="1" colspan="1" valign="top" align="center">−0.445</td><td rowspan="1" colspan="1" valign="top" align="center">0.182</td><td rowspan="1" colspan="1" valign="top" align="center">0.079</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">rs41478351</td><td rowspan="1" colspan="1" valign="top" align="center"><em>MGC45800</em></td><td rowspan="1" colspan="1" valign="top" align="center">0.101</td><td rowspan="1" colspan="1" valign="top" align="center">C</td><td rowspan="1" colspan="1" valign="top" align="center">4.20E-05</td><td rowspan="1" colspan="1" valign="top" align="center">−0.665</td><td rowspan="1" colspan="1" valign="top" align="center">0.545</td><td rowspan="1" colspan="1" valign="top" align="center">0.036</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">rs16931403</td><td rowspan="1" colspan="1" valign="top" align="center"><em>NFIB</em></td><td rowspan="1" colspan="1" valign="top" align="center">0.173</td><td rowspan="1" colspan="1" valign="top" align="center">G</td><td rowspan="1" colspan="1" valign="top" align="center">4.22E-05</td><td rowspan="1" colspan="1" valign="top" align="center">−0.457</td><td rowspan="1" colspan="1" valign="top" align="center">0.024</td><td rowspan="1" colspan="1" valign="top" align="center">0.136</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">rs9344006</td><td rowspan="1" colspan="1" valign="top" align="center"><em>–</em></td><td rowspan="1" colspan="1" valign="top" align="center">0.122</td><td rowspan="1" colspan="1" valign="top" align="center">G</td><td rowspan="1" colspan="1" valign="top" align="center">4.31E-05</td><td rowspan="1" colspan="1" valign="top" align="center">−0.524</td><td rowspan="1" colspan="1" valign="top" align="center">0.785</td><td rowspan="1" colspan="1" valign="top" align="center">−0.016</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">rs4843860</td><td rowspan="1" colspan="1" valign="top" align="center"><em>IRF8</em></td><td rowspan="1" colspan="1" valign="top" align="center">0.763</td><td rowspan="1" colspan="1" valign="top" align="center">A</td><td rowspan="1" colspan="1" valign="top" align="center">4.47E-05</td><td rowspan="1" colspan="1" valign="top" align="center">−0.426</td><td rowspan="1" colspan="1" valign="top" align="center">0.022</td><td rowspan="1" colspan="1" valign="top" align="center">0.135</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">rs9352839</td><td rowspan="1" colspan="1" valign="top" align="center"><em>–</em></td><td rowspan="1" colspan="1" valign="top" align="center">0.118</td><td rowspan="1" colspan="1" valign="top" align="center">A</td><td rowspan="1" colspan="1" valign="top" align="center">4.69E-05</td><td rowspan="1" colspan="1" valign="top" align="center">−0.532</td><td rowspan="1" colspan="1" valign="top" align="center">0.846</td><td rowspan="1" colspan="1" valign="top" align="center">0.012</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">rs41430546</td><td rowspan="1" colspan="1" valign="top" align="center"><em>–</em></td><td rowspan="1" colspan="1" valign="top" align="center">0.070</td><td rowspan="1" colspan="1" valign="top" align="center">G</td><td rowspan="1" colspan="1" valign="top" align="center">4.73E-05</td><td rowspan="1" colspan="1" valign="top" align="center">−0.754</td><td rowspan="1" colspan="1" valign="top" align="center">0.219</td><td rowspan="1" colspan="1" valign="top" align="center">0.073</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">rs3850825</td><td rowspan="1" colspan="1" valign="top" align="center"><em>ZNF496</em></td><td rowspan="1" colspan="1" valign="top" align="center">0.240</td><td rowspan="1" colspan="1" valign="top" align="center">G</td><td rowspan="1" colspan="1" valign="top" align="center">5.01E-05</td><td rowspan="1" colspan="1" valign="top" align="center">−0.416</td><td rowspan="1" colspan="1" valign="top" align="center">0.884</td><td rowspan="1" colspan="1" valign="top" align="center">0.009</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">rs6817370</td><td rowspan="1" colspan="1" valign="top" align="center"><em>–</em></td><td rowspan="1" colspan="1" valign="top" align="center">0.865</td><td rowspan="1" colspan="1" valign="top" align="center">T</td><td rowspan="1" colspan="1" valign="top" align="center">5.11E-05</td><td rowspan="1" colspan="1" valign="top" align="center">−0.557</td><td rowspan="1" colspan="1" valign="top" align="center">0.092</td><td rowspan="1" colspan="1" valign="top" align="center">0.099</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">rs9522086</td><td rowspan="1" colspan="1" valign="top" align="center"><em>–</em></td><td rowspan="1" colspan="1" valign="top" align="center">0.191</td><td rowspan="1" colspan="1" valign="top" align="center">A</td><td rowspan="1" colspan="1" valign="top" align="center">5.49E-05</td><td rowspan="1" colspan="1" valign="top" align="center">−0.442</td><td rowspan="1" colspan="1" valign="top" align="center">0.062</td><td rowspan="1" colspan="1" valign="top" align="center">0.110</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">rs2664109</td><td rowspan="1" colspan="1" valign="top" align="center"><em>SRGAP3</em></td><td rowspan="1" colspan="1" valign="top" align="center">0.642</td><td rowspan="1" colspan="1" valign="top" align="center">A</td><td rowspan="1" colspan="1" valign="top" align="center">5.99E-05</td><td rowspan="1" colspan="1" valign="top" align="center">−0.402</td><td rowspan="1" colspan="1" valign="top" align="center">0.265</td><td rowspan="1" colspan="1" valign="top" align="center">0.066</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">rs1940080</td><td rowspan="1" colspan="1" valign="top" align="center"><em>DLG2</em></td><td rowspan="1" colspan="1" valign="top" align="center">0.501</td><td rowspan="1" colspan="1" valign="top" align="center">A</td><td rowspan="1" colspan="1" valign="top" align="center">6.00E-05</td><td rowspan="1" colspan="1" valign="top" align="center">−0.376</td><td rowspan="1" colspan="1" valign="top" align="center">0.717</td><td rowspan="1" colspan="1" valign="top" align="center">0.021</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">rs7738642</td><td rowspan="1" colspan="1" valign="top" align="center"><em>–</em></td><td rowspan="1" colspan="1" valign="top" align="center">0.130</td><td rowspan="1" colspan="1" valign="top" align="center">T</td><td rowspan="1" colspan="1" valign="top" align="center">6.26E-05</td><td rowspan="1" colspan="1" valign="top" align="center">−0.497</td><td rowspan="1" colspan="1" valign="top" align="center">0.530</td><td rowspan="1" colspan="1" valign="top" align="center">−0.037</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">rs3863992</td><td rowspan="1" colspan="1" valign="top" align="center"><em>–</em></td><td rowspan="1" colspan="1" valign="top" align="center">0.171</td><td rowspan="1" colspan="1" valign="top" align="center">A</td><td rowspan="1" colspan="1" valign="top" align="center">8.04E-05</td><td rowspan="1" colspan="1" valign="top" align="center">−0.478</td><td rowspan="1" colspan="1" valign="top" align="center">0.328</td><td rowspan="1" colspan="1" valign="top" align="center">0.058</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">rs11165740</td><td rowspan="1" colspan="1" valign="top" align="center"><em>–</em></td><td rowspan="1" colspan="1" valign="top" align="center">0.360</td><td rowspan="1" colspan="1" valign="top" align="center">T</td><td rowspan="1" colspan="1" valign="top" align="center">8.38E-05</td><td rowspan="1" colspan="1" valign="top" align="center">−0.379</td><td rowspan="1" colspan="1" valign="top" align="center">0.187</td><td rowspan="1" colspan="1" valign="top" align="center">0.078</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">rs948640</td><td rowspan="1" colspan="1" valign="top" align="center"><em>–</em></td><td rowspan="1" colspan="1" valign="top" align="center">0.812</td><td rowspan="1" colspan="1" valign="top" align="center">C</td><td rowspan="1" colspan="1" valign="top" align="center">8.40E-05</td><td rowspan="1" colspan="1" valign="top" align="center">−0.454</td><td rowspan="1" colspan="1" valign="top" align="center">0.946</td><td rowspan="1" colspan="1" valign="top" align="center">−0.004</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">rs7522071</td><td rowspan="1" colspan="1" valign="top" align="center"><em>ZNF496</em></td><td rowspan="1" colspan="1" valign="top" align="center">0.229</td><td rowspan="1" colspan="1" valign="top" align="center">T</td><td rowspan="1" colspan="1" valign="top" align="center">8.41E-05</td><td rowspan="1" colspan="1" valign="top" align="center">−0.411</td><td rowspan="1" colspan="1" valign="top" align="center">0.627</td><td rowspan="1" colspan="1" valign="top" align="center">−0.029</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">rs1588571</td><td rowspan="1" colspan="1" valign="top" align="center"><em>LOC100129666</em></td><td rowspan="1" colspan="1" valign="top" align="center">0.062</td><td rowspan="1" colspan="1" valign="top" align="center">A</td><td rowspan="1" colspan="1" valign="top" align="center">8.53E-05</td><td rowspan="1" colspan="1" valign="top" align="center">−0.776</td><td rowspan="1" colspan="1" valign="top" align="center">0.002</td><td rowspan="1" colspan="1" valign="top" align="center">0.181</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">rs13179406</td><td rowspan="1" colspan="1" valign="top" align="center"><em>RNF130</em></td><td rowspan="1" colspan="1" valign="top" align="center">0.890</td><td rowspan="1" colspan="1" valign="top" align="center">A</td><td rowspan="1" colspan="1" valign="top" align="center">8.54E-05</td><td rowspan="1" colspan="1" valign="top" align="center">−0.536</td><td rowspan="1" colspan="1" valign="top" align="center">0.754</td><td rowspan="1" colspan="1" valign="top" align="center">0.019</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">rs987341</td><td rowspan="1" colspan="1" valign="top" align="center"><em>–</em></td><td rowspan="1" colspan="1" valign="top" align="center">0.062</td><td rowspan="1" colspan="1" valign="top" align="center">T</td><td rowspan="1" colspan="1" valign="top" align="center">8.60E-05</td><td rowspan="1" colspan="1" valign="top" align="center">−0.758</td><td rowspan="1" colspan="1" valign="top" align="center">0.784</td><td rowspan="1" colspan="1" valign="top" align="center">0.016</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">rs4937993</td><td rowspan="1" colspan="1" valign="top" align="center"><em>NCAM1</em></td><td rowspan="1" colspan="1" valign="top" align="center">0.520</td><td rowspan="1" colspan="1" valign="top" align="center">T</td><td rowspan="1" colspan="1" valign="top" align="center">8.75E-05</td><td rowspan="1" colspan="1" valign="top" align="center">−0.370</td><td rowspan="1" colspan="1" valign="top" align="center">0.013</td><td rowspan="1" colspan="1" valign="top" align="center">0.146</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">rs2297694</td><td rowspan="1" colspan="1" valign="top" align="center"><em>C9orf72</em></td><td rowspan="1" colspan="1" valign="top" align="center">0.275</td><td rowspan="1" colspan="1" valign="top" align="center">G</td><td rowspan="1" colspan="1" valign="top" align="center">9.05E-05</td><td rowspan="1" colspan="1" valign="top" align="center">−0.413</td><td rowspan="1" colspan="1" valign="top" align="center">0.208</td><td rowspan="1" colspan="1" valign="top" align="center">0.075</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">rs17079966</td><td rowspan="1" colspan="1" valign="top" align="center"><em>RNF130</em></td><td rowspan="1" colspan="1" valign="top" align="center">0.865</td><td rowspan="1" colspan="1" valign="top" align="center">G</td><td rowspan="1" colspan="1" valign="top" align="center">9.22E-05</td><td rowspan="1" colspan="1" valign="top" align="center">−0.494</td><td rowspan="1" colspan="1" valign="top" align="center">0.834</td><td rowspan="1" colspan="1" valign="top" align="center">−0.012</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">rs16839677</td><td rowspan="1" colspan="1" valign="top" align="center"><em>OLFML2B</em></td><td rowspan="1" colspan="1" valign="top" align="center">0.076</td><td rowspan="1" colspan="1" valign="top" align="center">A</td><td rowspan="1" colspan="1" valign="top" align="center">9.26E-05</td><td rowspan="1" colspan="1" valign="top" align="center">−0.692</td><td rowspan="1" colspan="1" valign="top" align="center">0.683</td><td rowspan="1" colspan="1" valign="top" align="center">−0.024</td></tr></tbody></table></div><div id="largeobj_idm139927698862064" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC5821586/table/T5/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="TFN11"><p id="__p32" class="p p-first-last">Abbreviations: SNP ID, single-nucleotide polymorphism identifier according to the dbSNP database; AUC, area under the plasma drug concentration−time curve</p></div><div id="TFN12"><sup>a</sup>Adjusted for age, genetic ancestry, treatment risk, and BMD Z-score at diagnosis.</div></div></div><p id="P23">Across the genome, the strongest association of a SNP with BMD Z-score changes from diagnosis to week 120 was observed for a SNP in the <em>COL11A1</em> gene (rs2622849) in chromosome 1p21.1 (<a href="/pmc/articles/PMC5821586/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Fig. 2B</span></a>). The T allele of this intronic SNP was associated with a significant decrease in BMD Z-score (coefficient of −1.071; <em>P</em> = 2.39 × 10<sup>−7</sup>) (<a href="/pmc/articles/PMC5821586/table/T5/" target="table" class="fig-table-link figpopup" rid-figpopup="T5" rid-ob="ob-T5" co-legend-rid=""><span>Table 5</span></a>). Similarly, the A allele of the <em>NELL1</em> SNP (rs11025915) (<a href="/pmc/articles/PMC5821586/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Fig. 2C</span></a>) was associated with a decrease in BMD Z-score (coefficient of −1.306; <em>P</em> = 4.07 × 10<sup>−6</sup>).</p><p id="P24" class="p p-last">As the dexamethasone AUC was negatively associated with BMD Z-score changes, we evaluated the associations of 38 germline SNP genotypes that are significant for a decrease in BMD Z-score from diagnosis to week 120 with larger dexamethasone AUCs. Five SNPs (13.2%) had <em>P</em>-values of less than 0.05 (<a href="/pmc/articles/PMC5821586/table/T5/" target="table" class="fig-table-link figpopup" rid-figpopup="T5" rid-ob="ob-T5" co-legend-rid=""><span>Table 5</span></a>), including <em>NELL1</em> (the A allele of rs11025915, <em>P</em> = 0.003) and <em>NFIB</em> (the G allele of rs16931403, <em>P</em> = 0.024).</p></div></div><div id="S19" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S19title">DISCUSSION</h2><p id="P25" class="p p-first">We showed that BMD in patients with ALL treated without cranial irradiation significantly decreased by week 120 of continuation therapy and partly recovered by 2 years off therapy. The BMD in most patients with a low BMD Z-score (&lt;−1.5) at diagnosis remained low at week 120 and 2 years off therapy. BMD Z-scores significantly decreased from diagnosis to week 120 in older patients and in those with higher BMD Z-scores at diagnosis, greater dexamethasone exposure, and/or SNPs identified by a GWAS.</p><p id="P26">The median BMD Z-score at diagnosis in our patients (0.06) was comparable to that in the general population, but the scores ranged from −3.27 to 3.56. As a result of leukemia cell proliferation in the bone marrow and cytokine-mediated osteoclast activity, children with ALL can present with low BMD Z-scores at diagnosis,<sup><a href="#R4" rid="R4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_668014887" role="button" aria-expanded="false" aria-haspopup="true">4</a></sup> and low Z-scores at diagnosis are associated with persistently low BMD Z-scores during and after therapy. BMD Z-scores at diagnosis were significantly higher in patients aged 10 years or older at diagnosis; however, these patients are considered to have a higher leukemia risk and typically receive higher and more intense doses of chemotherapeutic agents that disturb bone mineralization, resulting in a greater decline in BMD over the course of therapy. Among the clinical characteristics, a decline in height Z-score from diagnosis to week 120 was significantly associated with a decline in BMD Z-score in the same period. BMD and height increase significantly during puberty,<sup><a href="#R2" rid="R2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_668014849" role="button" aria-expanded="false" aria-haspopup="true">2</a>, <a href="#R19" rid="R19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_668014853" role="button" aria-expanded="false" aria-haspopup="true">19</a></sup> and normal accruals might have been compromised and/or delayed during chemotherapy, causing significantly more patients in this age group to have a BMD Z-score of less than −1.5 at week 120. The associations of older age and low BMD Z-score at diagnosis with lower BMD during continuation therapy have been described.<sup><a href="#R20" rid="R20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_668014851" role="button" aria-expanded="false" aria-haspopup="true">20</a></sup></p><p id="P27">A larger dexamethasone AUC, a known factor for bone morbidity,<sup><a href="#R12" rid="R12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_668014872" role="button" aria-expanded="false" aria-haspopup="true">12</a></sup> was significantly associated with a decrease in BMD Z-score during therapy. Although glucocorticoids play important roles in BMD deficits, other chemotherapeutic agents can contribute to such deficits. Low albumin and high triglyceride and total cholesterol levels in week 7 of continuation were significantly associated with a decrease in BMD Z-score, although these factors did not remain significant with the AIC and/or in multivariable analysis. Lower albumin levels and older age are associated with a larger dexamethasone AUC.<sup><a href="#R12" rid="R12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_668014873" role="button" aria-expanded="false" aria-haspopup="true">12</a></sup> Hypoalbuminemia is caused by the administration of asparaginase, which is more frequently used in older patients. Hypertriglyceridemia and hypercholesterolemia, which occur frequently during ALL therapy, are associated with asparaginase activity because asparaginase can inhibit lipoprotein lipase activities.<sup><a href="#R12" rid="R12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_668014894" role="button" aria-expanded="false" aria-haspopup="true">12</a></sup> Thus, asparaginase may indirectly cause a decline in BMD by increasing the dexamethasone AUC. Methotrexate reportedly reduces the proliferation of pre-osteoblasts and osteoblasts, increases the proliferation of osteoclasts,<sup><a href="#R21" rid="R21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_668014867" role="button" aria-expanded="false" aria-haspopup="true">21</a></sup> and contributes to calcium imbalance by interfering with renal function.<sup><a href="#R22" rid="R22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_668014856" role="button" aria-expanded="false" aria-haspopup="true">22</a></sup> However, the methotrexate AUC did not remain significant in the multivariable analysis.</p><p id="P28">In the GWAS, the 2 SNPs most associated with BMD Z-score change from diagnosis to week 120 were those in the <em>COL11A1</em> and <em>NFIB</em> genes, which are important in osteogenesis and bone mineralization. <em>COL11A1</em> encodes the alpha-1 chain of type XI collagen, which is composed of 3 alpha-chain products from <em>COL11A1</em>, <em>COL11A2</em>, and <em>COL2A1</em>.<sup><a href="#R23" rid="R23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_668014888" role="button" aria-expanded="false" aria-haspopup="true">23</a></sup> The phenotypes of type XI collagenopathies caused by <em>COL11A1</em> mutations in humans are heterogeneous and are associated not only with syndromes characterized by myopia, midfacial retrusion, and micrognathia but also with skeletal dysplasia. NELL1 is a secreted protein whose expression promotes osteoblast cell differentiation and terminal mineralization and inhibits osteoclast-induced bone resorption.<sup><a href="#R24" rid="R24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_668014858" role="button" aria-expanded="false" aria-haspopup="true">24</a></sup> NELL-1 overexpression results in craniosynostosis, whereas decreased NELL-1 expression leads to skeletal undermineralization. Administration of recombinant NELL-1 improves BMD in rodents. <em>NELL-1</em> and <em>NFIB</em> are associated with larger dexamethasone AUCs. NFIB is a cellular transcription factor that plays critical roles in osteoblast proliferation, differentiation, and survival and that regulates cartilage development.<sup><a href="#R25" rid="R25" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_668014882" role="button" aria-expanded="false" aria-haspopup="true">25</a></sup>
<em>Nfib</em> and the glucocorticoid receptor gene <em>Nr3c1</em> co-regulate genes related to lung maturation,<sup><a href="#R26" rid="R26" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_668014845" role="button" aria-expanded="false" aria-haspopup="true">26</a></sup> and NFIB and glucocorticoid receptor are critically involved in the development of milk-secreting alveolar epithelium in the mammary gland.<sup><a href="#R27" rid="R27" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_668014877" role="button" aria-expanded="false" aria-haspopup="true">27</a></sup> Such interactions may alter dexamethasone pharmacokinetics during chemotherapy.</p><p id="P29">In our study, BMDs partly recovered after patients completed therapy. This result must be interpreted cautiously, as patients who underwent a QCT examination at 2 years off therapy had lower BMD Z-scores at diagnosis and week 120 when compared to those who did not undergo a QCT examination, although there were no differences in other clinical characteristics. However, among patients who were evaluated by QCT at 2 years off therapy, the median BMD Z-score at 2 years off therapy (−0.72) was still lower than that at diagnosis (−0.05) and showed only partial improvement from that at week 120 (−1.13). Survivors treated without cranial irradiation have better BMD recovery after chemotherapy when compared to those who undergo irradiation.<sup><a href="#R3" rid="R3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_668014846" role="button" aria-expanded="false" aria-haspopup="true">3</a>, <a href="#R28" rid="R28" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_668014892" role="button" aria-expanded="false" aria-haspopup="true">28</a></sup> We evaluated clinical factors associated with changes in BMD Z-score from week 120 to 2 years off therapy. Importantly, at 2 years off therapy, the BMD Z-scores increased by a significantly greater extent in older patients than in younger patients, who did not lose BMD during therapy or gain it after therapy as did older patients. Although there was no significant difference between the age groups, the median BMD Z-score in younger patients was −0.79, compared with −0.26 in older patients. Patients with low BMD Z-scores at diagnosis had low BMD Z-scores not only at week 120 but also at 2 years off therapy. Younger patients with low BMD Z-scores at diagnosis may require long-term follow-up, and it needs to be determined whether they experience a typical physiologic BMD increase after the age of 10 years. In addition, patients with BMD Z-scores of less than −1.5 at 2 years off therapy require close observation and/or intervention.</p><p id="P30">Interventions to prevent bone loss during ALL therapy may include dietary counseling/supplementation to ensure adequate vitamin D and calcium intake,<sup><a href="#R13" rid="R13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_668014876" role="button" aria-expanded="false" aria-haspopup="true">13</a></sup> dexamethasone dose adjustment, and/or weight-bearing exercise.<sup><a href="#R29" rid="R29" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_668014881" role="button" aria-expanded="false" aria-haspopup="true">29</a></sup> However, persuading children and families to adhere to dietary modifications may be particularly challenging during ALL treatment. For adolescent and young adult survivors of ALL, supplementation with cholecalciferol and calcium conferred no additional benefit.<sup><a href="#R13" rid="R13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_668014852" role="button" aria-expanded="false" aria-haspopup="true">13</a></sup> Pharmacokinetics-based adjustment of the dexamethasone doses may compromise the desired anti-leukemia response. Weight-bearing exercise at the frequency and intensity necessary for optimal bone growth is difficult during ALL therapy and is discouraged for patients with osteonecrosis (another chemotherapy-related bone toxicity in ALL). However, it has been reported that low-magnitude, high-frequency mechanical stimulation (LMS) improves or prevents BMD loss in postmenopausal women,<sup><a href="#R30" rid="R30" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_668014855" role="button" aria-expanded="false" aria-haspopup="true">30</a></sup> patients with dystrophinopathies,<sup><a href="#R31" rid="R31" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_668014871" role="button" aria-expanded="false" aria-haspopup="true">31</a></sup> and children who have undergone cancer therapy.<sup><a href="#R32" rid="R32" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_668014870" role="button" aria-expanded="false" aria-haspopup="true">32</a></sup> As the patients need only stand on a vibrating platform for 10 min twice each day, the use of LMS to counter BMD loss during cancer therapy should be evaluated, and we are performing a placebo-controlled randomized study in patients with ALL (<a id="__tag_668014945" class="tag_hotlink" href="https://clinicaltrials.gov/ct2/show/NCT03117751" ref="reftype=extlink-clinical-trial&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CBody&amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov"><span class="tag-json" style="display:none">{"type":"clinical-trial","attrs":{"text":"NCT03117751","term_id":"NCT03117751"}}</span>NCT03117751</a>). The efficacy of pharmacologic agents such as bisphosphonate and receptor activator of NF-κB ligand (RANKL) inhibitor has been reported in pilot trials,<sup><a href="#R33" rid="R33" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_668014860" role="button" aria-expanded="false" aria-haspopup="true">33</a>–<a href="#R35" rid="R35" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_668014862" role="button" aria-expanded="false" aria-haspopup="true">35</a></sup> and these agents may be beneficial if a successful treatment approach is determined in the context of ALL therapy.</p><p id="P31">None of the SNPs that we evaluated reached genome-wide significance (&lt;5 × 10<sup>−8</sup>), probably because of the limited sample size; therefore, a further study including a replication cohort is required to confirm our findings. However, this is the first GWAS to investigate genetic risk factors for BMD changes in patients with ALL, and 2 SNPs have been found to play critical roles in bone development. Bone density can be evaluated by either QCT or dual X-ray absorptiometry (DXA). Both approaches have strengths and weaknesses, although DXA is more widely used.<sup><a href="#R36" rid="R36" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_668014854" role="button" aria-expanded="false" aria-haspopup="true">36</a>, <a href="#R37" rid="R37" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_668014891" role="button" aria-expanded="false" aria-haspopup="true">37</a></sup> DXA can assess the BMD of the whole body or individual areas and define BMD Z-scores by race-matched references in addition to age and sex. However, DXA measures a 2-dimensional area, with the volumetric result being generated by calculation, and this may lead to an underestimation of BMD in smaller bones. The BMD determination by QCT is volumetric and independent of bone size, and it is not hampered by longitudinal bone growth. Furthermore, the QCT software can correct for the curves in patients with scoliosis. In this study, we presented the trabecular BMD because trabecular bone is much more metabolically active than cortical bone and is considered a more sensitive indicator of skeletal metabolism and response to stresses and interventions.<sup><a href="#R38" rid="R38" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_668014880" role="button" aria-expanded="false" aria-haspopup="true">38</a></sup> Because the QCT reference data are based on the white population<sup><a href="#R14" rid="R14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_668014866" role="button" aria-expanded="false" aria-haspopup="true">14</a></sup> and the BMD Z-scores in black patients tended to be higher than those in white patients,<sup><a href="#R39" rid="R39" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_668014890" role="button" aria-expanded="false" aria-haspopup="true">39</a></sup> we adjusted the data for BMD Z-score changes and categories with respect to race. As baseline BMD Z-scores were significantly associated with subsequent values, we also adjusted these data to account for baseline values. Although we did not collect bone-fracture data prospectively, low BMD measured by QCT or DXA is associated with future fracture risk.<sup><a href="#R20" rid="R20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_668014875" role="button" aria-expanded="false" aria-haspopup="true">20</a>, <a href="#R40" rid="R40" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_668014895" role="button" aria-expanded="false" aria-haspopup="true">40</a>, <a href="#R41" rid="R41" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_668014865" role="button" aria-expanded="false" aria-haspopup="true">41</a></sup></p><p id="P32" class="p p-last">In conclusion, BMD Z-scores decrease significantly in children receiving contemporary therapy for ALL without cranial irradiation, and in many cases the scores do not fully recover by 2 years off therapy. Early recognition of BMD changes may facilitate developing strategies to optimize bone health, especially in patients with risk factors identified in this study.</p></div><div id="S20" class="tsec sec"><a id="supplementary-material-sec"></a><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S20title">Supplementary Material</h2><!--/article/body/sec/--><div class="sec suppmat" id="SD1"><h4>Supp FigS1</h4><div class="sup-box half_rhythm" id="d36e925"><a href="/pmc/articles/PMC5821586/bin/NIHMS926145-supplement-Supp_FigS1.tif" data-ga-action="click_feat_suppl">Click here to view.</a><sup>(341K, tif)</sup></div></div><div class="sec suppmat" id="SD2"><h4>Supp FigS2</h4><div class="sup-box half_rhythm" id="d36e929"><a href="/pmc/articles/PMC5821586/bin/NIHMS926145-supplement-Supp_FigS2.tif" data-ga-action="click_feat_suppl">Click here to view.</a><sup>(719K, tif)</sup></div></div><div class="sec suppmat" id="SD3"><h4>Supp TableS1-6</h4><div class="sup-box half_rhythm" id="d36e933"><a href="/pmc/articles/PMC5821586/bin/NIHMS926145-supplement-Supp_TableS1-6.docx" data-ga-action="click_feat_suppl">Click here to view.</a><sup>(64K, docx)</sup></div></div></div><div id="S21" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S21title">Acknowledgments</h2><div class="sec"><p id="__p2"><strong>Funding sources:</strong> This work was supported by grants CA21765, CA02394, and P50 GM115279 from the National Institutes of Health and by ALSAC.</p><p id="__p3">We thank Keith A. Laycock, PhD, ELS, (St. Jude Children’s Research Hospital) for editorial assistance.</p></div></div><div id="idm139927698477888" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm139927698477888title">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="FN3"></p><p id="__p4" class="p p-first-last"><strong>Conflict of interest disclosures:</strong> The authors have declared no conflicts of interest.</p><p></p><div><p id="__p5" class="p p-first"><strong>Author contributions</strong></p>Study concept: Hiroto Inaba, Sue C. Kaste<p id="__p7" class="p">Study design: Hiroto Inaba, Sue C. Kaste</p><p id="__p8" class="p">Data acquisition: Hiroto Inaba, Xueyuan Cao, Alice Han, John C. Panetta, Cheng Cheng, Ching-Hon Pui, Mary V. Relling, Sue C. Kaste</p><p id="__p9" class="p">Quality control of data and algorithms: Hiroto Inaba, Xueyuan Cao, Sue C. Kaste</p><p id="__p10" class="p">Data analysis and interpretation: Hiroto Inaba, Xueyuan Cao, John C. Panetta, Kirsten Ness, Monika L. Metzger, Jeffrey E. Rubnitz, Raul C. Ribeiro, John T. Sandlund, Sima Jeha, Cheng Cheng, Ching-Hon Pui, Mary V. Relling, Sue C. Kaste</p><p id="__p11" class="p">Statistical analysis: Xueyuan Cao, Cheng Cheng</p><p id="__p12" class="p">Manuscript preparation: Hiroto Inaba, Xueyuan Cao, Alice Han, Sue C. Kaste</p><p id="__p13" class="p">Manuscript editing: All authors</p><p id="__p14" class="p p-last">Manuscript review: All authors</p></div></div></div><div id="idm139927703586000" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm139927703586000title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="R1">1. <span class="element-citation">Inaba H, Greaves M, Mullighan CG. Acute lymphoblastic leukaemia. <span><span class="ref-journal">Lancet. </span>2013;<span class="ref-vol">381</span>:1943–1955.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3816716/">PMC free article</a>]</span> [<a href="/pubmed/23523389" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Acute+lymphoblastic+leukaemia&amp;author=H+Inaba&amp;author=M+Greaves&amp;author=CG+Mullighan&amp;volume=381&amp;publication_year=2013&amp;pages=1943-1955&amp;pmid=23523389&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R2">2. <span class="element-citation">Leonard MB, Elmi A, Mostoufi-Moab S, et al.  Effects of sex, race, and puberty on cortical bone and the functional muscle bone unit in children, adolescents, and young adults. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2010;<span class="ref-vol">95</span>:1681–1689.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2853999/">PMC free article</a>]</span> [<a href="/pubmed/20157194" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Endocrinol+Metab&amp;title=Effects+of+sex,+race,+and+puberty+on+cortical+bone+and+the+functional+muscle+bone+unit+in+children,+adolescents,+and+young+adults&amp;author=MB+Leonard&amp;author=A+Elmi&amp;author=S+Mostoufi-Moab&amp;volume=95&amp;publication_year=2010&amp;pages=1681-1689&amp;pmid=20157194&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R3">3. <span class="element-citation">Mostoufi-Moab S, Halton J. Bone morbidity in childhood leukemia: epidemiology, mechanisms, diagnosis, and treatment. <span><span class="ref-journal">Curr Osteoporos Rep. </span>2014;<span class="ref-vol">12</span>:300–312.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4131149/">PMC free article</a>]</span> [<a href="/pubmed/24986711" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Curr+Osteoporos+Rep&amp;title=Bone+morbidity+in+childhood+leukemia:+epidemiology,+mechanisms,+diagnosis,+and+treatment&amp;author=S+Mostoufi-Moab&amp;author=J+Halton&amp;volume=12&amp;publication_year=2014&amp;pages=300-312&amp;pmid=24986711&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R4">4. <span class="element-citation">van der Sluis IM, van den Heuvel-Eibrink MM, Hählen K, Krenning EP, de Muinck Keizer-Schrama SM. Altered bone mineral density and body composition, and increased fracture risk in childhood acute lymphoblastic leukemia. <span><span class="ref-journal">J Pediatr. </span>2002;<span class="ref-vol">141</span>:204–210.</span> [<a href="/pubmed/12183715" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Pediatr&amp;title=Altered+bone+mineral+density+and+body+composition,+and+increased+fracture+risk+in+childhood+acute+lymphoblastic+leukemia&amp;author=IM+van+der+Sluis&amp;author=MM+van+den+Heuvel-Eibrink&amp;author=K+Hählen&amp;author=EP+Krenning&amp;author=SM+de+Muinck+Keizer-Schrama&amp;volume=141&amp;publication_year=2002&amp;pages=204-210&amp;pmid=12183715&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R5">5. <span class="element-citation">Halton JM, Atkinson SA, Fraher L, et al.  Altered mineral metabolism and bone mass in children during treatment for acute lymphoblastic leukemia. <span><span class="ref-journal">J Bone Miner Res. </span>1996;<span class="ref-vol">11</span>:1774–1783.</span> [<a href="/pubmed/8915786" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Bone+Miner+Res&amp;title=Altered+mineral+metabolism+and+bone+mass+in+children+during+treatment+for+acute+lymphoblastic+leukemia&amp;author=JM+Halton&amp;author=SA+Atkinson&amp;author=L+Fraher&amp;volume=11&amp;publication_year=1996&amp;pages=1774-1783&amp;pmid=8915786&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R6">6. <span class="element-citation">Strauss AJ, Su JT, Dalton VM, Gelber RD, Sallan SE, Silverman LB. Bony morbidity in children treated for acute lymphoblastic leukemia. <span><span class="ref-journal">J Clin Oncol. </span>2001;<span class="ref-vol">19</span>:3066–3072.</span> [<a href="/pubmed/11408503" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Oncol&amp;title=Bony+morbidity+in+children+treated+for+acute+lymphoblastic+leukemia&amp;author=AJ+Strauss&amp;author=JT+Su&amp;author=VM+Dalton&amp;author=RD+Gelber&amp;author=SE+Sallan&amp;volume=19&amp;publication_year=2001&amp;pages=3066-3072&amp;pmid=11408503&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R7">7. <span class="element-citation">Pui CH, Campana D, Pei D, et al.  Treating childhood acute lymphoblastic leukemia without cranial irradiation. <span><span class="ref-journal">N Engl J Med. </span>2009;<span class="ref-vol">360</span>:2730–2741.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2754320/">PMC free article</a>]</span> [<a href="/pubmed/19553647" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=Treating+childhood+acute+lymphoblastic+leukemia+without+cranial+irradiation&amp;author=CH+Pui&amp;author=D+Campana&amp;author=D+Pei&amp;volume=360&amp;publication_year=2009&amp;pages=2730-2741&amp;pmid=19553647&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R8">8. <span class="element-citation">te Winkel ML, van Beek RD, de Muinck Keizer-Schrama SM, et al.  Pharmacogenetic risk factors for altered bone mineral density and body composition in pediatric acute lymphoblastic leukemia. <span><span class="ref-journal">Haematologica. </span>2010;<span class="ref-vol">95</span>:752–759.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2864381/">PMC free article</a>]</span> [<a href="/pubmed/20015871" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Haematologica&amp;title=Pharmacogenetic+risk+factors+for+altered+bone+mineral+density+and+body+composition+in+pediatric+acute+lymphoblastic+leukemia&amp;author=ML+te+Winkel&amp;author=RD+van+Beek&amp;author=SM+de+Muinck+Keizer-Schrama&amp;volume=95&amp;publication_year=2010&amp;pages=752-759&amp;pmid=20015871&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R9">9. <span class="element-citation">te Winkel ML, de Muinck Keizer-Schrama SM, de Jonge R, et al.  Germline variation in the <em>MTHFR</em> and <em>MTRR</em> genes determines the nadir of bone density in pediatric acute lymphoblastic leukemia: a prospective study. <span><span class="ref-journal">Bone. </span>2011;<span class="ref-vol">48</span>:571–577.</span> [<a href="/pubmed/20955826" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Bone&amp;title=Germline+variation+in+the+MTHFR+and+MTRR+genes+determines+the+nadir+of+bone+density+in+pediatric+acute+lymphoblastic+leukemia:+a+prospective+study&amp;author=ML+te+Winkel&amp;author=SM+de+Muinck+Keizer-Schrama&amp;author=R+de+Jonge&amp;volume=48&amp;publication_year=2011&amp;pages=571-577&amp;pmid=20955826&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R10">10. <span class="element-citation">Jones TS, Kaste SC, Liu W, et al.  <em>CRHR1</em> polymorphisms predict bone density in survivors of acute lymphoblastic leukemia. <span><span class="ref-journal">J Clin Oncol. </span>2008;<span class="ref-vol">26</span>:3031–3037.</span> [<a href="/pubmed/18565889" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Oncol&amp;title=CRHR1+polymorphisms+predict+bone+density+in+survivors+of+acute+lymphoblastic+leukemia&amp;author=TS+Jones&amp;author=SC+Kaste&amp;author=W+Liu&amp;volume=26&amp;publication_year=2008&amp;pages=3031-3037&amp;pmid=18565889&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R11">11. <span class="element-citation">Park HW, Tse S, Yang W, et al.  A genetic factor associated with low final bone mineral density in children after a long-term glucocorticoids treatment. <span><span class="ref-journal">Pharmacogenomics J. </span>2017;<span class="ref-vol">17</span>:180–185.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4980282/">PMC free article</a>]</span> [<a href="/pubmed/26856247" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacogenomics+J&amp;title=A+genetic+factor+associated+with+low+final+bone+mineral+density+in+children+after+a+long-term+glucocorticoids+treatment&amp;author=HW+Park&amp;author=S+Tse&amp;author=W+Yang&amp;volume=17&amp;publication_year=2017&amp;pages=180-185&amp;pmid=26856247&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R12">12. <span class="element-citation">Kawedia JD, Kaste SC, Pei D, et al.  Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemia. <span><span class="ref-journal">Blood. </span>2011;<span class="ref-vol">117</span>:2340–2347.</span> quiz 2556. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3062406/">PMC free article</a>]</span> [<a href="/pubmed/21148812" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Pharmacokinetic,+pharmacodynamic,+and+pharmacogenetic+determinants+of+osteonecrosis+in+children+with+acute+lymphoblastic+leukemia&amp;author=JD+Kawedia&amp;author=SC+Kaste&amp;author=D+Pei&amp;volume=117&amp;publication_year=2011&amp;pages=2340-2347&amp;pmid=21148812&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R13">13. <span class="element-citation">Kaste SC, Qi A, Smith K, et al.  Calcium and cholecalciferol supplementation provides no added benefit to nutritional counseling to improve bone mineral density in survivors of childhood acute lymphoblastic leukemia (ALL) <span><span class="ref-journal">Pediatr Blood Cancer. </span>2014;<span class="ref-vol">61</span>:885–893.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4160024/">PMC free article</a>]</span> [<a href="/pubmed/24395288" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pediatr+Blood+Cancer&amp;title=Calcium+and+cholecalciferol+supplementation+provides+no+added+benefit+to+nutritional+counseling+to+improve+bone+mineral+density+in+survivors+of+childhood+acute+lymphoblastic+leukemia+(ALL)&amp;author=SC+Kaste&amp;author=A+Qi&amp;author=K+Smith&amp;volume=61&amp;publication_year=2014&amp;pages=885-893&amp;pmid=24395288&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R14">14. <span class="element-citation">Gilsanz V, Gibbens DT, Roe TF, et al.  Vertebral bone density in children: effect of puberty. <span><span class="ref-journal">Radiology. </span>1988;<span class="ref-vol">166</span>:847–850.</span> [<a href="/pubmed/3340782" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Radiology&amp;title=Vertebral+bone+density+in+children:+effect+of+puberty&amp;author=V+Gilsanz&amp;author=DT+Gibbens&amp;author=TF+Roe&amp;volume=166&amp;publication_year=1988&amp;pages=847-850&amp;pmid=3340782&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R15">15. <span class="element-citation">Yang L, Panetta JC, Cai X, et al.  Asparaginase may influence dexamethasone pharmacokinetics in acute lymphoblastic leukemia. <span><span class="ref-journal">J Clin Oncol. </span>2008;<span class="ref-vol">26</span>:1932–1939.</span> [<a href="/pubmed/18421047" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Oncol&amp;title=Asparaginase+may+influence+dexamethasone+pharmacokinetics+in+acute+lymphoblastic+leukemia&amp;author=L+Yang&amp;author=JC+Panetta&amp;author=X+Cai&amp;volume=26&amp;publication_year=2008&amp;pages=1932-1939&amp;pmid=18421047&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R16">16. <span class="element-citation">Mikkelsen TS, Sparreboom A, Cheng C, et al.  Shortening infusion time for high-dose methotrexate alters antileukemic effects: a randomized prospective clinical trial. <span><span class="ref-journal">J Clin Oncol. </span>2011;<span class="ref-vol">29</span>:1771–1778.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3107765/">PMC free article</a>]</span> [<a href="/pubmed/21444869" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Oncol&amp;title=Shortening+infusion+time+for+high-dose+methotrexate+alters+antileukemic+effects:+a+randomized+prospective+clinical+trial&amp;author=TS+Mikkelsen&amp;author=A+Sparreboom&amp;author=C+Cheng&amp;volume=29&amp;publication_year=2011&amp;pages=1771-1778&amp;pmid=21444869&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R17">17. <span class="element-citation">Pauley JL, Panetta JC, Crews KR, et al.  Between-course targeting of methotrexate exposure using pharmacokinetically guided dosage adjustments. <span><span class="ref-journal">Cancer Chemother Pharmacol. </span>2013;<span class="ref-vol">72</span>:369–378.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3719000/">PMC free article</a>]</span> [<a href="/pubmed/23760811" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Chemother+Pharmacol&amp;title=Between-course+targeting+of+methotrexate+exposure+using+pharmacokinetically+guided+dosage+adjustments&amp;author=JL+Pauley&amp;author=JC+Panetta&amp;author=KR+Crews&amp;volume=72&amp;publication_year=2013&amp;pages=369-378&amp;pmid=23760811&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R18">18. <span class="element-citation">Cheng C, Pounds SB, Boyett JM, Pei D, Kuo ML, Roussel MF. Statistical significance threshold criteria for analysis of microarray gene expression data. <span><span class="ref-journal">Stat Appl Genet Mol Biol. </span>2004;<span class="ref-vol">3</span></span> Article36. [<a href="/pubmed/16646816" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Stat+Appl+Genet+Mol+Biol&amp;title=Statistical+significance+threshold+criteria+for+analysis+of+microarray+gene+expression+data&amp;author=C+Cheng&amp;author=SB+Pounds&amp;author=JM+Boyett&amp;author=D+Pei&amp;author=ML+Kuo&amp;volume=3&amp;publication_year=2004&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R19">19. <span class="element-citation">Naka H, Iki M, Morita A, Ikeda Y. Effects of pubertal development, height, weight, and grip strength on the bone mineral density of the lumbar spine and hip in peripubertal Japanese children: Kyoto kids increase density in the skeleton study (Kyoto KIDS study) <span><span class="ref-journal">J Bone Miner Metab. </span>2005;<span class="ref-vol">23</span>:463–469.</span> [<a href="/pubmed/16261453" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Bone+Miner+Metab&amp;title=Effects+of+pubertal+development,+height,+weight,+and+grip+strength+on+the+bone+mineral+density+of+the+lumbar+spine+and+hip+in+peripubertal+Japanese+children:+Kyoto+kids+increase+density+in+the+skeleton+study+(Kyoto+KIDS+study)&amp;author=H+Naka&amp;author=M+Iki&amp;author=A+Morita&amp;author=Y+Ikeda&amp;volume=23&amp;publication_year=2005&amp;pages=463-469&amp;pmid=16261453&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R20">20. <span class="element-citation">Rayar MS, Nayiager T, Webber CE, Barr RD, Athale UH. Predictors of bony morbidity in children with acute lymphoblastic leukemia. <span><span class="ref-journal">Pediatr Blood Cancer. </span>2012;<span class="ref-vol">59</span>:77–82.</span> [<a href="/pubmed/22190454" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pediatr+Blood+Cancer&amp;title=Predictors+of+bony+morbidity+in+children+with+acute+lymphoblastic+leukemia&amp;author=MS+Rayar&amp;author=T+Nayiager&amp;author=CE+Webber&amp;author=RD+Barr&amp;author=UH+Athale&amp;volume=59&amp;publication_year=2012&amp;pages=77-82&amp;pmid=22190454&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R21">21. <span class="element-citation">Xian CJ, Cool JC, Scherer MA, et al.  Cellular mechanisms for methotrexate chemotherapy-induced bone growth defects. <span><span class="ref-journal">Bone. </span>2007;<span class="ref-vol">41</span>:842–850.</span> [<a href="/pubmed/17884747" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Bone&amp;title=Cellular+mechanisms+for+methotrexate+chemotherapy-induced+bone+growth+defects&amp;author=CJ+Xian&amp;author=JC+Cool&amp;author=MA+Scherer&amp;volume=41&amp;publication_year=2007&amp;pages=842-850&amp;pmid=17884747&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R22">22. <span class="element-citation">van Leeuwen BL, Kamps WA, Jansen HW, Hoekstra HJ. The effect of chemotherapy on the growing skeleton. <span><span class="ref-journal">Cancer Treat Rev. </span>2000;<span class="ref-vol">26</span>:363–376.</span> [<a href="/pubmed/11006137" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Treat+Rev&amp;title=The+effect+of+chemotherapy+on+the+growing+skeleton&amp;author=BL+van+Leeuwen&amp;author=WA+Kamps&amp;author=HW+Jansen&amp;author=HJ+Hoekstra&amp;volume=26&amp;publication_year=2000&amp;pages=363-376&amp;pmid=11006137&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R23">23. <span class="element-citation">Li Y, Lacerda DA, Warman ML, et al.  A fibrillar collagen gene, <em>Col11a1</em>, is essential for skeletal morphogenesis. <span><span class="ref-journal">Cell. </span>1995;<span class="ref-vol">80</span>:423–430.</span> [<a href="/pubmed/7859283" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=A+fibrillar+collagen+gene,+Col11a1,+is+essential+for+skeletal+morphogenesis&amp;author=Y+Li&amp;author=DA+Lacerda&amp;author=ML+Warman&amp;volume=80&amp;publication_year=1995&amp;pages=423-430&amp;pmid=7859283&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R24">24. <span class="element-citation">James AW, Shen J, Zhang X, et al.  NELL-1 in the treatment of osteoporotic bone loss. <span><span class="ref-journal">Nat Commun. </span>2015;<span class="ref-vol">6</span>:7362.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4557288/">PMC free article</a>]</span> [<a href="/pubmed/26082355" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Commun&amp;title=NELL-1+in+the+treatment+of+osteoporotic+bone+loss&amp;author=AW+James&amp;author=J+Shen&amp;author=X+Zhang&amp;volume=6&amp;publication_year=2015&amp;pages=7362&amp;pmid=26082355&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R25">25. <span class="element-citation">Perez-Casellas LA, Wang X, Howard KD, Rehage MW, Strong DD, Linkhart TA. Nuclear factor I transcription factors regulate IGF binding protein 5 gene transcription in human osteoblasts. <span><span class="ref-journal">Biochim Biophys Acta. </span>2009;<span class="ref-vol">1789</span>:78–87.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2707257/">PMC free article</a>]</span> [<a href="/pubmed/18809517" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochim+Biophys+Acta&amp;title=Nuclear+factor+I+transcription+factors+regulate+IGF+binding+protein+5+gene+transcription+in+human+osteoblasts&amp;author=LA+Perez-Casellas&amp;author=X+Wang&amp;author=KD+Howard&amp;author=MW+Rehage&amp;author=DD+Strong&amp;volume=1789&amp;publication_year=2009&amp;pages=78-87&amp;pmid=18809517&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R26">26. <span class="element-citation">Lajoie M, Hsu YC, Gronostajski RM, Bailey TL. An overlapping set of genes is regulated by both NFIB and the glucocorticoid receptor during lung maturation. <span><span class="ref-journal">BMC Genomics. </span>2014;<span class="ref-vol">15</span>:231.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4023408/">PMC free article</a>]</span> [<a href="/pubmed/24661679" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=BMC+Genomics&amp;title=An+overlapping+set+of+genes+is+regulated+by+both+NFIB+and+the+glucocorticoid+receptor+during+lung+maturation&amp;author=M+Lajoie&amp;author=YC+Hsu&amp;author=RM+Gronostajski&amp;author=TL+Bailey&amp;volume=15&amp;publication_year=2014&amp;pages=231&amp;pmid=24661679&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R27">27. <span class="element-citation">Shin HY, Willi M, Yoo KH, et al.  Hierarchy within the mammary STAT5-driven Wap super-enhancer. <span><span class="ref-journal">Nat Genet. </span>2016;<span class="ref-vol">48</span>:904–911.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4963296/">PMC free article</a>]</span> [<a href="/pubmed/27376239" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=Hierarchy+within+the+mammary+STAT5-driven+Wap+super-enhancer&amp;author=HY+Shin&amp;author=M+Willi&amp;author=KH+Yoo&amp;volume=48&amp;publication_year=2016&amp;pages=904-911&amp;pmid=27376239&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R28">28. <span class="element-citation">Gurney JG, Kaste SC, Liu W, et al.  Bone mineral density among long-term survivors of childhood acute lymphoblastic leukemia: results from the St. Jude Lifetime Cohort Study. <span><span class="ref-journal">Pediatr Blood Cancer. </span>2014;<span class="ref-vol">61</span>:1270–1276.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4300194/">PMC free article</a>]</span> [<a href="/pubmed/24585546" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pediatr+Blood+Cancer&amp;title=Bone+mineral+density+among+long-term+survivors+of+childhood+acute+lymphoblastic+leukemia:+results+from+the+St.+Jude+Lifetime+Cohort+Study&amp;author=JG+Gurney&amp;author=SC+Kaste&amp;author=W+Liu&amp;volume=61&amp;publication_year=2014&amp;pages=1270-1276&amp;pmid=24585546&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R29">29. <span class="element-citation">Hartman A, te Winkel ML, van Beek RD, et al.  A randomized trial investigating an exercise program to prevent reduction of bone mineral density and impairment of motor performance during treatment for childhood acute lymphoblastic leukemia. <span><span class="ref-journal">Pediatr Blood Cancer. </span>2009;<span class="ref-vol">53</span>:64–71.</span> [<a href="/pubmed/19283791" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pediatr+Blood+Cancer&amp;title=A+randomized+trial+investigating+an+exercise+program+to+prevent+reduction+of+bone+mineral+density+and+impairment+of+motor+performance+during+treatment+for+childhood+acute+lymphoblastic+leukemia&amp;author=A+Hartman&amp;author=ML+te+Winkel&amp;author=RD+van+Beek&amp;volume=53&amp;publication_year=2009&amp;pages=64-71&amp;pmid=19283791&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R30">30. <span class="element-citation">Rubin C, Recker R, Cullen D, Ryaby J, McCabe J, McLeod K. Prevention of postmenopausal bone loss by a low-magnitude, high-frequency mechanical stimuli: a clinical trial assessing compliance, efficacy, and safety. <span><span class="ref-journal">J Bone Miner Res. </span>2004;<span class="ref-vol">19</span>:343–351.</span> [<a href="/pubmed/15040821" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Bone+Miner+Res&amp;title=Prevention+of+postmenopausal+bone+loss+by+a+low-magnitude,+high-frequency+mechanical+stimuli:+a+clinical+trial+assessing+compliance,+efficacy,+and+safety&amp;author=C+Rubin&amp;author=R+Recker&amp;author=D+Cullen&amp;author=J+Ryaby&amp;author=J+McCabe&amp;volume=19&amp;publication_year=2004&amp;pages=343-351&amp;pmid=15040821&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R31">31. <span class="element-citation">Petryk A, Polgreen LE, Grames M, Lowe DA, Hodges JS, Karachunski P. Feasibility and tolerability of whole-body, low-intensity vibration and its effects on muscle function and bone in patients with dystrophinopathies: a pilot study. <span><span class="ref-journal">Muscle Nerve. </span>2017;<span class="ref-vol">55</span>:875–883.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5385164/">PMC free article</a>]</span> [<a href="/pubmed/27718512" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Muscle+Nerve&amp;title=Feasibility+and+tolerability+of+whole-body,+low-intensity+vibration+and+its+effects+on+muscle+function+and+bone+in+patients+with+dystrophinopathies:+a+pilot+study&amp;author=A+Petryk&amp;author=LE+Polgreen&amp;author=M+Grames&amp;author=DA+Lowe&amp;author=JS+Hodges&amp;volume=55&amp;publication_year=2017&amp;pages=875-883&amp;pmid=27718512&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R32">32. <span class="element-citation">Mogil RJ, Kaste SC, Ferry RJ, Jr, et al.  Effect of low-magnitude, high-frequency mechanical stimulation on BMD among young childhood cancer survivors: a randomized clinical trial. <span><span class="ref-journal">JAMA Oncol. </span>2016;<span class="ref-vol">2</span>:908–914.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4945422/">PMC free article</a>]</span> [<a href="/pubmed/26967465" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=JAMA+Oncol&amp;title=Effect+of+low-magnitude,+high-frequency+mechanical+stimulation+on+BMD+among+young+childhood+cancer+survivors:+a+randomized+clinical+trial&amp;author=RJ+Mogil&amp;author=SC+Kaste&amp;author=RJ+Ferry&amp;volume=2&amp;publication_year=2016&amp;pages=908-914&amp;pmid=26967465&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R33">33. <span class="element-citation">Barr RD, Guo CY, Wiernikowski J, Webber C, Wright M, Atkinson S. Osteopenia in children with acute lymphoblastic leukemia: a pilot study of amelioration with pamidronate. <span><span class="ref-journal">Med Pediatr Oncol. </span>2002;<span class="ref-vol">39</span>:44–46.</span> [<a href="/pubmed/12116079" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Med+Pediatr+Oncol&amp;title=Osteopenia+in+children+with+acute+lymphoblastic+leukemia:+a+pilot+study+of+amelioration+with+pamidronate&amp;author=RD+Barr&amp;author=CY+Guo&amp;author=J+Wiernikowski&amp;author=C+Webber&amp;author=M+Wright&amp;volume=39&amp;publication_year=2002&amp;pages=44-46&amp;pmid=12116079&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R34">34. <span class="element-citation">Wiernikowski JT, Barr RD, Webber C, Guo CY, Wright M, Atkinson SA. Alendronate for steroid-induced osteopenia in children with acute lymphoblastic leukaemia or non-Hodgkin’s lymphoma: results of a pilot study. <span><span class="ref-journal">J Oncol Pharm Pract. </span>2005;<span class="ref-vol">11</span>:51–56.</span> [<a href="/pubmed/16460605" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Oncol+Pharm+Pract&amp;title=Alendronate+for+steroid-induced+osteopenia+in+children+with+acute+lymphoblastic+leukaemia+or+non-Hodgkin’s+lymphoma:+results+of+a+pilot+study&amp;author=JT+Wiernikowski&amp;author=RD+Barr&amp;author=C+Webber&amp;author=CY+Guo&amp;author=M+Wright&amp;volume=11&amp;publication_year=2005&amp;pages=51-56&amp;pmid=16460605&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R35">35. <span class="element-citation">Mok CC, Ho LY, Ma KM. Switching of oral bisphosphonates to denosumab in chronic glucocorticoid users: a 12-month randomized controlled trial. <span><span class="ref-journal">Bone. </span>2015;<span class="ref-vol">75</span>:222–228.</span> [<a href="/pubmed/25761434" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Bone&amp;title=Switching+of+oral+bisphosphonates+to+denosumab+in+chronic+glucocorticoid+users:+a+12-month+randomized+controlled+trial&amp;author=CC+Mok&amp;author=LY+Ho&amp;author=KM+Ma&amp;volume=75&amp;publication_year=2015&amp;pages=222-228&amp;pmid=25761434&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R36">36. <span class="element-citation">Leonard MB. Assessment of bone health in children and adolescents with cancer: promises and pitfalls of current techniques. <span><span class="ref-journal">Med Pediatr Oncol. </span>2003;<span class="ref-vol">41</span>:198–207.</span> [<a href="/pubmed/12868119" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Med+Pediatr+Oncol&amp;title=Assessment+of+bone+health+in+children+and+adolescents+with+cancer:+promises+and+pitfalls+of+current+techniques&amp;author=MB+Leonard&amp;volume=41&amp;publication_year=2003&amp;pages=198-207&amp;pmid=12868119&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R37">37. <span class="element-citation">Kaste SC, Tong X, Hendrick JM, et al.  QCT versus DXA in 320 survivors of childhood cancer: association of BMD with fracture history. <span><span class="ref-journal">Pediatr Blood Cancer. </span>2006;<span class="ref-vol">47</span>:936–943.</span> [<a href="/pubmed/16602115" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pediatr+Blood+Cancer&amp;title=QCT+versus+DXA+in+320+survivors+of+childhood+cancer:+association+of+BMD+with+fracture+history&amp;author=SC+Kaste&amp;author=X+Tong&amp;author=JM+Hendrick&amp;volume=47&amp;publication_year=2006&amp;pages=936-943&amp;pmid=16602115&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R38">38. <span class="element-citation">Cann CE, Genant HK, Young DR. Comparison of vertebral and peripheral mineral losses in disuse osteoporosis in monkeys. <span><span class="ref-journal">Radiology. </span>1980;<span class="ref-vol">134</span>:525–529.</span> [<a href="/pubmed/6766220" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Radiology&amp;title=Comparison+of+vertebral+and+peripheral+mineral+losses+in+disuse+osteoporosis+in+monkeys&amp;author=CE+Cann&amp;author=HK+Genant&amp;author=DR+Young&amp;volume=134&amp;publication_year=1980&amp;pages=525-529&amp;pmid=6766220&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R39">39. <span class="element-citation">Gilsanz V, Roe TF, Mora S, Costin G, Goodman WG. Changes in vertebral bone density in black girls and white girls during childhood and puberty. <span><span class="ref-journal">N Engl J Med. </span>1991;<span class="ref-vol">325</span>:1597–1600.</span> [<a href="/pubmed/1944449" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=Changes+in+vertebral+bone+density+in+black+girls+and+white+girls+during+childhood+and+puberty&amp;author=V+Gilsanz&amp;author=TF+Roe&amp;author=S+Mora&amp;author=G+Costin&amp;author=WG+Goodman&amp;volume=325&amp;publication_year=1991&amp;pages=1597-1600&amp;pmid=1944449&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R40">40. <span class="element-citation">Cann CE, Genant HK, Kolb FO, Ettinger B. Quantitative computed tomography for prediction of vertebral fracture risk. <span><span class="ref-journal">Bone. </span>1985;<span class="ref-vol">6</span>:1–7.</span> [<a href="/pubmed/3994856" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Bone&amp;title=Quantitative+computed+tomography+for+prediction+of+vertebral+fracture+risk&amp;author=CE+Cann&amp;author=HK+Genant&amp;author=FO+Kolb&amp;author=B+Ettinger&amp;volume=6&amp;publication_year=1985&amp;pages=1-7&amp;pmid=3994856&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R41">41. <span class="element-citation">te Winkel ML, Pieters R, Hop WC, et al.  Bone mineral density at diagnosis determines fracture rate in children with acute lymphoblastic leukemia treated according to the DCOG-ALL9 protocol. <span><span class="ref-journal">Bone. </span>2014;<span class="ref-vol">59</span>:223–228.</span> [<a href="/pubmed/24287213" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Bone&amp;title=Bone+mineral+density+at+diagnosis+determines+fracture+rate+in+children+with+acute+lymphoblastic+leukemia+treated+according+to+the+DCOG-ALL9+protocol&amp;author=ML+te+Winkel&amp;author=R+Pieters&amp;author=WC+Hop&amp;volume=59&amp;publication_year=2014&amp;pages=223-228&amp;pmid=24287213&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div></div></div><div style="display: none; width: 200px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbilinksmenu"><ul id="ui-ncbiinpagenav-2"><li><a href="#ui-ncbiinpagenav-heading-3">Associated Data</a></li><li><a href="#idm139927713698240title">Abstract</a></li><li><a href="#S5title">INTRODUCTION</a></li><li><a href="#S6title">METHODS</a></li><li><a href="#S13title">RESULTS</a></li><li><a href="#S19title">DISCUSSION</a></li><li><a href="#S20title">Supplementary Material</a></li><li><a href="#S21title">Acknowledgments</a></li><li><a href="#idm139927698477888title">Footnotes</a></li><li><a href="#idm139927703586000title">References</a></li></ul></div></div><!--post-content--></div>
            
            
        
            
        </div>
        <!-- Book content -->
    </div>
    
    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            
        </div>
        
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC5821586/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC5821586/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC5821586/pdf/nihms926145.pdf">PDF (692K)</a></li> | <li><a href="#" data-citationid="PMC5821586" class="citationexporter ctxp" role="button" aria-expanded="false" aria-haspopup="true">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5821586%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook">
                             Facebook
                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5821586%2F&amp;text=Bone%20mineral%20density%20in%20children%20with%20acute%20lymphoblastic%20leukemia" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter">
                             Twitter
                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5821586%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus">
                             Google+
                        </a></li></ul></div>
        
        <div id="ajax-portlets" data-pmid="29266176" data-aiid="5821586" data-aid="5821586" data-iid="307045" data-domainid="319" data-domain="nihpa" data-accid="PMC5821586" data-md5="b52dcc655045a15ea9c8f36c0ee9a860">
<div class="portlet pubmed_favoritesad">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Save items</span></h3></div>
<a name="Shutter" sid="1" href="#" class="portlet_shutter ui-ncbitoggler-open" title="Show/hide content" remembercollapsed="true" pgsec_name="pmfavad" toggles="ui-portlet_content-5" role="button" aria-expanded="true" style="position: absolute; padding: 0px;"></a>
</div>
<div class="ui-helper-reset" aria-live="assertive"><div class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-5" aria-hidden="false"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<input name="absid" id="absid" value="5821586" type="hidden"><div id="pubmed_favoritesad" class="empty" data-db="pmc">
<span role="menubar"><div class="ui-ncbisetswitch ltd-hover" role="menuitem" aria-expanded="false" aria-haspopup="true"><a href="/myncbi/collections/" class="jig-ncbisetswitch blind collink ltd-hover ui-ncbisetswitch-hasStar" id="favList" data-jigconfig="destSelector:'#favUL',starExists:true,createCollectionUrl:'#',manageCollectionsUrl:'/myncbi/collections/'"><span class="star"></span>Add to Favorites</a><a class="ui-ncbisetswitch-button ltd-hover" title="View more options" href="#"><span class="ui-icon ui-icon-triangle-1-s ui-ncbisetswitch-down">View more options</span></a></div></span><div style="display: none; width: 200px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbilinksmenu ui-ncbisetswitch-popper"><ul id="favUL" class="ui-ncbisetswitch-options"></ul><ul class="ui-ncbisetswitch-actions"><li class="ui-ncbisetswitch-actions-create" style="display: block;"><a class="ui-ncbisetswitch-create-collection" href="#">Create collection...</a></li><li class="ui-ncbisetswitch-actions-manage" style="display: block;"><a class="ui-ncbisetswitch-manage-collections" href="/myncbi/collections/">Manage collections...</a></li></ul></div>
</div>
<div class="colloading">loading</div>
<span id="submenu_AddToCollections"><form method="post"><input class="button_apply" name="addtocollection" value="1" type="submit"></form></span>
</div></div></div>
</div><div class="portlet">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div>
<a name="Shutter" sid="1" href="#" class="portlet_shutter ui-ncbitoggler-open" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" toggles="ui-portlet_content-6" role="button" aria-expanded="true" style="position: absolute; padding: 0px;"></a>
</div>
<div class="ui-helper-reset" aria-live="assertive"><div class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-6" aria-hidden="false">
<ul>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="/pubmed/18293849" ref="reftype=relart&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">[Accretion of bone mass in patients treated for childhood acute lymphoblastic leukemia].</a><span class="source">[Pol Merkur Lekarski. 2007]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-7" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Muszyńska-Rosłan K, Konstantynowicz J, Krawczuk-Rybak M. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Pol Merkur Lekarski. 2007 Oct; 23(136):271-5. </em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="/pubmed/22190454" ref="reftype=relart&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Predictors of bony morbidity in children with acute lymphoblastic leukemia.</a><span class="source">[Pediatr Blood Cancer. 2012]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-8" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Rayar MS, Nayiager T, Webber CE, Barr RD, Athale UH. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Pediatr Blood Cancer. 2012 Jul 15; 59(1):77-82. Epub 2011 Dec 20.</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="/pubmed/27671543" ref="reftype=relart&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">No impact of disease and its treatment on bone mineral density in survivors of childhood acute lymphoblastic leukemia.</a><span class="source">[Pediatr Blood Cancer. 2017]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-9" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Jain S, Jain S, Kapoor G, Virmani A, Bajpai R. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Pediatr Blood Cancer. 2017 Apr; 64(4). Epub 2016 Sep 26.</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="/pubmed/20216235" ref="reftype=relart&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Assessment of bone mineral density and risk factors in children completing treatment for acute lymphoblastic leukemia.</a><span class="source">[J Pediatr Hematol Oncol. 2010]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-10" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Gunes AM, Can E, Saglam H, Ilçöl YO, Baytan B. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">J Pediatr Hematol Oncol. 2010 Apr; 32(3):e102-7. </em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="/pubmed/19213989" ref="reftype=relart&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Changes in bone mineral density during therapy in childhood acute lymphoblastic leukemia.</a><span class="source">[Indian Pediatr. 2009]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-11" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Kaushik A, Bansal D, Khandelwal N, Trehan A, Marwaha RK. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Indian Pediatr. 2009 Mar; 46(3):245-8. Epub 2009 Jan 21.</em>
</div>
</li>
</ul>
<a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=29266176&amp;log%24=relatedreviews&amp;logdbfrom=pmc" ref="reftype=relart&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Reviews&amp;rendering-type=normal">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=29266176&amp;log%24=relatedarticles&amp;logdbfrom=pmc" ref="reftype=relart&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Related%20Records&amp;rendering-type=normal">See all...</a>
</div></div>
</div><div class="portlet">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Cited by other articles in PMC</span></h3></div>
<a name="Shutter" sid="1" href="#" class="portlet_shutter ui-ncbitoggler-open" title="Show/hide content" remembercollapsed="true" pgsec_name="PMCVCitedByPmcArticlesP" toggles="ui-portlet_content-12" role="button" aria-expanded="true" style="position: absolute; padding: 0px;"></a>
</div>
<div class="ui-helper-reset" aria-live="assertive"><div class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-12" aria-hidden="false">
<ul><li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="/pmc/articles/PMC5908317/" ref="reftype=relart&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Physical training interventions for children and teenagers affected by acute lymphoblastic leukemia and related treatment impairments</a><span class="source">[Oncotarget. 2018]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-13" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Simioni C, Zauli G, Martelli AM, Vitale M, Ultimo S, Milani D, Neri LM. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Oncotarget. 2018 Mar 30; 9(24): 17199-17209</em>
</div>
</li></ul>
<a class="seemore" href="citedby/" ref="reftype=relart&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|CitedBy&amp;rendering-type=normal">See all...</a>
</div></div>
</div><div class="portlet">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Links</span></h3></div>
<a name="Shutter" sid="1" href="#" class="portlet_shutter ui-ncbitoggler-open" title="Show/hide content" remembercollapsed="true" pgsec_name="PMCVCitedByPmcArticlesP" toggles="ui-portlet_content-14" role="button" aria-expanded="true" style="position: absolute; padding: 0px;"></a>
</div>
<div class="ui-helper-reset" aria-live="assertive"><div class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-14" aria-hidden="false"><ul>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="/pmc/?Db=pccompound&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_pccompound&amp;IdsFromResult=5821586" ref="reftype=Compound&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|PubChem%20Compound&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Compound</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-15" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">Compound<div class="brieflinkpopdesc">PubChem Compound links</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="/pmc/?Db=medgen&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_medgen&amp;IdsFromResult=5821586" ref="reftype=MedGen&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|Unknown%20Link%20Name&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">MedGen</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-16" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">MedGen<div class="brieflinkpopdesc">Related information in MedGen</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="/pubmed/29266176/" ref="reftype=PubMed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|PubMed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">PubMed</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-17" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">PubMed<div class="brieflinkpopdesc">PubMed citations for these articles</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="/pmc/?Db=snp&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_snp&amp;IdsFromResult=5821586" ref="reftype=SNP&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|SNP&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">SNP</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-18" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">SNP<div class="brieflinkpopdesc">PMC to SNP links</div>
</div>
</li>
</ul></div></div>
</div><div class="portlet">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Recent Activity</span></h3></div>
<a name="Shutter" sid="1" href="#" class="portlet_shutter ui-ncbitoggler-open" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" toggles="ui-portlet_content-19" role="button" aria-expanded="true" style="position: absolute; padding: 0px;"></a>
</div>
<div class="ui-helper-reset" aria-live="assertive"><div class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-19" aria-hidden="false"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class="">
<div class="action">
<a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a>
</div>
<ul id="activity">
<li class="ra_rcd ralinkpopper two_line">
<a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5dd5b519dd2142621d00f3aa">Bone mineral density in children with acute lymphoblastic leukemia</a><div class="ralinkpop offscreen_noflow">Bone mineral density in children with acute lymphoblastic leukemia<div class="brieflinkpopdesc">NIHPA Author Manuscripts. 2018 Mar 1; 124(5)1025</div>
</div>
<div class="tertiary"></div>
</li>
<li class="ra_rcd ralinkpopper two_line">
<a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=2" href="/portal/utils/pageresolver.fcgi?recordid=5dd5b4efdde0893a8b09c202">Investigating the genetic architecture of dementia with Lewy bodies: a two-stage...</a><div class="ralinkpop offscreen_noflow">Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study<div class="brieflinkpopdesc">NIHPA Author Manuscripts. 2018 Jan; 17(1)64</div>
</div>
<div class="tertiary"></div>
</li>
<li class="ra_rcd ralinkpopper two_line">
<a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=3" href="/portal/utils/pageresolver.fcgi?recordid=5dd5b4c8dde0893a8b050df8">Association analysis in over 329,000 individuals identifies 116 independent vari...</a><div class="ralinkpop offscreen_noflow">Association analysis in over 329,000 individuals identifies 116 independent variants influencing neuroticism<div class="brieflinkpopdesc">UKPMC Funders Author Manuscripts. 2018 Jan; 50(1)6</div>
</div>
<div class="tertiary"></div>
</li>
<li class="ra_rcd ralinkpopper two_line">
<a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=4" href="/portal/utils/pageresolver.fcgi?recordid=5dd5b49075f66d018ff10186">Polymorphisms in the Wilms Tumor Gene Are Associated With Interindividual Variat...</a><div class="ralinkpop offscreen_noflow">Polymorphisms in the Wilms Tumor Gene Are Associated With Interindividual Variations in Rubella Virus–Specific Cellular Immunity After Measles-Mumps-Rubella II Vaccination<div class="brieflinkpopdesc">The Journal of Infectious Diseases. 2018 Feb 15; 217(4)560</div>
</div>
<div class="tertiary"></div>
</li>
<li class="ra_rcd ralinkpopper two_line">
<a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=5" href="/portal/utils/pageresolver.fcgi?recordid=5dd5b45e75f66d018feaefdf">Hierarchical Investigation of Genetic Influences on Response Inhibition in Healt...</a><div class="ralinkpop offscreen_noflow">Hierarchical Investigation of Genetic Influences on Response Inhibition in Healthy Young Adults<div class="brieflinkpopdesc">NIHPA Author Manuscripts. 2017 Dec; 25(6)512</div>
</div>
<div class="tertiary"></div>
</li>
</ul>
<p class="HTOn">Your browsing activity is empty.</p>
<p class="HTOff">Activity recording is turned off.</p>
<p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p>
<a class="seemore" href="/sites/myncbi/recentactivity">See more...</a>
</div></div></div>
</div>
<div>
<div class="portlet brieflink pmc_para_cit" id="crb--P5" name="crb--P5" rid="P5" style="position: absolute; visibility: visible; width: 370px; top: 1441px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-20"><ul>
<li class="two_line" reference_id="R1">
<a href="/pubmed/23523389/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Acute lymphoblastic leukaemia.</a><span class="one_line_source">[Lancet.  2013]</span><div class="alt-note">
<div class="authors">Inaba H, Greaves M, Mullighan CG</div>
<div class="citation">Lancet. 2013 Jun 1; 381(9881):1943-55.</div>
</div>
</li>
<li class="two_line" reference_id="R2">
<a href="/pubmed/20157194/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Effects of sex, race, and puberty on cortical bone and the functional muscle bone unit in children, adolescents, and young adults.</a><span class="one_line_source">[J Clin Endocrinol Metab.  2010]</span><div class="alt-note">
<div class="authors">Leonard MB, Elmi A, Mostoufi-Moab S, Shults J, Burnham JM, Thayu M, Kibe L, Wetzsteon RJ, Zemel BS</div>
<div class="citation">J Clin Endocrinol Metab. 2010 Apr; 95(4):1681-9.</div>
</div>
</li>
<li class="two_line" reference_id="R3">
<a href="/pubmed/24986711/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Bone morbidity in childhood leukemia: epidemiology, mechanisms, diagnosis, and treatment.</a><span class="one_line_source">[Curr Osteoporos Rep.  2014]</span><div class="alt-note">
<div class="authors">Mostoufi-Moab S, Halton J</div>
<div class="citation">Curr Osteoporos Rep. 2014 Sep; 12(3):300-12.</div>
</div>
</li>
<li class="two_line" reference_id="R6">
<a href="/pubmed/11408503/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Bony morbidity in children treated for acute lymphoblastic leukemia.</a><span class="one_line_source">[J Clin Oncol.  2001]</span><div class="alt-note">
<div class="authors">Strauss AJ, Su JT, Dalton VM, Gelber RD, Sallan SE, Silverman LB</div>
<div class="citation">J Clin Oncol. 2001 Jun 15; 19(12):3066-72.</div>
</div>
</li>
<li class="two_line" reference_id="R7">
<a href="/pubmed/19553647/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Treating childhood acute lymphoblastic leukemia without cranial irradiation.</a><span class="one_line_source">[N Engl J Med.  2009]</span><div class="alt-note">
<div class="authors">Pui CH, Campana D, Pei D, Bowman WP, Sandlund JT, Kaste SC, Ribeiro RC, Rubnitz JE, Raimondi SC, Onciu M, Coustan-Smith E, Kun LE, Jeha S, Cheng C, Howard SC, Simmons V, Bayles A, Metzger ML, Boyett JM, Leung W, Handgretinger R, Downing JR, Evans WE, Relling MV</div>
<div class="citation">N Engl J Med. 2009 Jun 25; 360(26):2730-41.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P6" name="crb--P6" rid="P6" style="position: absolute; visibility: visible; width: 370px; top: 1676px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-21"><ul>
<li class="two_line" reference_id="R8">
<a href="/pubmed/20015871/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Pharmacogenetic risk factors for altered bone mineral density and body composition in pediatric acute lymphoblastic leukemia.</a><span class="one_line_source">[Haematologica.  2010]</span><div class="alt-note">
<div class="authors">te Winkel ML, van Beek RD, de Muinck Keizer-Schrama SM, Uitterlinden AG, Hop WC, Pieters R, van den Heuvel-Eibrink MM</div>
<div class="citation">Haematologica. 2010 May; 95(5):752-9.</div>
</div>
</li>
<li class="two_line" reference_id="R9">
<a href="/pubmed/20955826/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Germline variation in the MTHFR and MTRR genes determines the nadir of bone density in pediatric acute lymphoblastic leukemia: a prospective study.</a><span class="one_line_source">[Bone.  2011]</span><div class="alt-note">
<div class="authors">te Winkel ML, de Muinck Keizer-Schrama SM, de Jonge R, van Beek RD, van der Sluis IM, Hop WC, Pieters R, van den Heuvel-Eibrink MM</div>
<div class="citation">Bone. 2011 Mar 1; 48(3):571-7.</div>
</div>
</li>
<li class="two_line" reference_id="R10">
<a href="/pubmed/18565889/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">CRHR1 polymorphisms predict bone density in survivors of acute lymphoblastic leukemia.</a><span class="one_line_source">[J Clin Oncol.  2008]</span><div class="alt-note">
<div class="authors">Jones TS, Kaste SC, Liu W, Cheng C, Yang W, Tantisira KG, Pui CH, Relling MV</div>
<div class="citation">J Clin Oncol. 2008 Jun 20; 26(18):3031-7.</div>
</div>
</li>
<li class="two_line" reference_id="R11">
<a href="/pubmed/26856247/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">A genetic factor associated with low final bone mineral density in children after a long-term glucocorticoids treatment.</a><span class="one_line_source">[Pharmacogenomics J.  2017]</span><div class="alt-note">
<div class="authors">Park HW, Tse S, Yang W, Kelly HW, Kaste SC, Pui CH, Relling MV, Tantisira KG</div>
<div class="citation">Pharmacogenomics J. 2017 Mar; 17(2):180-185.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P7" name="crb--P7" rid="P7" style="position: absolute; visibility: visible; width: 370px; top: 1968px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-22"><ul><li class="two_line" reference_id="R7">
<a href="/pubmed/19553647/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Treating childhood acute lymphoblastic leukemia without cranial irradiation.</a><span class="one_line_source">[N Engl J Med.  2009]</span><div class="alt-note">
<div class="authors">Pui CH, Campana D, Pei D, Bowman WP, Sandlund JT, Kaste SC, Ribeiro RC, Rubnitz JE, Raimondi SC, Onciu M, Coustan-Smith E, Kun LE, Jeha S, Cheng C, Howard SC, Simmons V, Bayles A, Metzger ML, Boyett JM, Leung W, Handgretinger R, Downing JR, Evans WE, Relling MV</div>
<div class="citation">N Engl J Med. 2009 Jun 25; 360(26):2730-41.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P8" name="crb--P8" rid="P8" style="position: absolute; visibility: visible; width: 370px; top: 2153px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-23"><ul>
<li class="two_line" reference_id="R7">
<a href="/pubmed/19553647/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Treating childhood acute lymphoblastic leukemia without cranial irradiation.</a><span class="one_line_source">[N Engl J Med.  2009]</span><div class="alt-note">
<div class="authors">Pui CH, Campana D, Pei D, Bowman WP, Sandlund JT, Kaste SC, Ribeiro RC, Rubnitz JE, Raimondi SC, Onciu M, Coustan-Smith E, Kun LE, Jeha S, Cheng C, Howard SC, Simmons V, Bayles A, Metzger ML, Boyett JM, Leung W, Handgretinger R, Downing JR, Evans WE, Relling MV</div>
<div class="citation">N Engl J Med. 2009 Jun 25; 360(26):2730-41.</div>
</div>
</li>
<li class="two_line" reference_id="R12">
<a href="/pubmed/21148812/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemia.</a><span class="one_line_source">[Blood.  2011]</span><div class="alt-note">
<div class="authors">Kawedia JD, Kaste SC, Pei D, Panetta JC, Cai X, Cheng C, Neale G, Howard SC, Evans WE, Pui CH, Relling MV</div>
<div class="citation">Blood. 2011 Feb 24; 117(8):2340-7; quiz 2556.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P9" name="crb--P9" rid="P9" style="position: absolute; visibility: visible; width: 370px; top: 2496px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-24"><ul>
<li class="two_line" reference_id="R13">
<a href="/pubmed/24395288/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Calcium and cholecalciferol supplementation provides no added benefit to nutritional counseling to improve bone mineral density in survivors of childhood acute lymphoblastic leukemia (ALL).</a><span class="one_line_source">[Pediatr Blood Cancer.  2014]</span><div class="alt-note">
<div class="authors">Kaste SC, Qi A, Smith K, Surprise H, Lovorn E, Boyett J, Ferry RJ Jr, Relling MV, Shurtleff SA, Pui CH, Carbone L, Hudson MM, Ness KK</div>
<div class="citation">Pediatr Blood Cancer. 2014 May; 61(5):885-93.</div>
</div>
</li>
<li class="two_line" reference_id="R14">
<a href="/pubmed/3340782/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Vertebral bone density in children: effect of puberty.</a><span class="one_line_source">[Radiology.  1988]</span><div class="alt-note">
<div class="authors">Gilsanz V, Gibbens DT, Roe TF, Carlson M, Senac MO, Boechat MI, Huang HK, Schulz EE, Libanati CR, Cann CC</div>
<div class="citation">Radiology. 1988 Mar; 166(3):847-50.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P10" name="crb--P10" rid="P10" style="position: absolute; visibility: visible; width: 370px; top: 2746px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-25"><ul>
<li class="two_line" reference_id="R12">
<a href="/pubmed/21148812/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemia.</a><span class="one_line_source">[Blood.  2011]</span><div class="alt-note">
<div class="authors">Kawedia JD, Kaste SC, Pei D, Panetta JC, Cai X, Cheng C, Neale G, Howard SC, Evans WE, Pui CH, Relling MV</div>
<div class="citation">Blood. 2011 Feb 24; 117(8):2340-7; quiz 2556.</div>
</div>
</li>
<li class="two_line" reference_id="R15">
<a href="/pubmed/18421047/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Asparaginase may influence dexamethasone pharmacokinetics in acute lymphoblastic leukemia.</a><span class="one_line_source">[J Clin Oncol.  2008]</span><div class="alt-note">
<div class="authors">Yang L, Panetta JC, Cai X, Yang W, Pei D, Cheng C, Kornegay N, Pui CH, Relling MV</div>
<div class="citation">J Clin Oncol. 2008 Apr 20; 26(12):1932-9.</div>
</div>
</li>
<li class="two_line" reference_id="R16">
<a href="/pubmed/21444869/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Shortening infusion time for high-dose methotrexate alters antileukemic effects: a randomized prospective clinical trial.</a><span class="one_line_source">[J Clin Oncol.  2011]</span><div class="alt-note">
<div class="authors">Mikkelsen TS, Sparreboom A, Cheng C, Zhou Y, Boyett JM, Raimondi SC, Panetta JC, Bowman WP, Sandlund JT, Pui CH, Relling MV, Evans WE</div>
<div class="citation">J Clin Oncol. 2011 May 1; 29(13):1771-8.</div>
</div>
</li>
<li class="two_line" reference_id="R17">
<a href="/pubmed/23760811/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Between-course targeting of methotrexate exposure using pharmacokinetically guided dosage adjustments.</a><span class="one_line_source">[Cancer Chemother Pharmacol.  2013]</span><div class="alt-note">
<div class="authors">Pauley JL, Panetta JC, Crews KR, Pei D, Cheng C, McCormick J, Howard SC, Sandlund JT, Jeha S, Ribeiro R, Rubnitz J, Pui CH, Evans WE, Relling MV</div>
<div class="citation">Cancer Chemother Pharmacol. 2013 Aug; 72(2):369-78.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P11" name="crb--P11" rid="P11" style="position: absolute; visibility: visible; width: 370px; top: 2935px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-26"><ul><li class="two_line" reference_id="R12">
<a href="/pubmed/21148812/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemia.</a><span class="one_line_source">[Blood.  2011]</span><div class="alt-note">
<div class="authors">Kawedia JD, Kaste SC, Pei D, Panetta JC, Cai X, Cheng C, Neale G, Howard SC, Evans WE, Pui CH, Relling MV</div>
<div class="citation">Blood. 2011 Feb 24; 117(8):2340-7; quiz 2556.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P14" name="crb--P14" rid="P14" style="position: absolute; visibility: visible; width: 370px; top: 3600px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-27"><ul><li class="two_line" reference_id="R18">
<a href="/pubmed/16646816/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Statistical significance threshold criteria for analysis of microarray gene expression data.</a><span class="one_line_source">[Stat Appl Genet Mol Biol.  2004]</span><div class="alt-note">
<div class="authors">Cheng C, Pounds SB, Boyett JM, Pei D, Kuo ML, Roussel MF</div>
<div class="citation">Stat Appl Genet Mol Biol. 2004; 3():Article36.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P26" name="crb--P26" rid="P26" style="position: absolute; visibility: visible; width: 370px; top: 10700px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-28"><ul>
<li class="two_line" reference_id="R4">
<a href="/pubmed/12183715/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Altered bone mineral density and body composition, and increased fracture risk in childhood acute lymphoblastic leukemia.</a><span class="one_line_source">[J Pediatr.  2002]</span><div class="alt-note">
<div class="authors">van der Sluis IM, van den Heuvel-Eibrink MM, Hählen K, Krenning EP, de Muinck Keizer-Schrama SM</div>
<div class="citation">J Pediatr. 2002 Aug; 141(2):204-10.</div>
</div>
</li>
<li class="two_line" reference_id="R2">
<a href="/pubmed/20157194/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Effects of sex, race, and puberty on cortical bone and the functional muscle bone unit in children, adolescents, and young adults.</a><span class="one_line_source">[J Clin Endocrinol Metab.  2010]</span><div class="alt-note">
<div class="authors">Leonard MB, Elmi A, Mostoufi-Moab S, Shults J, Burnham JM, Thayu M, Kibe L, Wetzsteon RJ, Zemel BS</div>
<div class="citation">J Clin Endocrinol Metab. 2010 Apr; 95(4):1681-9.</div>
</div>
</li>
<li class="two_line" reference_id="R19">
<a href="/pubmed/16261453/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Effects of pubertal development, height, weight, and grip strength on the bone mineral density of the lumbar spine and hip in peripubertal Japanese children: Kyoto kids increase density in the skeleton study (Kyoto KIDS study).</a><span class="one_line_source">[J Bone Miner Metab.  2005]</span><div class="alt-note">
<div class="authors">Naka H, Iki M, Morita A, Ikeda Y</div>
<div class="citation">J Bone Miner Metab. 2005; 23(6):463-9.</div>
</div>
</li>
<li class="two_line" reference_id="R20">
<a href="/pubmed/22190454/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Predictors of bony morbidity in children with acute lymphoblastic leukemia.</a><span class="one_line_source">[Pediatr Blood Cancer.  2012]</span><div class="alt-note">
<div class="authors">Rayar MS, Nayiager T, Webber CE, Barr RD, Athale UH</div>
<div class="citation">Pediatr Blood Cancer. 2012 Jul 15; 59(1):77-82.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P27" name="crb--P27" rid="P27" style="position: absolute; visibility: visible; width: 370px; top: 10999px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-29"><ul>
<li class="two_line" reference_id="R12">
<a href="/pubmed/21148812/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemia.</a><span class="one_line_source">[Blood.  2011]</span><div class="alt-note">
<div class="authors">Kawedia JD, Kaste SC, Pei D, Panetta JC, Cai X, Cheng C, Neale G, Howard SC, Evans WE, Pui CH, Relling MV</div>
<div class="citation">Blood. 2011 Feb 24; 117(8):2340-7; quiz 2556.</div>
</div>
</li>
<li class="two_line" reference_id="R21">
<a href="/pubmed/17884747/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Cellular mechanisms for methotrexate chemotherapy-induced bone growth defects.</a><span class="one_line_source">[Bone.  2007]</span><div class="alt-note">
<div class="authors">Xian CJ, Cool JC, Scherer MA, Macsai CE, Fan C, Covino M, Foster BK</div>
<div class="citation">Bone. 2007 Nov; 41(5):842-50.</div>
</div>
</li>
<li class="two_line" reference_id="R22">
<a href="/pubmed/11006137/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> The effect of chemotherapy on the growing skeleton.</a><span class="one_line_source">[Cancer Treat Rev.  2000]</span><div class="alt-note">
<div class="authors">van Leeuwen BL, Kamps WA, Jansen HW, Hoekstra HJ</div>
<div class="citation">Cancer Treat Rev. 2000 Oct; 26(5):363-76.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P28" name="crb--P28" rid="P28" style="position: absolute; visibility: visible; width: 370px; top: 11299px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-30"><ul>
<li class="two_line" reference_id="R23">
<a href="/pubmed/7859283/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">A fibrillar collagen gene, Col11a1, is essential for skeletal morphogenesis.</a><span class="one_line_source">[Cell.  1995]</span><div class="alt-note">
<div class="authors">Li Y, Lacerda DA, Warman ML, Beier DR, Yoshioka H, Ninomiya Y, Oxford JT, Morris NP, Andrikopoulos K, Ramirez F</div>
<div class="citation">Cell. 1995 Feb 10; 80(3):423-30.</div>
</div>
</li>
<li class="two_line" reference_id="R24">
<a href="/pubmed/26082355/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">NELL-1 in the treatment of osteoporotic bone loss.</a><span class="one_line_source">[Nat Commun.  2015]</span><div class="alt-note">
<div class="authors">James AW, Shen J, Zhang X, Asatrian G, Goyal R, Kwak JH, Jiang L, Bengs B, Culiat CT, Turner AS, Seim Iii HB, Wu BM, Lyons K, Adams JS, Ting K, Soo C</div>
<div class="citation">Nat Commun. 2015 Jun 17; 6():7362.</div>
</div>
</li>
<li class="two_line" reference_id="R25">
<a href="/pubmed/18809517/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Nuclear factor I transcription factors regulate IGF binding protein 5 gene transcription in human osteoblasts.</a><span class="one_line_source">[Biochim Biophys Acta.  2009]</span><div class="alt-note">
<div class="authors">Pérez-Casellas LA, Wang X, Howard KD, Rehage MW, Strong DD, Linkhart TA</div>
<div class="citation">Biochim Biophys Acta. 2009 Feb; 1789(2):78-87.</div>
</div>
</li>
<li class="two_line" reference_id="R26">
<a href="/pubmed/24661679/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">An overlapping set of genes is regulated by both NFIB and the glucocorticoid receptor during lung maturation.</a><span class="one_line_source">[BMC Genomics.  2014]</span><div class="alt-note">
<div class="authors">Lajoie M, Hsu YC, Gronostajski RM, Bailey TL</div>
<div class="citation">BMC Genomics. 2014 Mar 25; 15():231.</div>
</div>
</li>
<li class="two_line" reference_id="R27">
<a href="/pubmed/27376239/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Hierarchy within the mammary STAT5-driven Wap super-enhancer.</a><span class="one_line_source">[Nat Genet.  2016]</span><div class="alt-note">
<div class="authors">Shin HY, Willi M, HyunYoo K, Zeng X, Wang C, Metser G, Hennighausen L</div>
<div class="citation">Nat Genet. 2016 Aug; 48(8):904-911.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P29" name="crb--P29" rid="P29" style="position: absolute; visibility: visible; width: 370px; top: 11643px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-31"><ul>
<li class="two_line" reference_id="R3">
<a href="/pubmed/24986711/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Bone morbidity in childhood leukemia: epidemiology, mechanisms, diagnosis, and treatment.</a><span class="one_line_source">[Curr Osteoporos Rep.  2014]</span><div class="alt-note">
<div class="authors">Mostoufi-Moab S, Halton J</div>
<div class="citation">Curr Osteoporos Rep. 2014 Sep; 12(3):300-12.</div>
</div>
</li>
<li class="two_line" reference_id="R28">
<a href="/pubmed/24585546/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Bone mineral density among long-term survivors of childhood acute lymphoblastic leukemia: results from the St. Jude Lifetime Cohort Study.</a><span class="one_line_source">[Pediatr Blood Cancer.  2014]</span><div class="alt-note">
<div class="authors">Gurney JG, Kaste SC, Liu W, Srivastava DK, Chemaitilly W, Ness KK, Lanctot JQ, Ojha RP, Nottage KA, Wilson CL, Li Z, Robison LL, Hudson MM</div>
<div class="citation">Pediatr Blood Cancer. 2014 Jul; 61(7):1270-6.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P30" name="crb--P30" rid="P30" style="position: absolute; visibility: visible; width: 370px; top: 12029px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-32"><ul>
<li class="two_line" reference_id="R13">
<a href="/pubmed/24395288/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Calcium and cholecalciferol supplementation provides no added benefit to nutritional counseling to improve bone mineral density in survivors of childhood acute lymphoblastic leukemia (ALL).</a><span class="one_line_source">[Pediatr Blood Cancer.  2014]</span><div class="alt-note">
<div class="authors">Kaste SC, Qi A, Smith K, Surprise H, Lovorn E, Boyett J, Ferry RJ Jr, Relling MV, Shurtleff SA, Pui CH, Carbone L, Hudson MM, Ness KK</div>
<div class="citation">Pediatr Blood Cancer. 2014 May; 61(5):885-93.</div>
</div>
</li>
<li class="two_line" reference_id="R29">
<a href="/pubmed/19283791/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">A randomized trial investigating an exercise program to prevent reduction of bone mineral density and impairment of motor performance during treatment for childhood acute lymphoblastic leukemia.</a><span class="one_line_source">[Pediatr Blood Cancer.  2009]</span><div class="alt-note">
<div class="authors">Hartman A, te Winkel ML, van Beek RD, de Muinck Keizer-Schrama SM, Kemper HC, Hop WC, van den Heuvel-Eibrink MM, Pieters R</div>
<div class="citation">Pediatr Blood Cancer. 2009 Jul; 53(1):64-71.</div>
</div>
</li>
<li class="two_line" reference_id="R30">
<a href="/pubmed/15040821/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Prevention of postmenopausal bone loss by a low-magnitude, high-frequency mechanical stimuli: a clinical trial assessing compliance, efficacy, and safety.</a><span class="one_line_source">[J Bone Miner Res.  2004]</span><div class="alt-note">
<div class="authors">Rubin C, Recker R, Cullen D, Ryaby J, McCabe J, McLeod K</div>
<div class="citation">J Bone Miner Res. 2004 Mar; 19(3):343-51.</div>
</div>
</li>
<li class="two_line" reference_id="R31">
<a href="/pubmed/27718512/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Feasibility and tolerability of whole-body, low-intensity vibration and its effects on muscle function and bone in patients with dystrophinopathies: a pilot study.</a><span class="one_line_source">[Muscle Nerve.  2017]</span><div class="alt-note">
<div class="authors">Petryk A, Polgreen LE, Grames M, Lowe DA, Hodges JS, Karachunski P</div>
<div class="citation">Muscle Nerve. 2017 Jun; 55(6):875-883.</div>
</div>
</li>
<li class="two_line" reference_id="R32">
<a href="/pubmed/26967465/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Effect of Low-Magnitude, High-Frequency Mechanical Stimulation on BMD Among Young Childhood Cancer Survivors: A Randomized Clinical Trial.</a><span class="one_line_source">[JAMA Oncol.  2016]</span><div class="alt-note">
<div class="authors">Mogil RJ, Kaste SC, Ferry RJ Jr, Hudson MM, Mulrooney DA, Howell CR, Partin RE, Srivastava DK, Robison LL, Ness KK</div>
<div class="citation">JAMA Oncol. 2016 Jul 1; 2(7):908-14.</div>
</div>
</li>
<li class="two_line" reference_id="R33">
<a href="/pubmed/12116079/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Osteopenia in children with acute lymphoblastic leukemia: a pilot study of amelioration with Pamidronate.</a><span class="one_line_source">[Med Pediatr Oncol.  2002]</span><div class="alt-note">
<div class="authors">Barr RD, Guo CY, Wiernikowski J, Webber C, Wright M, Atkinson S</div>
<div class="citation">Med Pediatr Oncol. 2002 Jul; 39(1):44-6.</div>
</div>
</li>
<li class="two_line" reference_id="R35">
<a href="/pubmed/25761434/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Switching of oral bisphosphonates to denosumab in chronic glucocorticoid users: a 12-month randomized controlled trial.</a><span class="one_line_source">[Bone.  2015]</span><div class="alt-note">
<div class="authors">Mok CC, Ho LY, Ma KM</div>
<div class="citation">Bone. 2015 Jun; 75():222-8.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P31" name="crb--P31" rid="P31" style="position: absolute; visibility: visible; width: 370px; top: 12395px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-33"><ul>
<li class="two_line" reference_id="R36">
<a href="/pubmed/12868119/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Assessment of bone health in children and adolescents with cancer: promises and pitfalls of current techniques.</a><span class="one_line_source">[Med Pediatr Oncol.  2003]</span><div class="alt-note">
<div class="authors">Leonard MB</div>
<div class="citation">Med Pediatr Oncol. 2003 Sep; 41(3):198-207.</div>
</div>
</li>
<li class="two_line" reference_id="R37">
<a href="/pubmed/16602115/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">QCT versus DXA in 320 survivors of childhood cancer: association of BMD with fracture history.</a><span class="one_line_source">[Pediatr Blood Cancer.  2006]</span><div class="alt-note">
<div class="authors">Kaste SC, Tong X, Hendrick JM, Karimova EJ, Srivastava DK, Tylavsky FA, Snider TL, Carbone LD</div>
<div class="citation">Pediatr Blood Cancer. 2006 Dec; 47(7):936-43.</div>
</div>
</li>
<li class="two_line" reference_id="R38">
<a href="/pubmed/6766220/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Comparison of vertebral and peripheral mineral losses in disuse osteoporosis in monkeys.</a><span class="one_line_source">[Radiology.  1980]</span><div class="alt-note">
<div class="authors">Cann CE, Genant HK, Young DR</div>
<div class="citation">Radiology. 1980 Feb; 134(2):525-9.</div>
</div>
</li>
<li class="two_line" reference_id="R14">
<a href="/pubmed/3340782/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Vertebral bone density in children: effect of puberty.</a><span class="one_line_source">[Radiology.  1988]</span><div class="alt-note">
<div class="authors">Gilsanz V, Gibbens DT, Roe TF, Carlson M, Senac MO, Boechat MI, Huang HK, Schulz EE, Libanati CR, Cann CC</div>
<div class="citation">Radiology. 1988 Mar; 166(3):847-50.</div>
</div>
</li>
<li class="two_line" reference_id="R39">
<a href="/pubmed/1944449/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Changes in vertebral bone density in black girls and white girls during childhood and puberty.</a><span class="one_line_source">[N Engl J Med.  1991]</span><div class="alt-note">
<div class="authors">Gilsanz V, Roe TF, Mora S, Costin G, Goodman WG</div>
<div class="citation">N Engl J Med. 1991 Dec 5; 325(23):1597-600.</div>
</div>
</li>
<li class="two_line" reference_id="R20">
<a href="/pubmed/22190454/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Predictors of bony morbidity in children with acute lymphoblastic leukemia.</a><span class="one_line_source">[Pediatr Blood Cancer.  2012]</span><div class="alt-note">
<div class="authors">Rayar MS, Nayiager T, Webber CE, Barr RD, Athale UH</div>
<div class="citation">Pediatr Blood Cancer. 2012 Jul 15; 59(1):77-82.</div>
</div>
</li>
<li class="two_line" reference_id="R40">
<a href="/pubmed/3994856/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Quantitative computed tomography for prediction of vertebral fracture risk.</a><span class="one_line_source">[Bone.  1985]</span><div class="alt-note">
<div class="authors">Cann CE, Genant HK, Kolb FO, Ettinger B</div>
<div class="citation">Bone. 1985; 6(1):1-7.</div>
</div>
</li>
<li class="two_line" reference_id="R41">
<a href="/pubmed/24287213/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Bone mineral density at diagnosis determines fracture rate in children with acute lymphoblastic leukemia treated according to the DCOG-ALL9 protocol.</a><span class="one_line_source">[Bone.  2014]</span><div class="alt-note">
<div class="authors">te Winkel ML, Pieters R, Hop WC, Roos JC, Bökkerink JP, Leeuw JA, Bruin MC, Kollen WJ, Veerman AJ, de Groot-Kruseman HA, van der Sluis IM, van den Heuvel-Eibrink MM</div>
<div class="citation">Bone. 2014 Feb; 59():223-8.</div>
</div>
</li>
</ul></div>
</div>
</div>   
    </div>
                
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script>
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>



<div id="body-link-poppers"><div id="body-link-popper-R1" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> Acute lymphoblastic leukaemia.<div class="authors">Inaba H, Greaves M, Mullighan CG</div><div class="citation">Lancet. 2013 Jun 1; 381(9881):1943-55.</div><p>[<a href="/pubmed/23523389/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R1">Ref list</a>]</p></div><div id="body-link-popper-R2" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Effects of sex, race, and puberty on cortical bone and the functional muscle bone unit in children, adolescents, and young adults.<div class="authors">Leonard MB, Elmi A, Mostoufi-Moab S, Shults J, Burnham JM, Thayu M, Kibe L, Wetzsteon RJ, Zemel BS</div><div class="citation">J Clin Endocrinol Metab. 2010 Apr; 95(4):1681-9.</div><p>[<a href="/pubmed/20157194/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R2">Ref list</a>]</p></div><div id="body-link-popper-R3" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> Bone morbidity in childhood leukemia: epidemiology, mechanisms, diagnosis, and treatment.<div class="authors">Mostoufi-Moab S, Halton J</div><div class="citation">Curr Osteoporos Rep. 2014 Sep; 12(3):300-12.</div><p>[<a href="/pubmed/24986711/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R3">Ref list</a>]</p></div><div id="body-link-popper-R6" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Bony morbidity in children treated for acute lymphoblastic leukemia.<div class="authors">Strauss AJ, Su JT, Dalton VM, Gelber RD, Sallan SE, Silverman LB</div><div class="citation">J Clin Oncol. 2001 Jun 15; 19(12):3066-72.</div><p>[<a href="/pubmed/11408503/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R6">Ref list</a>]</p></div><div id="body-link-popper-R7" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Treating childhood acute lymphoblastic leukemia without cranial irradiation.<div class="authors">Pui CH, Campana D, Pei D, Bowman WP, Sandlund JT, Kaste SC, Ribeiro RC, Rubnitz JE, Raimondi SC, Onciu M, Coustan-Smith E, Kun LE, Jeha S, Cheng C, Howard SC, Simmons V, Bayles A, Metzger ML, Boyett JM, Leung W, Handgretinger R, Downing JR, Evans WE, Relling MV</div><div class="citation">N Engl J Med. 2009 Jun 25; 360(26):2730-41.</div><p>[<a href="/pubmed/19553647/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R7">Ref list</a>]</p></div><div id="body-link-popper-R8" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Pharmacogenetic risk factors for altered bone mineral density and body composition in pediatric acute lymphoblastic leukemia.<div class="authors">te Winkel ML, van Beek RD, de Muinck Keizer-Schrama SM, Uitterlinden AG, Hop WC, Pieters R, van den Heuvel-Eibrink MM</div><div class="citation">Haematologica. 2010 May; 95(5):752-9.</div><p>[<a href="/pubmed/20015871/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R8">Ref list</a>]</p></div><div id="body-link-popper-R9" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Germline variation in the MTHFR and MTRR genes determines the nadir of bone density in pediatric acute lymphoblastic leukemia: a prospective study.<div class="authors">te Winkel ML, de Muinck Keizer-Schrama SM, de Jonge R, van Beek RD, van der Sluis IM, Hop WC, Pieters R, van den Heuvel-Eibrink MM</div><div class="citation">Bone. 2011 Mar 1; 48(3):571-7.</div><p>[<a href="/pubmed/20955826/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R9">Ref list</a>]</p></div><div id="body-link-popper-R10" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">CRHR1 polymorphisms predict bone density in survivors of acute lymphoblastic leukemia.<div class="authors">Jones TS, Kaste SC, Liu W, Cheng C, Yang W, Tantisira KG, Pui CH, Relling MV</div><div class="citation">J Clin Oncol. 2008 Jun 20; 26(18):3031-7.</div><p>[<a href="/pubmed/18565889/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R10">Ref list</a>]</p></div><div id="body-link-popper-R11" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">A genetic factor associated with low final bone mineral density in children after a long-term glucocorticoids treatment.<div class="authors">Park HW, Tse S, Yang W, Kelly HW, Kaste SC, Pui CH, Relling MV, Tantisira KG</div><div class="citation">Pharmacogenomics J. 2017 Mar; 17(2):180-185.</div><p>[<a href="/pubmed/26856247/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R11">Ref list</a>]</p></div><div id="body-link-popper-R12" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemia.<div class="authors">Kawedia JD, Kaste SC, Pei D, Panetta JC, Cai X, Cheng C, Neale G, Howard SC, Evans WE, Pui CH, Relling MV</div><div class="citation">Blood. 2011 Feb 24; 117(8):2340-7; quiz 2556.</div><p>[<a href="/pubmed/21148812/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R12">Ref list</a>]</p></div><div id="body-link-popper-R13" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Calcium and cholecalciferol supplementation provides no added benefit to nutritional counseling to improve bone mineral density in survivors of childhood acute lymphoblastic leukemia (ALL).<div class="authors">Kaste SC, Qi A, Smith K, Surprise H, Lovorn E, Boyett J, Ferry RJ Jr, Relling MV, Shurtleff SA, Pui CH, Carbone L, Hudson MM, Ness KK</div><div class="citation">Pediatr Blood Cancer. 2014 May; 61(5):885-93.</div><p>[<a href="/pubmed/24395288/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R13">Ref list</a>]</p></div><div id="body-link-popper-R14" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Vertebral bone density in children: effect of puberty.<div class="authors">Gilsanz V, Gibbens DT, Roe TF, Carlson M, Senac MO, Boechat MI, Huang HK, Schulz EE, Libanati CR, Cann CC</div><div class="citation">Radiology. 1988 Mar; 166(3):847-50.</div><p>[<a href="/pubmed/3340782/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R14">Ref list</a>]</p></div><div id="body-link-popper-R15" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Asparaginase may influence dexamethasone pharmacokinetics in acute lymphoblastic leukemia.<div class="authors">Yang L, Panetta JC, Cai X, Yang W, Pei D, Cheng C, Kornegay N, Pui CH, Relling MV</div><div class="citation">J Clin Oncol. 2008 Apr 20; 26(12):1932-9.</div><p>[<a href="/pubmed/18421047/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R15">Ref list</a>]</p></div><div id="body-link-popper-R16" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Shortening infusion time for high-dose methotrexate alters antileukemic effects: a randomized prospective clinical trial.<div class="authors">Mikkelsen TS, Sparreboom A, Cheng C, Zhou Y, Boyett JM, Raimondi SC, Panetta JC, Bowman WP, Sandlund JT, Pui CH, Relling MV, Evans WE</div><div class="citation">J Clin Oncol. 2011 May 1; 29(13):1771-8.</div><p>[<a href="/pubmed/21444869/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R16">Ref list</a>]</p></div><div id="body-link-popper-R17" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Between-course targeting of methotrexate exposure using pharmacokinetically guided dosage adjustments.<div class="authors">Pauley JL, Panetta JC, Crews KR, Pei D, Cheng C, McCormick J, Howard SC, Sandlund JT, Jeha S, Ribeiro R, Rubnitz J, Pui CH, Evans WE, Relling MV</div><div class="citation">Cancer Chemother Pharmacol. 2013 Aug; 72(2):369-78.</div><p>[<a href="/pubmed/23760811/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R17">Ref list</a>]</p></div><div id="body-link-popper-R18" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Statistical significance threshold criteria for analysis of microarray gene expression data.<div class="authors">Cheng C, Pounds SB, Boyett JM, Pei D, Kuo ML, Roussel MF</div><div class="citation">Stat Appl Genet Mol Biol. 2004; 3():Article36.</div><p>[<a href="/pubmed/16646816/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R18">Ref list</a>]</p></div><div id="body-link-popper-R4" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Altered bone mineral density and body composition, and increased fracture risk in childhood acute lymphoblastic leukemia.<div class="authors">van der Sluis IM, van den Heuvel-Eibrink MM, Hählen K, Krenning EP, de Muinck Keizer-Schrama SM</div><div class="citation">J Pediatr. 2002 Aug; 141(2):204-10.</div><p>[<a href="/pubmed/12183715/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R4">Ref list</a>]</p></div><div id="body-link-popper-R19" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Effects of pubertal development, height, weight, and grip strength on the bone mineral density of the lumbar spine and hip in peripubertal Japanese children: Kyoto kids increase density in the skeleton study (Kyoto KIDS study).<div class="authors">Naka H, Iki M, Morita A, Ikeda Y</div><div class="citation">J Bone Miner Metab. 2005; 23(6):463-9.</div><p>[<a href="/pubmed/16261453/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R19">Ref list</a>]</p></div><div id="body-link-popper-R20" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Predictors of bony morbidity in children with acute lymphoblastic leukemia.<div class="authors">Rayar MS, Nayiager T, Webber CE, Barr RD, Athale UH</div><div class="citation">Pediatr Blood Cancer. 2012 Jul 15; 59(1):77-82.</div><p>[<a href="/pubmed/22190454/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R20">Ref list</a>]</p></div><div id="body-link-popper-R21" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Cellular mechanisms for methotrexate chemotherapy-induced bone growth defects.<div class="authors">Xian CJ, Cool JC, Scherer MA, Macsai CE, Fan C, Covino M, Foster BK</div><div class="citation">Bone. 2007 Nov; 41(5):842-50.</div><p>[<a href="/pubmed/17884747/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R21">Ref list</a>]</p></div><div id="body-link-popper-R22" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> The effect of chemotherapy on the growing skeleton.<div class="authors">van Leeuwen BL, Kamps WA, Jansen HW, Hoekstra HJ</div><div class="citation">Cancer Treat Rev. 2000 Oct; 26(5):363-76.</div><p>[<a href="/pubmed/11006137/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R22">Ref list</a>]</p></div><div id="body-link-popper-R23" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">A fibrillar collagen gene, Col11a1, is essential for skeletal morphogenesis.<div class="authors">Li Y, Lacerda DA, Warman ML, Beier DR, Yoshioka H, Ninomiya Y, Oxford JT, Morris NP, Andrikopoulos K, Ramirez F</div><div class="citation">Cell. 1995 Feb 10; 80(3):423-30.</div><p>[<a href="/pubmed/7859283/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R23">Ref list</a>]</p></div><div id="body-link-popper-R24" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">NELL-1 in the treatment of osteoporotic bone loss.<div class="authors">James AW, Shen J, Zhang X, Asatrian G, Goyal R, Kwak JH, Jiang L, Bengs B, Culiat CT, Turner AS, Seim Iii HB, Wu BM, Lyons K, Adams JS, Ting K, Soo C</div><div class="citation">Nat Commun. 2015 Jun 17; 6():7362.</div><p>[<a href="/pubmed/26082355/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R24">Ref list</a>]</p></div><div id="body-link-popper-R25" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Nuclear factor I transcription factors regulate IGF binding protein 5 gene transcription in human osteoblasts.<div class="authors">Pérez-Casellas LA, Wang X, Howard KD, Rehage MW, Strong DD, Linkhart TA</div><div class="citation">Biochim Biophys Acta. 2009 Feb; 1789(2):78-87.</div><p>[<a href="/pubmed/18809517/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R25">Ref list</a>]</p></div><div id="body-link-popper-R26" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">An overlapping set of genes is regulated by both NFIB and the glucocorticoid receptor during lung maturation.<div class="authors">Lajoie M, Hsu YC, Gronostajski RM, Bailey TL</div><div class="citation">BMC Genomics. 2014 Mar 25; 15():231.</div><p>[<a href="/pubmed/24661679/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R26">Ref list</a>]</p></div><div id="body-link-popper-R27" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Hierarchy within the mammary STAT5-driven Wap super-enhancer.<div class="authors">Shin HY, Willi M, HyunYoo K, Zeng X, Wang C, Metser G, Hennighausen L</div><div class="citation">Nat Genet. 2016 Aug; 48(8):904-911.</div><p>[<a href="/pubmed/27376239/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R27">Ref list</a>]</p></div><div id="body-link-popper-R28" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Bone mineral density among long-term survivors of childhood acute lymphoblastic leukemia: results from the St. Jude Lifetime Cohort Study.<div class="authors">Gurney JG, Kaste SC, Liu W, Srivastava DK, Chemaitilly W, Ness KK, Lanctot JQ, Ojha RP, Nottage KA, Wilson CL, Li Z, Robison LL, Hudson MM</div><div class="citation">Pediatr Blood Cancer. 2014 Jul; 61(7):1270-6.</div><p>[<a href="/pubmed/24585546/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R28">Ref list</a>]</p></div><div id="body-link-popper-R29" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">A randomized trial investigating an exercise program to prevent reduction of bone mineral density and impairment of motor performance during treatment for childhood acute lymphoblastic leukemia.<div class="authors">Hartman A, te Winkel ML, van Beek RD, de Muinck Keizer-Schrama SM, Kemper HC, Hop WC, van den Heuvel-Eibrink MM, Pieters R</div><div class="citation">Pediatr Blood Cancer. 2009 Jul; 53(1):64-71.</div><p>[<a href="/pubmed/19283791/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R29">Ref list</a>]</p></div><div id="body-link-popper-R30" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Prevention of postmenopausal bone loss by a low-magnitude, high-frequency mechanical stimuli: a clinical trial assessing compliance, efficacy, and safety.<div class="authors">Rubin C, Recker R, Cullen D, Ryaby J, McCabe J, McLeod K</div><div class="citation">J Bone Miner Res. 2004 Mar; 19(3):343-51.</div><p>[<a href="/pubmed/15040821/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R30">Ref list</a>]</p></div><div id="body-link-popper-R31" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Feasibility and tolerability of whole-body, low-intensity vibration and its effects on muscle function and bone in patients with dystrophinopathies: a pilot study.<div class="authors">Petryk A, Polgreen LE, Grames M, Lowe DA, Hodges JS, Karachunski P</div><div class="citation">Muscle Nerve. 2017 Jun; 55(6):875-883.</div><p>[<a href="/pubmed/27718512/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R31">Ref list</a>]</p></div><div id="body-link-popper-R32" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Effect of Low-Magnitude, High-Frequency Mechanical Stimulation on BMD Among Young Childhood Cancer Survivors: A Randomized Clinical Trial.<div class="authors">Mogil RJ, Kaste SC, Ferry RJ Jr, Hudson MM, Mulrooney DA, Howell CR, Partin RE, Srivastava DK, Robison LL, Ness KK</div><div class="citation">JAMA Oncol. 2016 Jul 1; 2(7):908-14.</div><p>[<a href="/pubmed/26967465/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R32">Ref list</a>]</p></div><div id="body-link-popper-R33" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Osteopenia in children with acute lymphoblastic leukemia: a pilot study of amelioration with Pamidronate.<div class="authors">Barr RD, Guo CY, Wiernikowski J, Webber C, Wright M, Atkinson S</div><div class="citation">Med Pediatr Oncol. 2002 Jul; 39(1):44-6.</div><p>[<a href="/pubmed/12116079/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R33">Ref list</a>]</p></div><div id="body-link-popper-R35" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Switching of oral bisphosphonates to denosumab in chronic glucocorticoid users: a 12-month randomized controlled trial.<div class="authors">Mok CC, Ho LY, Ma KM</div><div class="citation">Bone. 2015 Jun; 75():222-8.</div><p>[<a href="/pubmed/25761434/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R35">Ref list</a>]</p></div><div id="body-link-popper-R36" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> Assessment of bone health in children and adolescents with cancer: promises and pitfalls of current techniques.<div class="authors">Leonard MB</div><div class="citation">Med Pediatr Oncol. 2003 Sep; 41(3):198-207.</div><p>[<a href="/pubmed/12868119/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R36">Ref list</a>]</p></div><div id="body-link-popper-R37" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">QCT versus DXA in 320 survivors of childhood cancer: association of BMD with fracture history.<div class="authors">Kaste SC, Tong X, Hendrick JM, Karimova EJ, Srivastava DK, Tylavsky FA, Snider TL, Carbone LD</div><div class="citation">Pediatr Blood Cancer. 2006 Dec; 47(7):936-43.</div><p>[<a href="/pubmed/16602115/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R37">Ref list</a>]</p></div><div id="body-link-popper-R38" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Comparison of vertebral and peripheral mineral losses in disuse osteoporosis in monkeys.<div class="authors">Cann CE, Genant HK, Young DR</div><div class="citation">Radiology. 1980 Feb; 134(2):525-9.</div><p>[<a href="/pubmed/6766220/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R38">Ref list</a>]</p></div><div id="body-link-popper-R39" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Changes in vertebral bone density in black girls and white girls during childhood and puberty.<div class="authors">Gilsanz V, Roe TF, Mora S, Costin G, Goodman WG</div><div class="citation">N Engl J Med. 1991 Dec 5; 325(23):1597-600.</div><p>[<a href="/pubmed/1944449/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R39">Ref list</a>]</p></div><div id="body-link-popper-R40" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Quantitative computed tomography for prediction of vertebral fracture risk.<div class="authors">Cann CE, Genant HK, Kolb FO, Ettinger B</div><div class="citation">Bone. 1985; 6(1):1-7.</div><p>[<a href="/pubmed/3994856/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R40">Ref list</a>]</p></div><div id="body-link-popper-R41" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Bone mineral density at diagnosis determines fracture rate in children with acute lymphoblastic leukemia treated according to the DCOG-ALL9 protocol.<div class="authors">te Winkel ML, Pieters R, Hop WC, Roos JC, Bökkerink JP, Leeuw JA, Bruin MC, Kollen WJ, Veerman AJ, de Groot-Kruseman HA, van der Sluis IM, van den Heuvel-Eibrink MM</div><div class="citation">Bone. 2014 Feb; 59():223-8.</div><p>[<a href="/pubmed/24287213/" ref="reftype=pubmed&amp;article-id=5821586&amp;issue-id=307045&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R41">Ref list</a>]</p></div></div>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-11-20T16:50:17-05:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=portal106&amp;ncbi_phid=CE8D1C79DD5A5081000000000985057A&amp;ncbi_session=CE8C6010DD4F8B31_0740SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5821586%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        <div class="ui-ncbiautocomplete-holder shadow ui-ncbiautocomplete-holder-clearfix" aria-live="assertive" style="display: none; top: 68.1px; left: 377.2px; width: 670px; z-index: 1001;"><ul class="ui-ncbiautocomplete-options" role="listbox" aria-activedescendant="term"></ul><div class="ui-ncbiautocomplete-actions shadow" style="display: block;"><a class="ui-ncbiautocomplete-link-pref" style="display: none;">Preferences</a><a href="#" class="ui-ncbiautocomplete-link-off ui-ncbiautocomplete-link-pref-right" style="display: block;">Turn off</a></div></div><div style="display: none; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic">External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.</div></div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=nihpa&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC5821586/&amp;ncbi_app=pmc" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8C6010DD4F8B31_0740SID /projects/PMC/PMCViewer@4.46 portal106 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script>
<div class="ui-dialog ui-widget ui-widget-content ui-corner-all ui-front" style="display: none;" tabindex="-1" role="dialog" aria-describedby="epubDialog" aria-labelledby="ui-id-1"><div class="ui-dialog-titlebar ui-widget-header ui-corner-all ui-helper-clearfix"><span id="ui-id-1" class="ui-dialog-title">Making articles easier to read in PMC</span><button type="button" class="ui-button ui-widget ui-state-default ui-corner-all ui-button-icon-only ui-dialog-titlebar-close" role="button" title="Close"><span class="ui-button-icon-primary ui-icon ui-icon-closethick"></span><span class="ui-button-text">Close</span></button></div><div id="epubDialog" style="display: block;" class="ui-dialog-content ui-widget-content">  <p>We are experimenting with display styles that make it easier to read articles     in PMC.     Our first effort uses eBook readers, which have several "ease of reading"     features already built in.</p>  <p>These PMC articles are best viewed in the <em>iBooks     reader</em>. You may notice problems with the display of certain parts of an article     in other eReaders.</p>  <div class="ui-dialog-buttonpane ui-widget-content ui-helper-clearfix"><button id="cancelEpub" class="ui-state-default ui-corner-all">Cancel</button><button id="downloadEpub" style="float: left" class="ui-state-default ui-corner-all">Download article</button></div>          </div></div></body></html>